IMMZDAK vs IMMZDAK

CodeSystem Comparison between http://smart.who.int/immunizations/CodeSystem/IMMZDAK vs http://smart.who.int/immunizations/CodeSystem/IMMZDAK

Messages

Error

CodeSystem.version

Values for version differ: '1.0.0' vs '0.2.0'

Information

CodeSystem.date

Values for date differ: '2026-10-02T09:40:20+00:00' vs '2026-10-06T15:33:49+00:00'

Information

CodeSystem.jurisdiction

Added the item 'null#null'

Metadata

Name	Value	Comments
caseSensitive	false
compositional
content	complete
copyright
date	2026-10-02T09:40:20+00:00	2026-10-06T15:33:49+00:00	Values Differ
description	CodeSystem for Decision Tables for the Immunization DAK
experimental	false
hierarchyMeaning
jurisdiction
jurisdiction[0]		null#null	Added the item 'null#null'
name	IMMZDAK
publisher	WHO
purpose
status	active
title	IMMZDAK CodeSystem for Decision Tables
url	http://smart.who.int/immunizations/CodeSystem/IMMZDAK
version	1.0.0	0.2.0	Values Differ
versionNeeded

Name

Value

Comments

caseSensitive

false

compositional

content

complete

date

2026-10-02T09:40:20+00:00

2026-10-06T15:33:49+00:00

Values Differ

description

CodeSystem for Decision Tables for the Immunization DAK

experimental

false

hierarchyMeaning

jurisdiction

jurisdiction[0]

null#null

Added the item 'null#null'

name

IMMZDAK

publisher

WHO

purpose

status

active

title

IMMZDAK CodeSystem for Decision Tables

url

http://smart.who.int/immunizations/CodeSystem/IMMZDAK

version

1.0.0

0.2.0

Values Differ

versionNeeded

Concepts

Code	Display	table	table	Comments
At least one booster dose was administered-110	At least one booster dose was administered	IMMZ.D2.DT.TBE.Encepur Inputs	IMMZ.D2.DT.TBE.Encepur Inputs	IMMZ.D2.DT.TBE.Encepur Inputs	IMMZ.D2.DT.TBE.Encepur Inputs
At least one booster series dose was administered-115	At least one booster series dose was administered	IMMZ.D2.DT.Cholera.WC vaccines Inputs	IMMZ.D2.DT.Cholera.WC vaccines Inputs	IMMZ.D2.DT.Cholera.WC vaccines Inputs	IMMZ.D2.DT.Cholera.WC vaccines Inputs
At least one cholera primary series dose was administered-117	At least one cholera primary series dose was administered	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs
BCG immunization schedule is complete-140	BCG immunization schedule is complete	IMMZ.D2.DT.BCG Output	IMMZ.D2.DT.BCG Output	IMMZ.D2.DT.BCG Output	IMMZ.D2.DT.BCG Output
BCG vaccination could be contraindicated. Clinical judgement is required. Create a clinical note.-67	BCG vaccination could be contraindicated. Clinical judgement is required. Create a clinical note.	IMMZ.D5.DT.BCG contraindications Output	IMMZ.D5.DT.BCG contraindications Output	IMMZ.D5.DT.BCG contraindications Output	IMMZ.D5.DT.BCG contraindications Output
BCG vaccination is contraindicated-57	BCG vaccination is contraindicated	IMMZ.D5.DT.BCG contraindications Output	IMMZ.D5.DT.BCG contraindications Output	IMMZ.D5.DT.BCG contraindications Output	IMMZ.D5.DT.BCG contraindications Output
Bacille Calmette–Guérin (BCG) vaccination is contraindicated-57	Bacille Calmette–Guérin (BCG) vaccination is contraindicated	IMMZ.D5.DT.BCG contraindications Output	IMMZ.D5.DT.BCG contraindications Output	IMMZ.D5.DT.BCG contraindications Output	IMMZ.D5.DT.BCG contraindications Output
Booster IPV dose was administered. Polio immunization schedule has been completed-112	Booster IPV dose was administered. Polio immunization schedule has been completed	IMMZ.D18.S.Polio.IPV-only schedule Completion	IMMZ.D18.S.Polio.IPV-only schedule Completion	IMMZ.D18.S.Polio.IPV-only schedule Completion	IMMZ.D18.S.Polio.IPV-only schedule Completion
Booster dose was administered approximately less than 2 years ago-175	Booster dose was administered approximately less than 2 years ago	IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Completion	IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Completion	IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Completion	IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Completion
Booster dose was administered approximately less than 6 months ago-176	Booster dose was administered approximately less than 6 months ago	IMMZ.D18.S.Cholera.WC-rBS vaccine 3-dose schedule Completion	IMMZ.D18.S.Cholera.WC-rBS vaccine 3-dose schedule Completion	IMMZ.D18.S.Cholera.WC-rBS vaccine 3-dose schedule Completion	IMMZ.D18.S.Cholera.WC-rBS vaccine 3-dose schedule Completion
Booster series is complete-81	Booster series is complete	IMMZ.D2.DT.Cholera.WC vaccines Output	IMMZ.D2.DT.Cholera.WC vaccines Output	IMMZ.D2.DT.Cholera.WC vaccines Output	IMMZ.D2.DT.Cholera.WC vaccines Output
Child's birth and no cholera doses have been administered-134	Child's birth and no cholera doses have been administered	IMMZ.D18.S.Cholera.WC vaccines schedule Trigger	IMMZ.D18.S.Cholera.WC vaccines schedule Trigger	IMMZ.D18.S.Cholera.WC vaccines schedule Trigger	IMMZ.D18.S.Cholera.WC vaccines schedule Trigger
Child's birth when client's biological sex is female-34	Child's birth when client's biological sex is female	IMMZ.D18.S.HPV.2-dose schedule Trigger	IMMZ.D18.S.HPV.2-dose schedule Trigger	IMMZ.D18.S.HPV.2-dose schedule Trigger	IMMZ.D18.S.HPV.2-dose schedule Trigger
Child's birth-0	Child's birth	IMMZ.D18.S.Varicella.2-dose schedule Trigger	IMMZ.D18.S.Varicella.2-dose schedule Trigger	IMMZ.D18.S.Varicella.2-dose schedule Trigger	IMMZ.D18.S.Varicella.2-dose schedule Trigger
Child's birth-761	Child's birth	IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Trigger	IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Trigger	IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Trigger	IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Trigger
Child's birth-792	Child's birth	IMMZ.D18.S.Cholera.WC-rBS vaccine 3-dose schedule Trigger	IMMZ.D18.S.Cholera.WC-rBS vaccine 3-dose schedule Trigger	IMMZ.D18.S.Cholera.WC-rBS vaccine 3-dose schedule Trigger	IMMZ.D18.S.Cholera.WC-rBS vaccine 3-dose schedule Trigger
Client did not have preterm birth-22	Client did not have preterm birth	IMMZ.D2.DT.Pneumococcal.3 doses Inputs	IMMZ.D2.DT.Pneumococcal.3 doses Inputs	IMMZ.D2.DT.Pneumococcal.3 doses Inputs	IMMZ.D2.DT.Pneumococcal.3 doses Inputs
Client had preterm birth-22	Client had preterm birth	IMMZ.D2.DT.Pneumococcal.3 doses Inputs	IMMZ.D2.DT.Pneumococcal.3 doses Inputs	IMMZ.D2.DT.Pneumococcal.3 doses Inputs	IMMZ.D2.DT.Pneumococcal.3 doses Inputs
Client is at high risk for pneumococcal infection-48	Client is at high risk for pneumococcal infection	IMMZ.D2.DT.Pneumococcal.3 doses Inputs	IMMZ.D2.DT.Pneumococcal.3 doses Inputs	IMMZ.D2.DT.Pneumococcal.3 doses Inputs	IMMZ.D2.DT.Pneumococcal.3 doses Inputs
Client is clinically well-24	Client is clinically well	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs
Client is currently not receiving antiretroviral therapy-26	Client is currently not receiving antiretroviral therapy	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs
Client is currently pregnant-27	Client is currently pregnant	IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Inputs	IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Inputs	IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Inputs	IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Inputs
Client is currently receiving antiretroviral therapy-25	Client is currently receiving antiretroviral therapy	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs
Client is due for BCG vaccination-44	Client is due for BCG vaccination	IMMZ.D2.DT.BCG Output	IMMZ.D2.DT.BCG Output	IMMZ.D2.DT.BCG Output	IMMZ.D2.DT.BCG Output
Client is due for DTP vaccination-95	Client is due for DTP vaccination	IMMZ.D2.DT.DTP.Delayed or interrupted series Output	IMMZ.D2.DT.DTP.Delayed or interrupted series Output	IMMZ.D2.DT.DTP.Delayed or interrupted series Output	IMMZ.D2.DT.DTP.Delayed or interrupted series Output
Client is due for HPV vaccination-44	Client is due for HPV vaccination	IMMZ.D2.DT.HPV.Single dose Output	IMMZ.D2.DT.HPV.Single dose Output	IMMZ.D2.DT.HPV.Single dose Output	IMMZ.D2.DT.HPV.Single dose Output
Client is due for Hepatitis A vaccination-44	Client is due for Hepatitis A vaccination	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Output	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Output	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Output	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Output
Client is due for Hib vaccination-44	Client is due for Hib vaccination	IMMZ.D2.DT.Hib.2 doses with booster dose Output	IMMZ.D2.DT.Hib.2 doses with booster dose Output	IMMZ.D2.DT.Hib.2 doses with booster dose Output	IMMZ.D2.DT.Hib.2 doses with booster dose Output
Client is due for IPV vaccination-44	Client is due for IPV vaccination	IMMZ.D2.DT.Polio.IPV-only Output	IMMZ.D2.DT.Polio.IPV-only Output	IMMZ.D2.DT.Polio.IPV-only Output	IMMZ.D2.DT.Polio.IPV-only Output
Client is due for IPV vaccination-86	Client is due for IPV vaccination	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Output	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Output	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Output	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Output
Client is due for JE vaccination-44	Client is due for JE vaccination	IMMZ.D2.DT.JE.Live recombinant vaccine Output	IMMZ.D2.DT.JE.Live recombinant vaccine Output	IMMZ.D2.DT.JE.Live recombinant vaccine Output	IMMZ.D2.DT.JE.Live recombinant vaccine Output
Client is due for MCV1-44	Client is due for MCV1	IMMZ.D2.DT.Measles.Low transmission Output	IMMZ.D2.DT.Measles.Low transmission Output	IMMZ.D2.DT.Measles.Low transmission Output	IMMZ.D2.DT.Measles.Low transmission Output
Client is due for MCV2-44	Client is due for MCV2	IMMZ.D2.DT.Measles.Low transmission Output	IMMZ.D2.DT.Measles.Low transmission Output	IMMZ.D2.DT.Measles.Low transmission Output	IMMZ.D2.DT.Measles.Low transmission Output
Client is due for TBE vaccination-44	Client is due for TBE vaccination	IMMZ.D2.DT.TBE.EnceVir Output	IMMZ.D2.DT.TBE.EnceVir Output	IMMZ.D2.DT.TBE.EnceVir Output	IMMZ.D2.DT.TBE.EnceVir Output
Client is due for Typhoid vaccination-44	Client is due for Typhoid vaccination	IMMZ.D2.DT.Typhoid.Ty21a Output	IMMZ.D2.DT.Typhoid.Ty21a Output	IMMZ.D2.DT.Typhoid.Ty21a Output	IMMZ.D2.DT.Typhoid.Ty21a Output
Client is due for bOPV and IPV vaccination-133	Client is due for bOPV and IPV vaccination	IMMZ.D2.DT.Polio.bOPV plus IPV Output	IMMZ.D2.DT.Polio.bOPV plus IPV Output	IMMZ.D2.DT.Polio.bOPV plus IPV Output	IMMZ.D2.DT.Polio.bOPV plus IPV Output
Client is due for bOPV vaccination-87	Client is due for bOPV vaccination	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Output	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Output	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Output	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Output
Client is due for cholera booster dose-44	Client is due for cholera booster dose	IMMZ.D2.DT.Cholera.WC vaccines Output	IMMZ.D2.DT.Cholera.WC vaccines Output	IMMZ.D2.DT.Cholera.WC vaccines Output	IMMZ.D2.DT.Cholera.WC vaccines Output
Client is due for cholera vaccination-155	Client is due for cholera vaccination	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Output	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Output	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Output	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Output
Client is due for cholera vaccination-167	Client is due for cholera vaccination	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Output	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Output	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Output	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Output
Client is due for cholera vaccination-44	Client is due for cholera vaccination	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Output	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Output	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Output	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Output
Client is due for dengue vaccination-44	Client is due for dengue vaccination	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Output	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Output	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Output	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Output
Client is due for malaria vaccination-44	Client is due for malaria vaccination	IMMZ.D2.DT.Malaria Output	IMMZ.D2.DT.Malaria Output	IMMZ.D2.DT.Malaria Output	IMMZ.D2.DT.Malaria Output
Client is due for meningococcal vaccination-44	Client is due for meningococcal vaccination	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Output	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Output	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Output	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Output
Client is due for mumps vaccination-44	Client is due for mumps vaccination	IMMZ.D2.DT.Mumps Output	IMMZ.D2.DT.Mumps Output	IMMZ.D2.DT.Mumps Output	IMMZ.D2.DT.Mumps Output
Client is due for pneumococcal booster dose-44	Client is due for pneumococcal booster dose	IMMZ.D2.DT.Pneumococcal.3 doses Output	IMMZ.D2.DT.Pneumococcal.3 doses Output	IMMZ.D2.DT.Pneumococcal.3 doses Output	IMMZ.D2.DT.Pneumococcal.3 doses Output
Client is due for pneumococcal vaccination-44	Client is due for pneumococcal vaccination	IMMZ.D2.DT.Pneumococcal.3 doses Output	IMMZ.D2.DT.Pneumococcal.3 doses Output	IMMZ.D2.DT.Pneumococcal.3 doses Output	IMMZ.D2.DT.Pneumococcal.3 doses Output
Client is due for rabies vaccination-44	Client is due for rabies vaccination	IMMZ.D2.DT.Rabies Output	IMMZ.D2.DT.Rabies Output	IMMZ.D2.DT.Rabies Output	IMMZ.D2.DT.Rabies Output
Client is due for rotavirus vaccination-44	Client is due for rotavirus vaccination	IMMZ.D2.DT.Rotavirus Output	IMMZ.D2.DT.Rotavirus Output	IMMZ.D2.DT.Rotavirus Output	IMMZ.D2.DT.Rotavirus Output
Client is due for rubella vaccination-44	Client is due for rubella vaccination	IMMZ.D2.DT.Rubella.Low incidence Output	IMMZ.D2.DT.Rubella.Low incidence Output	IMMZ.D2.DT.Rubella.Low incidence Output	IMMZ.D2.DT.Rubella.Low incidence Output
Client is due for tetanus and diphtheria booster dose-114	Client is due for tetanus and diphtheria booster dose	IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Output	IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Output	IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Output	IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Output
Client is due for the bOPV birth dose-87	Client is due for the bOPV birth dose	IMMZ.D2.DT.Polio.Birth dose Output	IMMZ.D2.DT.Polio.Birth dose Output	IMMZ.D2.DT.Polio.Birth dose Output	IMMZ.D2.DT.Polio.Birth dose Output
Client is due for typhoid booster dose-44	Client is due for typhoid booster dose	IMMZ.D2.DT.Typhoid.Ty21a Output	IMMZ.D2.DT.Typhoid.Ty21a Output	IMMZ.D2.DT.Typhoid.Ty21a Output	IMMZ.D2.DT.Typhoid.Ty21a Output
Client is due for yellow fever vaccination-44	Client is due for yellow fever vaccination	IMMZ.D2.DT.Yellow fever Output	IMMZ.D2.DT.Yellow fever Output	IMMZ.D2.DT.Yellow fever Output	IMMZ.D2.DT.Yellow fever Output
Client is immunocompromised-26	Client is immunocompromised	IMMZ.D2.DT.HPV.Single dose Inputs	IMMZ.D2.DT.HPV.Single dose Inputs	IMMZ.D2.DT.HPV.Single dose Inputs	IMMZ.D2.DT.HPV.Single dose Inputs
Client is immunologically stable-31	Client is immunologically stable	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs
Client is not at high risk for pneumococcal infection-49	Client is not at high risk for pneumococcal infection	IMMZ.D2.DT.Pneumococcal.3 doses Inputs	IMMZ.D2.DT.Pneumococcal.3 doses Inputs	IMMZ.D2.DT.Pneumococcal.3 doses Inputs	IMMZ.D2.DT.Pneumococcal.3 doses Inputs
Client is not clinically well-25	Client is not clinically well	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs
Client is not due for BCG vaccination-48	Client is not due for BCG vaccination	IMMZ.D2.DT.BCG Output	IMMZ.D2.DT.BCG Output	IMMZ.D2.DT.BCG Output	IMMZ.D2.DT.BCG Output
Client is not due for DTP vaccination-99	Client is not due for DTP vaccination	IMMZ.D2.DT.DTP.Delayed or interrupted series Output	IMMZ.D2.DT.DTP.Delayed or interrupted series Output	IMMZ.D2.DT.DTP.Delayed or interrupted series Output	IMMZ.D2.DT.DTP.Delayed or interrupted series Output
Client is not due for HPV vaccination-48	Client is not due for HPV vaccination	IMMZ.D2.DT.HPV.Single dose Output	IMMZ.D2.DT.HPV.Single dose Output	IMMZ.D2.DT.HPV.Single dose Output	IMMZ.D2.DT.HPV.Single dose Output
Client is not due for Hepatitis A vaccination-48	Client is not due for Hepatitis A vaccination	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Output	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Output	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Output	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Output
Client is not due for Hib vaccination-48	Client is not due for Hib vaccination	IMMZ.D2.DT.Hib.2 doses with booster dose Output	IMMZ.D2.DT.Hib.2 doses with booster dose Output	IMMZ.D2.DT.Hib.2 doses with booster dose Output	IMMZ.D2.DT.Hib.2 doses with booster dose Output
Client is not due for IPV vaccination-48	Client is not due for IPV vaccination	IMMZ.D2.DT.Polio.IPV-only Output	IMMZ.D2.DT.Polio.IPV-only Output	IMMZ.D2.DT.Polio.IPV-only Output	IMMZ.D2.DT.Polio.IPV-only Output
Client is not due for JE vaccination-48	Client is not due for JE vaccination	IMMZ.D2.DT.JE.Live recombinant vaccine Output	IMMZ.D2.DT.JE.Live recombinant vaccine Output	IMMZ.D2.DT.JE.Live recombinant vaccine Output	IMMZ.D2.DT.JE.Live recombinant vaccine Output
Client is not due for MCV0-48	Client is not due for MCV0	IMMZ.D2.DT.Measles.MCV dose 0 Output	IMMZ.D2.DT.Measles.MCV dose 0 Output	IMMZ.D2.DT.Measles.MCV dose 0 Output	IMMZ.D2.DT.Measles.MCV dose 0 Output
Client is not due for MCV1-48	Client is not due for MCV1	IMMZ.D2.DT.Measles.Low transmission Output	IMMZ.D2.DT.Measles.Low transmission Output	IMMZ.D2.DT.Measles.Low transmission Output	IMMZ.D2.DT.Measles.Low transmission Output
Client is not due for MCV2-48	Client is not due for MCV2	IMMZ.D2.DT.Measles.Low transmission Output	IMMZ.D2.DT.Measles.Low transmission Output	IMMZ.D2.DT.Measles.Low transmission Output	IMMZ.D2.DT.Measles.Low transmission Output
Client is not due for TBE vaccination-48	Client is not due for TBE vaccination	IMMZ.D2.DT.TBE.EnceVir Output	IMMZ.D2.DT.TBE.EnceVir Output	IMMZ.D2.DT.TBE.EnceVir Output	IMMZ.D2.DT.TBE.EnceVir Output
Client is not due for Typhoid vaccination-48	Client is not due for Typhoid vaccination	IMMZ.D2.DT.Typhoid.Ty21a Output	IMMZ.D2.DT.Typhoid.Ty21a Output	IMMZ.D2.DT.Typhoid.Ty21a Output	IMMZ.D2.DT.Typhoid.Ty21a Output
Client is not due for bOPV vaccination-48	Client is not due for bOPV vaccination	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Output	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Output	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Output	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Output
Client is not due for cholera booster dose-48	Client is not due for cholera booster dose	IMMZ.D2.DT.Cholera.WC vaccines Output	IMMZ.D2.DT.Cholera.WC vaccines Output	IMMZ.D2.DT.Cholera.WC vaccines Output	IMMZ.D2.DT.Cholera.WC vaccines Output
Client is not due for cholera vaccination-48	Client is not due for cholera vaccination	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Output	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Output	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Output	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Output
Client is not due for dengue vaccination-48	Client is not due for dengue vaccination	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Output	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Output	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Output	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Output
Client is not due for first dose of measles-containing vaccine (MCV1)-48	Client is not due for first dose of measles-containing vaccine (MCV1)	IMMZ.D2.DT.Measles.Ongoing transmission Output	IMMZ.D2.DT.Measles.Ongoing transmission Output	IMMZ.D2.DT.Measles.Ongoing transmission Output	IMMZ.D2.DT.Measles.Ongoing transmission Output
Client is not due for malaria vaccination-48	Client is not due for malaria vaccination	IMMZ.D2.DT.Malaria Output	IMMZ.D2.DT.Malaria Output	IMMZ.D2.DT.Malaria Output	IMMZ.D2.DT.Malaria Output
Client is not due for measles supplementary dose-48	Client is not due for measles supplementary dose	IMMZ.D2.DT.Measles.Supplementary dose Output	IMMZ.D2.DT.Measles.Supplementary dose Output	IMMZ.D2.DT.Measles.Supplementary dose Output	IMMZ.D2.DT.Measles.Supplementary dose Output
Client is not due for meningococcal vaccination-48	Client is not due for meningococcal vaccination	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Output	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Output	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Output	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Output
Client is not due for mumps vaccination-48	Client is not due for mumps vaccination	IMMZ.D2.DT.Mumps Output	IMMZ.D2.DT.Mumps Output	IMMZ.D2.DT.Mumps Output	IMMZ.D2.DT.Mumps Output
Client is not due for pertussis booster dose-48	Client is not due for pertussis booster dose	IMMZ.D2.DT.DTP.On-time start Output	IMMZ.D2.DT.DTP.On-time start Output	IMMZ.D2.DT.DTP.On-time start Output	IMMZ.D2.DT.DTP.On-time start Output
Client is not due for pneumococcal booster dose-48	Client is not due for pneumococcal booster dose	IMMZ.D2.DT.Pneumococcal.3 doses Output	IMMZ.D2.DT.Pneumococcal.3 doses Output	IMMZ.D2.DT.Pneumococcal.3 doses Output	IMMZ.D2.DT.Pneumococcal.3 doses Output
Client is not due for pneumococcal vaccination-48	Client is not due for pneumococcal vaccination	IMMZ.D2.DT.Pneumococcal.3 doses Output	IMMZ.D2.DT.Pneumococcal.3 doses Output	IMMZ.D2.DT.Pneumococcal.3 doses Output	IMMZ.D2.DT.Pneumococcal.3 doses Output
Client is not due for polio vaccination-48	Client is not due for polio vaccination	IMMZ.D2.DT.Polio.bOPV plus IPV Output	IMMZ.D2.DT.Polio.bOPV plus IPV Output	IMMZ.D2.DT.Polio.bOPV plus IPV Output	IMMZ.D2.DT.Polio.bOPV plus IPV Output
Client is not due for rabies vaccination-48	Client is not due for rabies vaccination	IMMZ.D2.DT.Rabies Output	IMMZ.D2.DT.Rabies Output	IMMZ.D2.DT.Rabies Output	IMMZ.D2.DT.Rabies Output
Client is not due for rotavirus vaccination if immunization schedule is not complete.-109	Client is not due for rotavirus vaccination if immunization schedule is not complete.	IMMZ.D2.DT.Rotavirus Output	IMMZ.D2.DT.Rotavirus Output	IMMZ.D2.DT.Rotavirus Output	IMMZ.D2.DT.Rotavirus Output
Client is not due for rotavirus vaccination-48	Client is not due for rotavirus vaccination	IMMZ.D2.DT.Rotavirus Output	IMMZ.D2.DT.Rotavirus Output	IMMZ.D2.DT.Rotavirus Output	IMMZ.D2.DT.Rotavirus Output
Client is not due for rubella vaccination-48	Client is not due for rubella vaccination	IMMZ.D2.DT.Rubella.Low incidence Output	IMMZ.D2.DT.Rubella.Low incidence Output	IMMZ.D2.DT.Rubella.Low incidence Output	IMMZ.D2.DT.Rubella.Low incidence Output
Client is not due for second dose of measles-containing vaccine (MCV2)-48	Client is not due for second dose of measles-containing vaccine (MCV2)	IMMZ.D2.DT.Measles.Ongoing transmission Output	IMMZ.D2.DT.Measles.Ongoing transmission Output	IMMZ.D2.DT.Measles.Ongoing transmission Output	IMMZ.D2.DT.Measles.Ongoing transmission Output
Client is not due for tetanus and diphtheria booster dose-118	Client is not due for tetanus and diphtheria booster dose	IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Output	IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Output	IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Output	IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Output
Client is not due for the bOPV birth dose-48	Client is not due for the bOPV birth dose	IMMZ.D2.DT.Polio.Birth dose Output	IMMZ.D2.DT.Polio.Birth dose Output	IMMZ.D2.DT.Polio.Birth dose Output	IMMZ.D2.DT.Polio.Birth dose Output
Client is not due for typhoid booster dose-48	Client is not due for typhoid booster dose	IMMZ.D2.DT.Typhoid.Ty21a Output	IMMZ.D2.DT.Typhoid.Ty21a Output	IMMZ.D2.DT.Typhoid.Ty21a Output	IMMZ.D2.DT.Typhoid.Ty21a Output
Client is not due for yellow fever vaccination-48	Client is not due for yellow fever vaccination	IMMZ.D2.DT.Yellow fever Output	IMMZ.D2.DT.Yellow fever Output	IMMZ.D2.DT.Yellow fever Output	IMMZ.D2.DT.Yellow fever Output
Client is not immunocompromised-26	Client is not immunocompromised	IMMZ.D2.DT.HPV.Single dose Inputs	IMMZ.D2.DT.HPV.Single dose Inputs	IMMZ.D2.DT.HPV.Single dose Inputs	IMMZ.D2.DT.HPV.Single dose Inputs
Client is not immunologically stable-32	Client is not immunologically stable	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs
Client should follow 'delayed or interrupted series' decision logic-0	Client should follow 'delayed or interrupted series' decision logic	IMMZ.D2.DT.DTP.Pregnancy Output	IMMZ.D2.DT.DTP.Pregnancy Output	IMMZ.D2.DT.DTP.Pregnancy Output	IMMZ.D2.DT.DTP.Pregnancy Output
Client should follow 'pregnancy starting with 3 doses' decision logic-0	Client should follow 'pregnancy starting with 3 doses' decision logic	IMMZ.D2.DT.DTP.Pregnancy Output	IMMZ.D2.DT.DTP.Pregnancy Output	IMMZ.D2.DT.DTP.Pregnancy Output	IMMZ.D2.DT.DTP.Pregnancy Output
Client should follow 'pregnancy starting with 4 doses' decision logic-0	Client should follow 'pregnancy starting with 4 doses' decision logic	IMMZ.D2.DT.DTP.Pregnancy Output	IMMZ.D2.DT.DTP.Pregnancy Output	IMMZ.D2.DT.DTP.Pregnancy Output	IMMZ.D2.DT.DTP.Pregnancy Output
Client's HIV status is negative or unknown-29	Client's HIV status is negative or unknown	IMMZ.D2.DT.HPV.Single dose Inputs	IMMZ.D2.DT.HPV.Single dose Inputs	IMMZ.D2.DT.HPV.Single dose Inputs	IMMZ.D2.DT.HPV.Single dose Inputs
Client's HIV status is positive-29	Client's HIV status is positive	IMMZ.D2.DT.HPV.Single dose Inputs	IMMZ.D2.DT.HPV.Single dose Inputs	IMMZ.D2.DT.HPV.Single dose Inputs	IMMZ.D2.DT.HPV.Single dose Inputs
Client's TB infection test result is negative-39	Client's TB infection test result is negative	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs
Client's TB infection test result is positive-39	Client's TB infection test result is positive	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs
Client's TB infection test result is unknown (test not done or no result yet)-34	Client's TB infection test result is unknown (test not done or no result yet)	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs
Client's age is 2–5 years-50	Client's age is 2–5 years	IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Inputs	IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Inputs	IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Inputs	IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Inputs
Client's age is 6–9 months-52	Client's age is 6–9 months	IMMZ.D5.DT.Yellow fever contraindications Inputs	IMMZ.D5.DT.Yellow fever contraindications Inputs	IMMZ.D5.DT.Yellow fever contraindications Inputs	IMMZ.D5.DT.Yellow fever contraindications Inputs
Client's age is at least 6 weeks and not more than 5 years-49	Client's age is at least 6 weeks and not more than 5 years	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs
Client's age is at least 6 weeks and not more than 5 years-50	Client's age is at least 6 weeks and not more than 5 years	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs
Client's age is between 1 year and 6 years-49	Client's age is between 1 year and 6 years	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs
Client's age is between 28 days and 5 years-50	Client's age is between 28 days and 5 years	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs
Client's age is between 6 months and 24 months-52	Client's age is between 6 months and 24 months	IMMZ.D2.DT.Rotavirus Inputs	IMMZ.D2.DT.Rotavirus Inputs	IMMZ.D2.DT.Rotavirus Inputs	IMMZ.D2.DT.Rotavirus Inputs
Client's age is between 6 months and 45 years-52	Client's age is between 6 months and 45 years	IMMZ.D2.DT.Typhoid.TCV Inputs	IMMZ.D2.DT.Typhoid.TCV Inputs	IMMZ.D2.DT.Typhoid.TCV Inputs	IMMZ.D2.DT.Typhoid.TCV Inputs
Client's age is between 6 months and 9 months-52	Client's age is between 6 months and 9 months	IMMZ.D2.DT.Measles.MCV dose 0 Inputs	IMMZ.D2.DT.Measles.MCV dose 0 Inputs	IMMZ.D2.DT.Measles.MCV dose 0 Inputs	IMMZ.D2.DT.Measles.MCV dose 0 Inputs
Client's age is between 6 weeks and 1 year-49	Client's age is between 6 weeks and 1 year	IMMZ.D2.DT.DTP.On-time start Inputs	IMMZ.D2.DT.DTP.On-time start Inputs	IMMZ.D2.DT.DTP.On-time start Inputs	IMMZ.D2.DT.DTP.On-time start Inputs
Client's age is between 6 weeks and 14 weeks-51	Client's age is between 6 weeks and 14 weeks	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs
Client's age is between 6 weeks and 24 months-52	Client's age is between 6 weeks and 24 months	IMMZ.D2.DT.Rotavirus Inputs	IMMZ.D2.DT.Rotavirus Inputs	IMMZ.D2.DT.Rotavirus Inputs	IMMZ.D2.DT.Rotavirus Inputs
Client's age is between 6 weeks and 3 months-51	Client's age is between 6 weeks and 3 months	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs
Client's age is between 6 weeks and 5 years-50	Client's age is between 6 weeks and 5 years	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs
Client's age is between 6 weeks and not more than 5 years-50	Client's age is between 6 weeks and not more than 5 years	IMMZ.D2.DT.Hib.3 doses with booster dose Inputs	IMMZ.D2.DT.Hib.3 doses with booster dose Inputs	IMMZ.D2.DT.Hib.3 doses with booster dose Inputs	IMMZ.D2.DT.Hib.3 doses with booster dose Inputs
Client's age is between 9 and 14 years-51	Client's age is between 9 and 14 years	IMMZ.D2.DT.HPV.2 doses Inputs	IMMZ.D2.DT.HPV.2 doses Inputs	IMMZ.D2.DT.HPV.2 doses Inputs	IMMZ.D2.DT.HPV.2 doses Inputs
Client's age is between 9 and 20 years-51	Client's age is between 9 and 20 years	IMMZ.D2.DT.HPV.Single dose Inputs	IMMZ.D2.DT.HPV.Single dose Inputs	IMMZ.D2.DT.HPV.Single dose Inputs	IMMZ.D2.DT.HPV.Single dose Inputs
Client's age is between 9 years and 45 years-51	Client's age is between 9 years and 45 years	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs
Client's age is less than 1 week-39	Client's age is less than 1 week	IMMZ.D2.DT.Polio.Birth dose Inputs	IMMZ.D2.DT.Polio.Birth dose Inputs	IMMZ.D2.DT.Polio.Birth dose Inputs	IMMZ.D2.DT.Polio.Birth dose Inputs
Client's age is less than 1 year-14	Client's age is less than 1 year	IMMZ.D5.DT.BCG contraindications Inputs	IMMZ.D5.DT.BCG contraindications Inputs	IMMZ.D5.DT.BCG contraindications Inputs	IMMZ.D5.DT.BCG contraindications Inputs
Client's age is less than 1 year-39	Client's age is less than 1 year	IMMZ.D2.DT.Cholera.WC vaccines Inputs	IMMZ.D2.DT.Cholera.WC vaccines Inputs	IMMZ.D2.DT.Cholera.WC vaccines Inputs	IMMZ.D2.DT.Cholera.WC vaccines Inputs
Client's age is less than 12 months-42	Client's age is less than 12 months	IMMZ.D2.DT.Mumps Inputs	IMMZ.D2.DT.Mumps Inputs	IMMZ.D2.DT.Mumps Inputs	IMMZ.D2.DT.Mumps Inputs
Client's age is less than 14 weeks-41	Client's age is less than 14 weeks	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs
Client's age is less than 15 months-42	Client's age is less than 15 months	IMMZ.D2.DT.Measles.Low transmission Inputs	IMMZ.D2.DT.Measles.Low transmission Inputs	IMMZ.D2.DT.Measles.Low transmission Inputs	IMMZ.D2.DT.Measles.Low transmission Inputs
Client's age is less than 18 months-42	Client's age is less than 18 months	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs
Client's age is less than 2 months-41	Client's age is less than 2 months	IMMZ.D2.DT.Meningococcal.Monovalent MenC conjugate vaccine Inputs	IMMZ.D2.DT.Meningococcal.Monovalent MenC conjugate vaccine Inputs	IMMZ.D2.DT.Meningococcal.Monovalent MenC conjugate vaccine Inputs	IMMZ.D2.DT.Meningococcal.Monovalent MenC conjugate vaccine Inputs
Client's age is less than 2 years-40	Client's age is less than 2 years	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs
Client's age is less than 3 months-41	Client's age is less than 3 months	IMMZ.D2.DT.Meningococcal.MenA conjugate vaccine 2 doses Inputs	IMMZ.D2.DT.Meningococcal.MenA conjugate vaccine 2 doses Inputs	IMMZ.D2.DT.Meningococcal.MenA conjugate vaccine 2 doses Inputs	IMMZ.D2.DT.Meningococcal.MenA conjugate vaccine 2 doses Inputs
Client's age is less than 3 years-40	Client's age is less than 3 years	IMMZ.D2.DT.TBE.EnceVir Inputs	IMMZ.D2.DT.TBE.EnceVir Inputs	IMMZ.D2.DT.TBE.EnceVir Inputs	IMMZ.D2.DT.TBE.EnceVir Inputs
Client's age is less than 4 years-40	Client's age is less than 4 years	IMMZ.D2.DT.DTP.On-time start Inputs	IMMZ.D2.DT.DTP.On-time start Inputs	IMMZ.D2.DT.DTP.On-time start Inputs	IMMZ.D2.DT.DTP.On-time start Inputs
Client's age is less than 5 months-41	Client's age is less than 5 months	IMMZ.D2.DT.Malaria Inputs	IMMZ.D2.DT.Malaria Inputs	IMMZ.D2.DT.Malaria Inputs	IMMZ.D2.DT.Malaria Inputs
Client's age is less than 6 months-41	Client's age is less than 6 months	IMMZ.D5.DT.Yellow fever contraindications Inputs	IMMZ.D5.DT.Yellow fever contraindications Inputs	IMMZ.D5.DT.Yellow fever contraindications Inputs	IMMZ.D5.DT.Yellow fever contraindications Inputs
Client's age is less than 6 weeks-40	Client's age is less than 6 weeks	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs
Client's age is less than 6 weeks-41	Client's age is less than 6 weeks	IMMZ.D2.DT.Rotavirus Inputs	IMMZ.D2.DT.Rotavirus Inputs	IMMZ.D2.DT.Rotavirus Inputs	IMMZ.D2.DT.Rotavirus Inputs
Client's age is less than 6 years-40	Client's age is less than 6 years	IMMZ.D2.DT.Typhoid.Ty21a Inputs	IMMZ.D2.DT.Typhoid.Ty21a Inputs	IMMZ.D2.DT.Typhoid.Ty21a Inputs	IMMZ.D2.DT.Typhoid.Ty21a Inputs
Client's age is less than 8 months-41	Client's age is less than 8 months	IMMZ.D2.DT.JE.Live attenuated vaccine Inputs	IMMZ.D2.DT.JE.Live attenuated vaccine Inputs	IMMZ.D2.DT.JE.Live attenuated vaccine Inputs	IMMZ.D2.DT.JE.Live attenuated vaccine Inputs
Client's age is less than 8 weeks-40	Client's age is less than 8 weeks	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Inputs	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Inputs	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Inputs	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Inputs
Client's age is less than 9 months-41	Client's age is less than 9 months	IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Inputs	IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Inputs	IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Inputs	IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Inputs
Client's age is less than 9 years-40	Client's age is less than 9 years	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs
Client's age is less than or equal to 28 days-40	Client's age is less than or equal to 28 days	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs
Client's age is more than 1 year-39	Client's age is more than 1 year	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs
Client's age is more than 2 years-40	Client's age is more than 2 years	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs
Client's age is more than 20 years-41	Client's age is more than 20 years	IMMZ.D2.DT.HPV.Single dose Inputs	IMMZ.D2.DT.HPV.Single dose Inputs	IMMZ.D2.DT.HPV.Single dose Inputs	IMMZ.D2.DT.HPV.Single dose Inputs
Client's age is more than 24 months-27	Client's age is more than 24 months	IMMZ.D2.DT.Rotavirus Inputs	IMMZ.D2.DT.Rotavirus Inputs	IMMZ.D2.DT.Rotavirus Inputs	IMMZ.D2.DT.Rotavirus Inputs
Client's age is more than 3 months-41	Client's age is more than 3 months	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs
Client's age is more than 45 years-41	Client's age is more than 45 years	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs
Client's age is more than 5 years-40	Client's age is more than 5 years	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs
Client's age is more than 6 years-40	Client's age is more than 6 years	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs
Client's age is more than 9 months-41	Client's age is more than 9 months	IMMZ.D2.DT.Meningococcal.MenA conjugate vaccine 1 dose Inputs	IMMZ.D2.DT.Meningococcal.MenA conjugate vaccine 1 dose Inputs	IMMZ.D2.DT.Meningococcal.MenA conjugate vaccine 1 dose Inputs	IMMZ.D2.DT.Meningococcal.MenA conjugate vaccine 1 dose Inputs
Client's age is more than or equal to 1 week-39	Client's age is more than or equal to 1 week	IMMZ.D2.DT.Polio.Birth dose Inputs	IMMZ.D2.DT.Polio.Birth dose Inputs	IMMZ.D2.DT.Polio.Birth dose Inputs	IMMZ.D2.DT.Polio.Birth dose Inputs
Client's age is more than or equal to 1 year-14	Client's age is more than or equal to 1 year	IMMZ.D5.DT.BCG contraindications Inputs	IMMZ.D5.DT.BCG contraindications Inputs	IMMZ.D5.DT.BCG contraindications Inputs	IMMZ.D5.DT.BCG contraindications Inputs
Client's age is more than or equal to 1 year-39	Client's age is more than or equal to 1 year	IMMZ.D2.DT.Cholera.WC vaccines Inputs	IMMZ.D2.DT.Cholera.WC vaccines Inputs	IMMZ.D2.DT.Cholera.WC vaccines Inputs	IMMZ.D2.DT.Cholera.WC vaccines Inputs
Client's age is more than or equal to 12 months-42	Client's age is more than or equal to 12 months	IMMZ.D2.DT.Mumps Inputs	IMMZ.D2.DT.Mumps Inputs	IMMZ.D2.DT.Mumps Inputs	IMMZ.D2.DT.Mumps Inputs
Client's age is more than or equal to 14 weeks-41	Client's age is more than or equal to 14 weeks	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs
Client's age is more than or equal to 15 months-42	Client's age is more than or equal to 15 months	IMMZ.D2.DT.Measles.Low transmission Inputs	IMMZ.D2.DT.Measles.Low transmission Inputs	IMMZ.D2.DT.Measles.Low transmission Inputs	IMMZ.D2.DT.Measles.Low transmission Inputs
Client's age is more than or equal to 18 months-42	Client's age is more than or equal to 18 months	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs
Client's age is more than or equal to 2 months-41	Client's age is more than or equal to 2 months	IMMZ.D2.DT.Meningococcal.Monovalent MenC conjugate vaccine Inputs	IMMZ.D2.DT.Meningococcal.Monovalent MenC conjugate vaccine Inputs	IMMZ.D2.DT.Meningococcal.Monovalent MenC conjugate vaccine Inputs	IMMZ.D2.DT.Meningococcal.Monovalent MenC conjugate vaccine Inputs
Client's age is more than or equal to 2 years-40	Client's age is more than or equal to 2 years	IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 1 dose Inputs	IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 1 dose Inputs	IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 1 dose Inputs	IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 1 dose Inputs
Client's age is more than or equal to 3 months-41	Client's age is more than or equal to 3 months	IMMZ.D2.DT.Meningococcal.MenA conjugate vaccine 2 doses Inputs	IMMZ.D2.DT.Meningococcal.MenA conjugate vaccine 2 doses Inputs	IMMZ.D2.DT.Meningococcal.MenA conjugate vaccine 2 doses Inputs	IMMZ.D2.DT.Meningococcal.MenA conjugate vaccine 2 doses Inputs
Client's age is more than or equal to 3 years-40	Client's age is more than or equal to 3 years	IMMZ.D2.DT.TBE.EnceVir Inputs	IMMZ.D2.DT.TBE.EnceVir Inputs	IMMZ.D2.DT.TBE.EnceVir Inputs	IMMZ.D2.DT.TBE.EnceVir Inputs
Client's age is more than or equal to 4 years-40	Client's age is more than or equal to 4 years	IMMZ.D2.DT.DTP.On-time start Inputs	IMMZ.D2.DT.DTP.On-time start Inputs	IMMZ.D2.DT.DTP.On-time start Inputs	IMMZ.D2.DT.DTP.On-time start Inputs
Client's age is more than or equal to 45 years-41	Client's age is more than or equal to 45 years	IMMZ.D2.DT.Typhoid.TCV Inputs	IMMZ.D2.DT.Typhoid.TCV Inputs	IMMZ.D2.DT.Typhoid.TCV Inputs	IMMZ.D2.DT.Typhoid.TCV Inputs
Client's age is more than or equal to 5 months-41	Client's age is more than or equal to 5 months	IMMZ.D2.DT.Malaria Inputs	IMMZ.D2.DT.Malaria Inputs	IMMZ.D2.DT.Malaria Inputs	IMMZ.D2.DT.Malaria Inputs
Client's age is more than or equal to 6 months-41	Client's age is more than or equal to 6 months	IMMZ.D2.DT.JE.Inactivated Vero cell-derived vaccine Inputs	IMMZ.D2.DT.JE.Inactivated Vero cell-derived vaccine Inputs	IMMZ.D2.DT.JE.Inactivated Vero cell-derived vaccine Inputs	IMMZ.D2.DT.JE.Inactivated Vero cell-derived vaccine Inputs
Client's age is more than or equal to 6 weeks-40	Client's age is more than or equal to 6 weeks	IMMZ.D2.DT.Polio.IPV-only Inputs	IMMZ.D2.DT.Polio.IPV-only Inputs	IMMZ.D2.DT.Polio.IPV-only Inputs	IMMZ.D2.DT.Polio.IPV-only Inputs
Client's age is more than or equal to 6 years-40	Client's age is more than or equal to 6 years	IMMZ.D2.DT.Typhoid.Ty21a Inputs	IMMZ.D2.DT.Typhoid.Ty21a Inputs	IMMZ.D2.DT.Typhoid.Ty21a Inputs	IMMZ.D2.DT.Typhoid.Ty21a Inputs
Client's age is more than or equal to 60 years-41	Client's age is more than or equal to 60 years	IMMZ.D5.DT.Yellow fever contraindications Inputs	IMMZ.D5.DT.Yellow fever contraindications Inputs	IMMZ.D5.DT.Yellow fever contraindications Inputs	IMMZ.D5.DT.Yellow fever contraindications Inputs
Client's age is more than or equal to 8 months-41	Client's age is more than or equal to 8 months	IMMZ.D2.DT.JE.Live attenuated vaccine Inputs	IMMZ.D2.DT.JE.Live attenuated vaccine Inputs	IMMZ.D2.DT.JE.Live attenuated vaccine Inputs	IMMZ.D2.DT.JE.Live attenuated vaccine Inputs
Client's age is more than or equal to 8 weeks-40	Client's age is more than or equal to 8 weeks	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Inputs	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Inputs	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Inputs	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Inputs
Client's age is more than or equal to 9 months-41	Client's age is more than or equal to 9 months	IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Inputs	IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Inputs	IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Inputs	IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Inputs
Client's age is more than or equal to 9 years-40	Client's age is more than or equal to 9 years	IMMZ.D2.DT.DTP.On-time start Inputs	IMMZ.D2.DT.DTP.On-time start Inputs	IMMZ.D2.DT.DTP.On-time start Inputs	IMMZ.D2.DT.DTP.On-time start Inputs
Client's age more than or equal to 15 years-41	Client's age more than or equal to 15 years	IMMZ.D2.DT.HPV.2 doses Inputs	IMMZ.D2.DT.HPV.2 doses Inputs	IMMZ.D2.DT.HPV.2 doses Inputs	IMMZ.D2.DT.HPV.2 doses Inputs
Client's age was 6 weeks when the primary series was started-138	Client's age was 6 weeks when the primary series was started	IMMZ.D2.DT.Polio.IPV-only Inputs	IMMZ.D2.DT.Polio.IPV-only Inputs	IMMZ.D2.DT.Polio.IPV-only Inputs	IMMZ.D2.DT.Polio.IPV-only Inputs
Client's age was less than 1 year when first Hib dose was administered-129	Client's age was less than 1 year when first Hib dose was administered	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs
Client's age was less than or equal to 11 months when the primary series was started-110	Client's age was less than or equal to 11 months when the primary series was started	IMMZ.D2.DT.Meningococcal.Monovalent MenC conjugate vaccine Inputs	IMMZ.D2.DT.Meningococcal.Monovalent MenC conjugate vaccine Inputs	IMMZ.D2.DT.Meningococcal.Monovalent MenC conjugate vaccine Inputs	IMMZ.D2.DT.Meningococcal.Monovalent MenC conjugate vaccine Inputs
Client's age was less than or equal to 23 months when the primary series was started-110	Client's age was less than or equal to 23 months when the primary series was started	IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Inputs	IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Inputs	IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Inputs	IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Inputs
Client's age was more than 1 year when first Hib dose was administered-129	Client's age was more than 1 year when first Hib dose was administered	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs
Client's age was more than 11 months when the primary series was started-110	Client's age was more than 11 months when the primary series was started	IMMZ.D2.DT.Meningococcal.Monovalent MenC conjugate vaccine Inputs	IMMZ.D2.DT.Meningococcal.Monovalent MenC conjugate vaccine Inputs	IMMZ.D2.DT.Meningococcal.Monovalent MenC conjugate vaccine Inputs	IMMZ.D2.DT.Meningococcal.Monovalent MenC conjugate vaccine Inputs
Client's age was more than 23 months when the primary series was started-110	Client's age was more than 23 months when the primary series was started	IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Inputs	IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Inputs	IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Inputs	IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Inputs
Client's age was more than 6 weeks when the primary series was started-138	Client's age was more than 6 weeks when the primary series was started	IMMZ.D2.DT.Polio.IPV-only Inputs	IMMZ.D2.DT.Polio.IPV-only Inputs	IMMZ.D2.DT.Polio.IPV-only Inputs	IMMZ.D2.DT.Polio.IPV-only Inputs
Client's biological sex is female-16	Client's biological sex is female	IMMZ.D2.DT.HPV.2 doses Inputs	IMMZ.D2.DT.HPV.2 doses Inputs	IMMZ.D2.DT.HPV.2 doses Inputs	IMMZ.D2.DT.HPV.2 doses Inputs
Client's biological sex is not female-16	Client's biological sex is not female	IMMZ.D2.DT.HPV.2 doses Inputs	IMMZ.D2.DT.HPV.2 doses Inputs	IMMZ.D2.DT.HPV.2 doses Inputs	IMMZ.D2.DT.HPV.2 doses Inputs
Client's dengue serostatus is negative-32	Client's dengue serostatus is negative	IMMZ.D2.DT.Dengue.3 doses with pre-vaccination screening Inputs	IMMZ.D2.DT.Dengue.3 doses with pre-vaccination screening Inputs	IMMZ.D2.DT.Dengue.3 doses with pre-vaccination screening Inputs	IMMZ.D2.DT.Dengue.3 doses with pre-vaccination screening Inputs
Client's dengue serostatus is positive-32	Client's dengue serostatus is positive	IMMZ.D2.DT.Dengue.3 doses with pre-vaccination screening Inputs	IMMZ.D2.DT.Dengue.3 doses with pre-vaccination screening Inputs	IMMZ.D2.DT.Dengue.3 doses with pre-vaccination screening Inputs	IMMZ.D2.DT.Dengue.3 doses with pre-vaccination screening Inputs
Clinical judgement is required. Create a clinical note-66	Clinical judgement is required. Create a clinical note	IMMZ.D5.DT.Rabies contraindications Output	IMMZ.D5.DT.Rabies contraindications Output	IMMZ.D5.DT.Rabies contraindications Output	IMMZ.D5.DT.Rabies contraindications Output
Clinical judgement is required. Create a clinical note.-66	Clinical judgement is required. Create a clinical note.	IMMZ.D2.DT.HPV.Single dose Output	IMMZ.D2.DT.HPV.Single dose Output	IMMZ.D2.DT.HPV.Single dose Output	IMMZ.D2.DT.HPV.Single dose Output
Clinical judgement is required. Create clinical note-66	Clinical judgement is required. Create clinical note	IMMZ.D5.DT.Varicella contraindications Output	IMMZ.D5.DT.Varicella contraindications Output	IMMZ.D5.DT.Varicella contraindications Output	IMMZ.D5.DT.Varicella contraindications Output
Clinical judgement is required. Create clinical note-67	Clinical judgement is required. Create clinical note	IMMZ.D5.DT.Varicella contraindications Output	IMMZ.D5.DT.Varicella contraindications Output	IMMZ.D5.DT.Varicella contraindications Output	IMMZ.D5.DT.Varicella contraindications Output
Clinical judgement is required. Create clinical note.-66	Clinical judgement is required. Create clinical note.	IMMZ.D2.DT.BCG Output	IMMZ.D2.DT.BCG Output	IMMZ.D2.DT.BCG Output	IMMZ.D2.DT.BCG Output
Clinical judgement is required. Create clinical note.-67	Clinical judgement is required. Create clinical note.	IMMZ.D2.DT.BCG Output	IMMZ.D2.DT.BCG Output	IMMZ.D2.DT.BCG Output	IMMZ.D2.DT.BCG Output
Clinical judgement is required.-89	Clinical judgement is required.	IMMZ.D2.DT.TBE.FSME-Immun Output	IMMZ.D2.DT.TBE.FSME-Immun Output	IMMZ.D2.DT.TBE.FSME-Immun Output	IMMZ.D2.DT.TBE.FSME-Immun Output
Clinical judgement required. Create a clinical note-66	Clinical judgement required. Create a clinical note	IMMZ.D5.DT.Measles contraindications Output	IMMZ.D5.DT.Measles contraindications Output	IMMZ.D5.DT.Measles contraindications Output	IMMZ.D5.DT.Measles contraindications Output
Consider MCV0.-90	Consider MCV0.	IMMZ.D2.DT.Measles.MCV dose 0 Output	IMMZ.D2.DT.Measles.MCV dose 0 Output	IMMZ.D2.DT.Measles.MCV dose 0 Output	IMMZ.D2.DT.Measles.MCV dose 0 Output
Consider measles supplementary dose. Create a clinical note-66	Consider measles supplementary dose. Create a clinical note	IMMZ.D2.DT.Measles.Supplementary dose Output	IMMZ.D2.DT.Measles.Supplementary dose Output	IMMZ.D2.DT.Measles.Supplementary dose Output	IMMZ.D2.DT.Measles.Supplementary dose Output
Decision ID-0	Decision ID	IMMZ.D2.DT.Measles.Supplementary dose Inputs	IMMZ.D2.DT.Measles.Supplementary dose Inputs	IMMZ.D2.DT.Measles.Supplementary dose Inputs	IMMZ.D2.DT.Measles.Supplementary dose Inputs
Dengue immunization schedule is complete-143	Dengue immunization schedule is complete	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Output	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Output	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Output	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Output
Dengue vaccination could be contraindicated. Clinical judgement is required. Create a clinical note.-66	Dengue vaccination could be contraindicated. Clinical judgement is required. Create a clinical note.	IMMZ.D5.DT.Dengue contraindications Output	IMMZ.D5.DT.Dengue contraindications Output	IMMZ.D5.DT.Dengue contraindications Output	IMMZ.D5.DT.Dengue contraindications Output
Dengue vaccination is contraindicated-56	Dengue vaccination is contraindicated	IMMZ.D5.DT.Dengue contraindications Output	IMMZ.D5.DT.Dengue contraindications Output	IMMZ.D5.DT.Dengue contraindications Output	IMMZ.D5.DT.Dengue contraindications Output
Dose number of the latest dose is one-68	Dose number of the latest dose is one	IMMZ.D2.DT.Cholera.WC vaccines Inputs	IMMZ.D2.DT.Cholera.WC vaccines Inputs	IMMZ.D2.DT.Cholera.WC vaccines Inputs	IMMZ.D2.DT.Cholera.WC vaccines Inputs
Dose number of the latest dose is two-68	Dose number of the latest dose is two	IMMZ.D2.DT.Cholera.WC vaccines Inputs	IMMZ.D2.DT.Cholera.WC vaccines Inputs	IMMZ.D2.DT.Cholera.WC vaccines Inputs	IMMZ.D2.DT.Cholera.WC vaccines Inputs
Dose number of the latest primary series dose is less than three-106	Dose number of the latest primary series dose is less than three	IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Inputs	IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Inputs	IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Inputs	IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Inputs
Dose number of the latest primary series dose is more than or equal to two-107	Dose number of the latest primary series dose is more than or equal to two	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs
Dose number of the latest primary series dose is one-106	Dose number of the latest primary series dose is one	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs
Dose number of the latest primary series dose is three-106	Dose number of the latest primary series dose is three	IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Inputs	IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Inputs	IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Inputs	IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Inputs
Dose number of the latest primary series dose is two-106	Dose number of the latest primary series dose is two	IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Inputs	IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Inputs	IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Inputs	IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Inputs
First DTP dose from the primary series was administered-123	First DTP dose from the primary series was administered	IMMZ.D18.S.DTP.Delayed or interrupted schedule Trigger	IMMZ.D18.S.DTP.Delayed or interrupted schedule Trigger	IMMZ.D18.S.DTP.Delayed or interrupted schedule Trigger	IMMZ.D18.S.DTP.Delayed or interrupted schedule Trigger
First HPV dose from the primary series was administered and client's HIV status is positive or client is immunocompromised-140	First HPV dose from the primary series was administered and client's HIV status is positive or client is immunocompromised	IMMZ.D18.S.Single-dose schedule Trigger	IMMZ.D18.S.Single-dose schedule Trigger	IMMZ.D18.S.Single-dose schedule Trigger	IMMZ.D18.S.Single-dose schedule Trigger
First HPV dose from the primary series was administered-112	First HPV dose from the primary series was administered	IMMZ.D18.S.HPV.2-dose schedule Trigger	IMMZ.D18.S.HPV.2-dose schedule Trigger	IMMZ.D18.S.HPV.2-dose schedule Trigger	IMMZ.D18.S.HPV.2-dose schedule Trigger
First HPV dose from the primary series was administered-74	First HPV dose from the primary series was administered	IMMZ.D18.S.Single-dose schedule Completion	IMMZ.D18.S.Single-dose schedule Completion	IMMZ.D18.S.Single-dose schedule Completion	IMMZ.D18.S.Single-dose schedule Completion
First Hib dose from the primary series was administered to the client within 1 year of age. Client's age is less than 5 years-302	First Hib dose from the primary series was administered to the client within 1 year of age. Client's age is less than 5 years	IMMZ.D18.S.Hib.2 doses with booster dose schedule Trigger	IMMZ.D18.S.Hib.2 doses with booster dose schedule Trigger	IMMZ.D18.S.Hib.2 doses with booster dose schedule Trigger	IMMZ.D18.S.Hib.2 doses with booster dose schedule Trigger
First Hib dose from the primary series was administered-279	First Hib dose from the primary series was administered	IMMZ.D18.S.Hib.2 doses with booster dose schedule Completion	IMMZ.D18.S.Hib.2 doses with booster dose schedule Completion	IMMZ.D18.S.Hib.2 doses with booster dose schedule Completion	IMMZ.D18.S.Hib.2 doses with booster dose schedule Completion
First IPV dose from the primary series was administered-76	First IPV dose from the primary series was administered	IMMZ.D18.S.Polio.Sequential IPV–bOPV schedule Trigger	IMMZ.D18.S.Polio.Sequential IPV–bOPV schedule Trigger	IMMZ.D18.S.Polio.Sequential IPV–bOPV schedule Trigger	IMMZ.D18.S.Polio.Sequential IPV–bOPV schedule Trigger
First IPV dose from the primary series was administered-92	First IPV dose from the primary series was administered	IMMZ.D18.S.Polio.IPV-only schedule Trigger	IMMZ.D18.S.Polio.IPV-only schedule Trigger	IMMZ.D18.S.Polio.IPV-only schedule Trigger	IMMZ.D18.S.Polio.IPV-only schedule Trigger
First TBE dose from the primary series was administered-112	First TBE dose from the primary series was administered	IMMZ.D18.S.TBE.EnceVir schedule Trigger	IMMZ.D18.S.TBE.EnceVir schedule Trigger	IMMZ.D18.S.TBE.EnceVir schedule Trigger	IMMZ.D18.S.TBE.EnceVir schedule Trigger
First bOPV dose from the primary series was administered-115	First bOPV dose from the primary series was administered	IMMZ.D18.S.Polio.bOPV plus IPV schedule Trigger	IMMZ.D18.S.Polio.bOPV plus IPV schedule Trigger	IMMZ.D18.S.Polio.bOPV plus IPV schedule Trigger	IMMZ.D18.S.Polio.bOPV plus IPV schedule Trigger
First bOPV dose from the primary series was administered-77	First bOPV dose from the primary series was administered	IMMZ.D18.S.Polio.Sequential IPV–bOPV schedule Trigger	IMMZ.D18.S.Polio.Sequential IPV–bOPV schedule Trigger	IMMZ.D18.S.Polio.Sequential IPV–bOPV schedule Trigger	IMMZ.D18.S.Polio.Sequential IPV–bOPV schedule Trigger
First cholera booster dose administered-103	First cholera booster dose administered	IMMZ.D18.S.Cholera.WC vaccines schedule Trigger	IMMZ.D18.S.Cholera.WC vaccines schedule Trigger	IMMZ.D18.S.Cholera.WC vaccines schedule Trigger	IMMZ.D18.S.Cholera.WC vaccines schedule Trigger
First cholera booster dose was administered-105	First cholera booster dose was administered	IMMZ.D18.S.Cholera.WC vaccines schedule Completion	IMMZ.D18.S.Cholera.WC vaccines schedule Completion	IMMZ.D18.S.Cholera.WC vaccines schedule Completion	IMMZ.D18.S.Cholera.WC vaccines schedule Completion
First cholera dose administered-105	First cholera dose administered	IMMZ.D18.S.Cholera.WC vaccines schedule Trigger	IMMZ.D18.S.Cholera.WC vaccines schedule Trigger	IMMZ.D18.S.Cholera.WC vaccines schedule Trigger	IMMZ.D18.S.Cholera.WC vaccines schedule Trigger
First cholera dose was administered-107	First cholera dose was administered	IMMZ.D18.S.Cholera.WC vaccines schedule Completion	IMMZ.D18.S.Cholera.WC vaccines schedule Completion	IMMZ.D18.S.Cholera.WC vaccines schedule Completion	IMMZ.D18.S.Cholera.WC vaccines schedule Completion
First cholera dose was administered-115	First cholera dose was administered	IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Trigger	IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Trigger	IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Trigger	IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Trigger
First cholera dose was administered-125	First cholera dose was administered	IMMZ.D18.S.Cholera.WC-rBS vaccine 3-dose schedule Trigger	IMMZ.D18.S.Cholera.WC-rBS vaccine 3-dose schedule Trigger	IMMZ.D18.S.Cholera.WC-rBS vaccine 3-dose schedule Trigger	IMMZ.D18.S.Cholera.WC-rBS vaccine 3-dose schedule Trigger
First cholera dose was administered-68	First cholera dose was administered	IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Completion	IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Completion	IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Completion	IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Completion
First dengue dose from the primary series was administered-115	First dengue dose from the primary series was administered	IMMZ.D18.S.Dengue schedule Trigger	IMMZ.D18.S.Dengue schedule Trigger	IMMZ.D18.S.Dengue schedule Trigger	IMMZ.D18.S.Dengue schedule Trigger
First hepatitis A dose from the primary series was administered-131	First hepatitis A dose from the primary series was administered	IMMZ.D18.S.Hepatitis A.Inactivated HAV 2-dose schedule Trigger	IMMZ.D18.S.Hepatitis A.Inactivated HAV 2-dose schedule Trigger	IMMZ.D18.S.Hepatitis A.Inactivated HAV 2-dose schedule Trigger	IMMZ.D18.S.Hepatitis A.Inactivated HAV 2-dose schedule Trigger
First hepatitis A dose from the primary series was administered. The primary series has been completed-108	First hepatitis A dose from the primary series was administered. The primary series has been completed	IMMZ.D18.S.Hepatitis A.Live attenuated HAV 1-dose schedule Completion	IMMZ.D18.S.Hepatitis A.Live attenuated HAV 1-dose schedule Completion	IMMZ.D18.S.Hepatitis A.Live attenuated HAV 1-dose schedule Completion	IMMZ.D18.S.Hepatitis A.Live attenuated HAV 1-dose schedule Completion
First malaria dose from the primary series was administered-116	First malaria dose from the primary series was administered	IMMZ.D18.S.Malaria schedule Trigger	IMMZ.D18.S.Malaria schedule Trigger	IMMZ.D18.S.Malaria schedule Trigger	IMMZ.D18.S.Malaria schedule Trigger
First meningococcal dose from the primary series was administered and client started the series when client's age was less than or equal to 11 months-237	First meningococcal dose from the primary series was administered and client started the series when client's age was less than or equal to 11 months	IMMZ.D18.S.Meningococcal.Monovalent MenC conjugate vaccine schedule Trigger	IMMZ.D18.S.Meningococcal.Monovalent MenC conjugate vaccine schedule Trigger	IMMZ.D18.S.Meningococcal.Monovalent MenC conjugate vaccine schedule Trigger	IMMZ.D18.S.Meningococcal.Monovalent MenC conjugate vaccine schedule Trigger
First meningococcal dose from the primary series was administered-338	First meningococcal dose from the primary series was administered	IMMZ.D18.S.Meningococcal.Monovalent MenC conjugate vaccine schedule Completion	IMMZ.D18.S.Meningococcal.Monovalent MenC conjugate vaccine schedule Completion	IMMZ.D18.S.Meningococcal.Monovalent MenC conjugate vaccine schedule Completion	IMMZ.D18.S.Meningococcal.Monovalent MenC conjugate vaccine schedule Completion
First meningococcal dose from the primary series was administered-84	First meningococcal dose from the primary series was administered	IMMZ.D18.S.Meningococcal.Quadrivalent conjugate vaccines 2-dose schedule Trigger	IMMZ.D18.S.Meningococcal.Quadrivalent conjugate vaccines 2-dose schedule Trigger	IMMZ.D18.S.Meningococcal.Quadrivalent conjugate vaccines 2-dose schedule Trigger	IMMZ.D18.S.Meningococcal.Quadrivalent conjugate vaccines 2-dose schedule Trigger
First mumps dose from the primary series was administered-125	First mumps dose from the primary series was administered	IMMZ.D18.S.Mumps schedule Trigger	IMMZ.D18.S.Mumps schedule Trigger	IMMZ.D18.S.Mumps schedule Trigger	IMMZ.D18.S.Mumps schedule Trigger
First pneumococcal dose from the primary series was administered to client, who is less than or equal to 5 years of age, within 24 months post birth-280	First pneumococcal dose from the primary series was administered to client, who is less than or equal to 5 years of age, within 24 months post birth	IMMZ.D18.S.Pneumococcal.3 doses schedule Trigger	IMMZ.D18.S.Pneumococcal.3 doses schedule Trigger	IMMZ.D18.S.Pneumococcal.3 doses schedule Trigger	IMMZ.D18.S.Pneumococcal.3 doses schedule Trigger
First pneumococcal dose from the primary series was administered to client, who is less than or equal to 5 years of age. Pneumococcal dose was not administered within 24 months post birth. Client is at high risk for pneumococcal infection.-333	First pneumococcal dose from the primary series was administered to client, who is less than or equal to 5 years of age. Pneumococcal dose was not administered within 24 months post birth. Client is at high risk for pneumococcal infection.	IMMZ.D18.S.Pneumococcal.3 doses schedule Trigger	IMMZ.D18.S.Pneumococcal.3 doses schedule Trigger	IMMZ.D18.S.Pneumococcal.3 doses schedule Trigger	IMMZ.D18.S.Pneumococcal.3 doses schedule Trigger
First pneumococcal dose from the primary series was administered to the client, who is less than or equal to 5 years of age, either within 24 months of birth or if client is at high risk for pneumococcal infection-333	First pneumococcal dose from the primary series was administered to the client, who is less than or equal to 5 years of age, either within 24 months of birth or if client is at high risk for pneumococcal infection	IMMZ.D18.S.Pneumococcal.2 doses with booster dose schedule Trigger	IMMZ.D18.S.Pneumococcal.2 doses with booster dose schedule Trigger	IMMZ.D18.S.Pneumococcal.2 doses with booster dose schedule Trigger	IMMZ.D18.S.Pneumococcal.2 doses with booster dose schedule Trigger
First pneumococcal dose from the primary series was administered-121	First pneumococcal dose from the primary series was administered	IMMZ.D18.S.Pneumococcal.3 doses schedule Completion	IMMZ.D18.S.Pneumococcal.3 doses schedule Completion	IMMZ.D18.S.Pneumococcal.3 doses schedule Completion	IMMZ.D18.S.Pneumococcal.3 doses schedule Completion
First rabies dose from the primary series was administered-115	First rabies dose from the primary series was administered	IMMZ.D18.S.Rabies schedule Trigger	IMMZ.D18.S.Rabies schedule Trigger	IMMZ.D18.S.Rabies schedule Trigger	IMMZ.D18.S.Rabies schedule Trigger
First rotavirus dose from the primary series was administered-118	First rotavirus dose from the primary series was administered	IMMZ.D18.S.Rotavirus schedule Trigger	IMMZ.D18.S.Rotavirus schedule Trigger	IMMZ.D18.S.Rotavirus schedule Trigger	IMMZ.D18.S.Rotavirus schedule Trigger
First tetanus and diphtheria booster dose was administered-140	First tetanus and diphtheria booster dose was administered	IMMZ.D18.S.DTP.Pregnancy starting with 3 doses schedule Trigger	IMMZ.D18.S.DTP.Pregnancy starting with 3 doses schedule Trigger	IMMZ.D18.S.DTP.Pregnancy starting with 3 doses schedule Trigger	IMMZ.D18.S.DTP.Pregnancy starting with 3 doses schedule Trigger
First varicella dose from the primary series was administered-128	First varicella dose from the primary series was administered	IMMZ.D18.S.Varicella.2-dose schedule Trigger	IMMZ.D18.S.Varicella.2-dose schedule Trigger	IMMZ.D18.S.Varicella.2-dose schedule Trigger	IMMZ.D18.S.Varicella.2-dose schedule Trigger
Five poliovirus primary series doses were administered-130	Five poliovirus primary series doses were administered	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs
For a series containing more than two doses, two rotavirus primary series doses of mixed series or a series with unknown vaccine products were administered-324	For a series containing more than two doses, two rotavirus primary series doses of mixed series or a series with unknown vaccine products were administered	IMMZ.D18.S.Rotavirus schedule Trigger	IMMZ.D18.S.Rotavirus schedule Trigger	IMMZ.D18.S.Rotavirus schedule Trigger	IMMZ.D18.S.Rotavirus schedule Trigger
Four malaria primary series doses were administered-116	Four malaria primary series doses were administered	IMMZ.D2.DT.Malaria Inputs	IMMZ.D2.DT.Malaria Inputs	IMMZ.D2.DT.Malaria Inputs	IMMZ.D2.DT.Malaria Inputs
Four poliovirus primary series doses were administered-130	Four poliovirus primary series doses were administered	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Inputs	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Inputs	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Inputs	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Inputs
Fourth malaria dose from the primary series was administered. The primary series has been completed-94	Fourth malaria dose from the primary series was administered. The primary series has been completed	IMMZ.D18.S.Malaria schedule Completion	IMMZ.D18.S.Malaria schedule Completion	IMMZ.D18.S.Malaria schedule Completion	IMMZ.D18.S.Malaria schedule Completion
From the four doses administered, one is IPV and three are bOPV-115	From the four doses administered, one is IPV and three are bOPV	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs
From the four doses administered, two are IPV and two are bOPV-115	From the four doses administered, two are IPV and two are bOPV	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs
From the three doses administered, one is IPV and two are bOPV-115	From the three doses administered, one is IPV and two are bOPV	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs
From the three doses administered, one is bOPV and two are IPV-115	From the three doses administered, one is bOPV and two are IPV	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs
From the two doses administered one is bOPV and one is IPV-115	From the two doses administered one is bOPV and one is IPV	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs	IMMZ.D2.DT.Polio.bOPV plus IPV Inputs
HPV immunization schedule is complete-49	HPV immunization schedule is complete	IMMZ.D2.DT.HPV.Single dose Output	IMMZ.D2.DT.HPV.Single dose Output	IMMZ.D2.DT.HPV.Single dose Output	IMMZ.D2.DT.HPV.Single dose Output
HPV vaccination could be contraindicated. Clinical judgement is required. Create a clinical note-66	HPV vaccination could be contraindicated. Clinical judgement is required. Create a clinical note	IMMZ.D5.DT.HPV contraindications Output	IMMZ.D5.DT.HPV contraindications Output	IMMZ.D5.DT.HPV contraindications Output	IMMZ.D5.DT.HPV contraindications Output
Hepatitis A immunization schedule is complete-158	Hepatitis A immunization schedule is complete	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Output	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Output	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Output	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Output
Hepatitis A vaccination could be contraindicated. Clinical judgement is required. Create a clinical note-66	Hepatitis A vaccination could be contraindicated. Clinical judgement is required. Create a clinical note	IMMZ.D5.DT.Hepatitis A contraindications Output	IMMZ.D5.DT.Hepatitis A contraindications Output	IMMZ.D5.DT.Hepatitis A contraindications Output	IMMZ.D5.DT.Hepatitis A contraindications Output
Hib immunization schedule is complete-150	Hib immunization schedule is complete	IMMZ.D2.DT.Hib.2 doses with booster dose Output	IMMZ.D2.DT.Hib.2 doses with booster dose Output	IMMZ.D2.DT.Hib.2 doses with booster dose Output	IMMZ.D2.DT.Hib.2 doses with booster dose Output
Hib immunization schedule is complete-49	Hib immunization schedule is complete	IMMZ.D2.DT.Hib.2 doses with booster dose Output	IMMZ.D2.DT.Hib.2 doses with booster dose Output	IMMZ.D2.DT.Hib.2 doses with booster dose Output	IMMZ.D2.DT.Hib.2 doses with booster dose Output
Hib vaccination could be contraindicated. Clinical judgement is required. Create a clinical note.-66	Hib vaccination could be contraindicated. Clinical judgement is required. Create a clinical note.	IMMZ.D5.DT.Hib contraindications Output	IMMZ.D5.DT.Hib contraindications Output	IMMZ.D5.DT.Hib contraindications Output	IMMZ.D5.DT.Hib contraindications Output
Human papillomavirus (HPV) vaccination is contraindicated-56	Human papillomavirus (HPV) vaccination is contraindicated	IMMZ.D5.DT.HPV contraindications Output	IMMZ.D5.DT.HPV contraindications Output	IMMZ.D5.DT.HPV contraindications Output	IMMZ.D5.DT.HPV contraindications Output
IMMZ.D5.DT.Measles contraindications-0	IMMZ.D5.DT.Measles contraindications	IMMZ.D2.DT.Measles.Supplementary dose Inputs	IMMZ.D2.DT.Measles.Supplementary dose Inputs	IMMZ.D2.DT.Measles.Supplementary dose Inputs	IMMZ.D2.DT.Measles.Supplementary dose Inputs
JE immunization schedule is complete-138	JE immunization schedule is complete	IMMZ.D2.DT.JE.Live recombinant vaccine Output	IMMZ.D2.DT.JE.Live recombinant vaccine Output	IMMZ.D2.DT.JE.Live recombinant vaccine Output	IMMZ.D2.DT.JE.Live recombinant vaccine Output
Live attentuated Hepatitis A-containing vaccine is contraindicated-131	Live attentuated Hepatitis A-containing vaccine is contraindicated	IMMZ.D5.DT.Hepatitis A contraindications Output	IMMZ.D5.DT.Hepatitis A contraindications Output	IMMZ.D5.DT.Hepatitis A contraindications Output	IMMZ.D5.DT.Hepatitis A contraindications Output
Live vaccine was administered in last 4 weeks-92	Live vaccine was administered in last 4 weeks	IMMZ.D2.DT.Rotavirus Inputs	IMMZ.D2.DT.Rotavirus Inputs	IMMZ.D2.DT.Rotavirus Inputs	IMMZ.D2.DT.Rotavirus Inputs
Live vaccine was administered in the last 4 weeks-92	Live vaccine was administered in the last 4 weeks	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs
Live vaccine was administered in the last four weeks-92	Live vaccine was administered in the last four weeks	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs
Live vaccine was administered in the last the 4 weeks-92	Live vaccine was administered in the last the 4 weeks	IMMZ.D2.DT.Rubella.Low incidence Inputs	IMMZ.D2.DT.Rubella.Low incidence Inputs	IMMZ.D2.DT.Rubella.Low incidence Inputs	IMMZ.D2.DT.Rubella.Low incidence Inputs
Live vaccine was administered in the past 4 weeks-92	Live vaccine was administered in the past 4 weeks	IMMZ.D2.DT.Mumps Inputs	IMMZ.D2.DT.Mumps Inputs	IMMZ.D2.DT.Mumps Inputs	IMMZ.D2.DT.Mumps Inputs
Live vaccine, other than typhoid, was administered in the past 4 weeks-132	Live vaccine, other than typhoid, was administered in the past 4 weeks	IMMZ.D2.DT.Typhoid.Ty21a Inputs	IMMZ.D2.DT.Typhoid.Ty21a Inputs	IMMZ.D2.DT.Typhoid.Ty21a Inputs	IMMZ.D2.DT.Typhoid.Ty21a Inputs
Live vaccines was administered in the last 4 weeks-92	Live vaccines was administered in the last 4 weeks	IMMZ.D2.DT.Rotavirus Inputs	IMMZ.D2.DT.Rotavirus Inputs	IMMZ.D2.DT.Rotavirus Inputs	IMMZ.D2.DT.Rotavirus Inputs
MCV supplementary dose was administered-131	MCV supplementary dose was administered	IMMZ.D18.S.Measles.Supplementary dose schedule Completion	IMMZ.D18.S.Measles.Supplementary dose schedule Completion	IMMZ.D18.S.Measles.Supplementary dose schedule Completion	IMMZ.D18.S.Measles.Supplementary dose schedule Completion
MCV0 was administered-119	MCV0 was administered	IMMZ.D18.S.Measles.MCV dose 0 schedule Completion	IMMZ.D18.S.Measles.MCV dose 0 schedule Completion	IMMZ.D18.S.Measles.MCV dose 0 schedule Completion	IMMZ.D18.S.Measles.MCV dose 0 schedule Completion
MCV0 was not administered-119	MCV0 was not administered	IMMZ.D2.DT.Measles.MCV dose 0 Inputs	IMMZ.D2.DT.Measles.MCV dose 0 Inputs	IMMZ.D2.DT.Measles.MCV dose 0 Inputs	IMMZ.D2.DT.Measles.MCV dose 0 Inputs
MCV1 was administered-127	MCV1 was administered	IMMZ.D18.S.Measles.Low transmission schedule Trigger	IMMZ.D18.S.Measles.Low transmission schedule Trigger	IMMZ.D18.S.Measles.Low transmission schedule Trigger	IMMZ.D18.S.Measles.Low transmission schedule Trigger
MCV2 was administered-127	MCV2 was administered	IMMZ.D2.DT.Measles.Low transmission Inputs	IMMZ.D2.DT.Measles.Low transmission Inputs	IMMZ.D2.DT.Measles.Low transmission Inputs	IMMZ.D2.DT.Measles.Low transmission Inputs
MCV2 was administered. The primary series has been completed-104	MCV2 was administered. The primary series has been completed	IMMZ.D18.S.Measles.Low transmission schedule Completion	IMMZ.D18.S.Measles.Low transmission schedule Completion	IMMZ.D18.S.Measles.Low transmission schedule Completion	IMMZ.D18.S.Measles.Low transmission schedule Completion
MCV2 was administered. The primary series has been completed.-104	MCV2 was administered. The primary series has been completed.	IMMZ.D18.S.Measles.Ongoing transmission schedule Completion	IMMZ.D18.S.Measles.Ongoing transmission schedule Completion	IMMZ.D18.S.Measles.Ongoing transmission schedule Completion	IMMZ.D18.S.Measles.Ongoing transmission schedule Completion
Malaria immunization schedule is complete-144	Malaria immunization schedule is complete	IMMZ.D2.DT.Malaria Output	IMMZ.D2.DT.Malaria Output	IMMZ.D2.DT.Malaria Output	IMMZ.D2.DT.Malaria Output
Malaria vaccination could be contraindicated. Clinical judgement is required. Create a clinical note-66	Malaria vaccination could be contraindicated. Clinical judgement is required. Create a clinical note	IMMZ.D5.DT.Malaria contraindications Output	IMMZ.D5.DT.Malaria contraindications Output	IMMZ.D5.DT.Malaria contraindications Output	IMMZ.D5.DT.Malaria contraindications Output
Measles immunization schedule is complete-49	Measles immunization schedule is complete	IMMZ.D2.DT.Measles.Supplementary dose Output	IMMZ.D2.DT.Measles.Supplementary dose Output	IMMZ.D2.DT.Measles.Supplementary dose Output	IMMZ.D2.DT.Measles.Supplementary dose Output
Measles primary series is complete-104	Measles primary series is complete	IMMZ.D2.DT.Measles.Low transmission Output	IMMZ.D2.DT.Measles.Low transmission Output	IMMZ.D2.DT.Measles.Low transmission Output	IMMZ.D2.DT.Measles.Low transmission Output
Measles routine immunization schedule is complete-104	Measles routine immunization schedule is complete	IMMZ.D2.DT.Measles.Supplementary dose Inputs	IMMZ.D2.DT.Measles.Supplementary dose Inputs	IMMZ.D2.DT.Measles.Supplementary dose Inputs	IMMZ.D2.DT.Measles.Supplementary dose Inputs
Measles supplementary dose was administered-131	Measles supplementary dose was administered	IMMZ.D2.DT.Measles.Supplementary dose Inputs	IMMZ.D2.DT.Measles.Supplementary dose Inputs	IMMZ.D2.DT.Measles.Supplementary dose Inputs	IMMZ.D2.DT.Measles.Supplementary dose Inputs
Measles supplementary dose was not administered-131	Measles supplementary dose was not administered	IMMZ.D2.DT.Measles.Supplementary dose Inputs	IMMZ.D2.DT.Measles.Supplementary dose Inputs	IMMZ.D2.DT.Measles.Supplementary dose Inputs	IMMZ.D2.DT.Measles.Supplementary dose Inputs
Measles vaccination contraindicated-56	Measles vaccination contraindicated	IMMZ.D5.DT.Measles contraindications Output	IMMZ.D5.DT.Measles contraindications Output	IMMZ.D5.DT.Measles contraindications Output	IMMZ.D5.DT.Measles contraindications Output
Measles vaccination could be contraindicated. Clinical judgement required. Create a clinical note-66	Measles vaccination could be contraindicated. Clinical judgement required. Create a clinical note	IMMZ.D5.DT.Measles contraindications Output	IMMZ.D5.DT.Measles contraindications Output	IMMZ.D5.DT.Measles contraindications Output	IMMZ.D5.DT.Measles contraindications Output
Meningococcal booster dose was administered for the client that started the series when client's age was less than or equal to 11 months. Immunization schedule has been completed-120	Meningococcal booster dose was administered for the client that started the series when client's age was less than or equal to 11 months. Immunization schedule has been completed	IMMZ.D18.S.Meningococcal.Monovalent MenC conjugate vaccine schedule Completion	IMMZ.D18.S.Meningococcal.Monovalent MenC conjugate vaccine schedule Completion	IMMZ.D18.S.Meningococcal.Monovalent MenC conjugate vaccine schedule Completion	IMMZ.D18.S.Meningococcal.Monovalent MenC conjugate vaccine schedule Completion
Meningococcal booster dose was administered-120	Meningococcal booster dose was administered	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs
Meningococcal booster dose was administered. The immunization schedule has been completed-120	Meningococcal booster dose was administered. The immunization schedule has been completed	IMMZ.D18.S.Meningococcal.Polysaccharide vaccines schedule Completion	IMMZ.D18.S.Meningococcal.Polysaccharide vaccines schedule Completion	IMMZ.D18.S.Meningococcal.Polysaccharide vaccines schedule Completion	IMMZ.D18.S.Meningococcal.Polysaccharide vaccines schedule Completion
Meningococcal immunization schedule is complete-149	Meningococcal immunization schedule is complete	IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Output	IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Output	IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Output	IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Output
Meningococcal immunization schedule is complete-49	Meningococcal immunization schedule is complete	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Output	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Output	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Output	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Output
Meningococcal vaccination could be contraindicated. Clinical judgement is required. Create a clinical note-130	Meningococcal vaccination could be contraindicated. Clinical judgement is required. Create a clinical note	IMMZ.D5.DT.Meningococcal contraindications Output	IMMZ.D5.DT.Meningococcal contraindications Output	IMMZ.D5.DT.Meningococcal contraindications Output	IMMZ.D5.DT.Meningococcal contraindications Output
Mumps immunization schedule is complete-153	Mumps immunization schedule is complete	IMMZ.D2.DT.Mumps Output	IMMZ.D2.DT.Mumps Output	IMMZ.D2.DT.Mumps Output	IMMZ.D2.DT.Mumps Output
Mumps vaccination could be contraindicated. Clinical judgement is required.-88	Mumps vaccination could be contraindicated. Clinical judgement is required.	IMMZ.D5.DT.Mumps contraindications Output	IMMZ.D5.DT.Mumps contraindications Output	IMMZ.D5.DT.Mumps contraindications Output	IMMZ.D5.DT.Mumps contraindications Output
Mumps vaccination is contraindicated-56	Mumps vaccination is contraindicated	IMMZ.D5.DT.Mumps contraindications Output	IMMZ.D5.DT.Mumps contraindications Output	IMMZ.D5.DT.Mumps contraindications Output	IMMZ.D5.DT.Mumps contraindications Output
No BCG primary series dose was administered-112	No BCG primary series dose was administered	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs
No DTP doses were administered and client's age is more than 1 year-129	No DTP doses were administered and client's age is more than 1 year	IMMZ.D18.S.DTP.Delayed or interrupted schedule Trigger	IMMZ.D18.S.DTP.Delayed or interrupted schedule Trigger	IMMZ.D18.S.DTP.Delayed or interrupted schedule Trigger	IMMZ.D18.S.DTP.Delayed or interrupted schedule Trigger
No DTP primary series doses were administered-123	No DTP primary series doses were administered	IMMZ.D2.DT.DTP.On-time start Inputs	IMMZ.D2.DT.DTP.On-time start Inputs	IMMZ.D2.DT.DTP.On-time start Inputs	IMMZ.D2.DT.DTP.On-time start Inputs
No DTP primary series doses were administered-124	No DTP primary series doses were administered	IMMZ.D2.DT.DTP.Pregnancy Inputs	IMMZ.D2.DT.DTP.Pregnancy Inputs	IMMZ.D2.DT.DTP.Pregnancy Inputs	IMMZ.D2.DT.DTP.Pregnancy Inputs
No HPV primary series doses were administered-112	No HPV primary series doses were administered	IMMZ.D2.DT.HPV.Single dose Inputs	IMMZ.D2.DT.HPV.Single dose Inputs	IMMZ.D2.DT.HPV.Single dose Inputs	IMMZ.D2.DT.HPV.Single dose Inputs
No Hib booster doses were administered-120	No Hib booster doses were administered	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs
No Hib booster doses were administered-121	No Hib booster doses were administered	IMMZ.D2.DT.Hib.3 doses with booster dose Inputs	IMMZ.D2.DT.Hib.3 doses with booster dose Inputs	IMMZ.D2.DT.Hib.3 doses with booster dose Inputs	IMMZ.D2.DT.Hib.3 doses with booster dose Inputs
No Hib primary series doses were administered-123	No Hib primary series doses were administered	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs
No Hib primary series doses were administered-124	No Hib primary series doses were administered	IMMZ.D2.DT.Hib.3 doses with booster dose Inputs	IMMZ.D2.DT.Hib.3 doses with booster dose Inputs	IMMZ.D2.DT.Hib.3 doses with booster dose Inputs	IMMZ.D2.DT.Hib.3 doses with booster dose Inputs
No JE primary series doses were administered-111	No JE primary series doses were administered	IMMZ.D2.DT.JE.Live recombinant vaccine Inputs	IMMZ.D2.DT.JE.Live recombinant vaccine Inputs	IMMZ.D2.DT.JE.Live recombinant vaccine Inputs	IMMZ.D2.DT.JE.Live recombinant vaccine Inputs
No TBE booster dose was administered-110	No TBE booster dose was administered	IMMZ.D2.DT.TBE.Encepur Inputs	IMMZ.D2.DT.TBE.Encepur Inputs	IMMZ.D2.DT.TBE.Encepur Inputs	IMMZ.D2.DT.TBE.Encepur Inputs
No TBE primary series doses were administered-112	No TBE primary series doses were administered	IMMZ.D2.DT.TBE.EnceVir Inputs	IMMZ.D2.DT.TBE.EnceVir Inputs	IMMZ.D2.DT.TBE.EnceVir Inputs	IMMZ.D2.DT.TBE.EnceVir Inputs
No cholera booster series dose was administered-114	No cholera booster series dose was administered	IMMZ.D2.DT.Cholera.WC vaccines Inputs	IMMZ.D2.DT.Cholera.WC vaccines Inputs	IMMZ.D2.DT.Cholera.WC vaccines Inputs	IMMZ.D2.DT.Cholera.WC vaccines Inputs
No cholera primary series dose was administered-116	No cholera primary series dose was administered	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs
No dengue doses from primary series were administered-115	No dengue doses from primary series were administered	IMMZ.D18.S.Dengue schedule Trigger	IMMZ.D18.S.Dengue schedule Trigger	IMMZ.D18.S.Dengue schedule Trigger	IMMZ.D18.S.Dengue schedule Trigger
No dengue primary series doses were administered-115	No dengue primary series doses were administered	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs
No hepatitis A primary series dose was administered-131	No hepatitis A primary series dose was administered	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs
No hepatitis A primary series doses were administered-131	No hepatitis A primary series doses were administered	IMMZ.D2.DT.Hepatitis A.Inactivated HAV 2 doses Inputs	IMMZ.D2.DT.Hepatitis A.Inactivated HAV 2 doses Inputs	IMMZ.D2.DT.Hepatitis A.Inactivated HAV 2 doses Inputs	IMMZ.D2.DT.Hepatitis A.Inactivated HAV 2 doses Inputs
No live vaccine was administered in last 4 weeks-92	No live vaccine was administered in last 4 weeks	IMMZ.D2.DT.Rotavirus Inputs	IMMZ.D2.DT.Rotavirus Inputs	IMMZ.D2.DT.Rotavirus Inputs	IMMZ.D2.DT.Rotavirus Inputs
No live vaccine was administered in the last 4 weeks-101	No live vaccine was administered in the last 4 weeks	IMMZ.D2.DT.JE.Live attenuated vaccine Inputs	IMMZ.D2.DT.JE.Live attenuated vaccine Inputs	IMMZ.D2.DT.JE.Live attenuated vaccine Inputs	IMMZ.D2.DT.JE.Live attenuated vaccine Inputs
No live vaccine was administered in the last 4 weeks-92	No live vaccine was administered in the last 4 weeks	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs
No live vaccine was administered in the last four weeks-92	No live vaccine was administered in the last four weeks	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs
No live vaccine was administered in the past 4 weeks-92	No live vaccine was administered in the past 4 weeks	IMMZ.D2.DT.Mumps Inputs	IMMZ.D2.DT.Mumps Inputs	IMMZ.D2.DT.Mumps Inputs	IMMZ.D2.DT.Mumps Inputs
No live vaccine was administered-90	No live vaccine was administered	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs
No live vaccine, other than typhoid, was administered in the past 4 weeks-132	No live vaccine, other than typhoid, was administered in the past 4 weeks	IMMZ.D2.DT.Typhoid.Ty21a Inputs	IMMZ.D2.DT.Typhoid.Ty21a Inputs	IMMZ.D2.DT.Typhoid.Ty21a Inputs	IMMZ.D2.DT.Typhoid.Ty21a Inputs
No malaria primary series doses were administered-116	No malaria primary series doses were administered	IMMZ.D2.DT.Malaria Inputs	IMMZ.D2.DT.Malaria Inputs	IMMZ.D2.DT.Malaria Inputs	IMMZ.D2.DT.Malaria Inputs
No measles primary series doses were administered-127	No measles primary series doses were administered	IMMZ.D2.DT.Measles.Low transmission Inputs	IMMZ.D2.DT.Measles.Low transmission Inputs	IMMZ.D2.DT.Measles.Low transmission Inputs	IMMZ.D2.DT.Measles.Low transmission Inputs
No meningococcal booster dose was administered-120	No meningococcal booster dose was administered	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs
No meningococcal primary series dose was administered-122	No meningococcal primary series dose was administered	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs
No mumps primary series doses were administered-125	No mumps primary series doses were administered	IMMZ.D2.DT.Mumps Inputs	IMMZ.D2.DT.Mumps Inputs	IMMZ.D2.DT.Mumps Inputs	IMMZ.D2.DT.Mumps Inputs
No pertussis booster doses were administered-126	No pertussis booster doses were administered	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs
No pertussis booster doses were administered-127	No pertussis booster doses were administered	IMMZ.D2.DT.DTP.On-time start Inputs	IMMZ.D2.DT.DTP.On-time start Inputs	IMMZ.D2.DT.DTP.On-time start Inputs	IMMZ.D2.DT.DTP.On-time start Inputs
No pneumococcal booster dose was administered-119	No pneumococcal booster dose was administered	IMMZ.D2.DT.Pneumococcal.3 doses Inputs	IMMZ.D2.DT.Pneumococcal.3 doses Inputs	IMMZ.D2.DT.Pneumococcal.3 doses Inputs	IMMZ.D2.DT.Pneumococcal.3 doses Inputs
No pneumococcal primary series doses were administered-121	No pneumococcal primary series doses were administered	IMMZ.D2.DT.Pneumococcal.3 doses Inputs	IMMZ.D2.DT.Pneumococcal.3 doses Inputs	IMMZ.D2.DT.Pneumococcal.3 doses Inputs	IMMZ.D2.DT.Pneumococcal.3 doses Inputs
No polio booster dose was administered-128	No polio booster dose was administered	IMMZ.D2.DT.Polio.IPV-only Inputs	IMMZ.D2.DT.Polio.IPV-only Inputs	IMMZ.D2.DT.Polio.IPV-only Inputs	IMMZ.D2.DT.Polio.IPV-only Inputs
No poliovirus primary series doses were administered-130	No poliovirus primary series doses were administered	IMMZ.D2.DT.Polio.IPV-only Inputs	IMMZ.D2.DT.Polio.IPV-only Inputs	IMMZ.D2.DT.Polio.IPV-only Inputs	IMMZ.D2.DT.Polio.IPV-only Inputs
No rabies primary series doses were administered-115	No rabies primary series doses were administered	IMMZ.D2.DT.Rabies Inputs	IMMZ.D2.DT.Rabies Inputs	IMMZ.D2.DT.Rabies Inputs	IMMZ.D2.DT.Rabies Inputs
No rotavirus primary series doses were administered-118	No rotavirus primary series doses were administered	IMMZ.D2.DT.Rotavirus Inputs	IMMZ.D2.DT.Rotavirus Inputs	IMMZ.D2.DT.Rotavirus Inputs	IMMZ.D2.DT.Rotavirus Inputs
No rubella primary series dose was administered-127	No rubella primary series dose was administered	IMMZ.D2.DT.Rubella.Low incidence Inputs	IMMZ.D2.DT.Rubella.Low incidence Inputs	IMMZ.D2.DT.Rubella.Low incidence Inputs	IMMZ.D2.DT.Rubella.Low incidence Inputs
No tetanus and diphtheria booster dose was administered-140	No tetanus and diphtheria booster dose was administered	IMMZ.D2.DT.DTP.Pregnancy Inputs	IMMZ.D2.DT.DTP.Pregnancy Inputs	IMMZ.D2.DT.DTP.Pregnancy Inputs	IMMZ.D2.DT.DTP.Pregnancy Inputs
No tetanus and diphtheria booster doses were administered-140	No tetanus and diphtheria booster doses were administered	IMMZ.D2.DT.DTP.Pregnancy starting with 3 doses Inputs	IMMZ.D2.DT.DTP.Pregnancy starting with 3 doses Inputs	IMMZ.D2.DT.DTP.Pregnancy starting with 3 doses Inputs	IMMZ.D2.DT.DTP.Pregnancy starting with 3 doses Inputs
No tetanus and diphtheria booster doses were administered-141	No tetanus and diphtheria booster doses were administered	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs
No typhoid primary series doses were administered-116	No typhoid primary series doses were administered	IMMZ.D2.DT.Typhoid.ViPS Inputs	IMMZ.D2.DT.Typhoid.ViPS Inputs	IMMZ.D2.DT.Typhoid.ViPS Inputs	IMMZ.D2.DT.Typhoid.ViPS Inputs
No yellow fever primary series doses were administered-121	No yellow fever primary series doses were administered	IMMZ.D2.DT.Yellow fever Inputs	IMMZ.D2.DT.Yellow fever Inputs	IMMZ.D2.DT.Yellow fever Inputs	IMMZ.D2.DT.Yellow fever Inputs
One BCG dose from the primary series was administered. The primary series has been completed-89	One BCG dose from the primary series was administered. The primary series has been completed	IMMZ.D18.S.BCG schedule Completion	IMMZ.D18.S.BCG schedule Completion	IMMZ.D18.S.BCG schedule Completion	IMMZ.D18.S.BCG schedule Completion
One BCG primary series dose was administered-112	One BCG primary series dose was administered	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs	IMMZ.D2.DT.BCG Inputs
One DTP primary series dose was administered-123	One DTP primary series dose was administered	IMMZ.D2.DT.DTP.On-time start Inputs	IMMZ.D2.DT.DTP.On-time start Inputs	IMMZ.D2.DT.DTP.On-time start Inputs	IMMZ.D2.DT.DTP.On-time start Inputs
One DTP primary series dose was administered-124	One DTP primary series dose was administered	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs
One HPV primary series dose was administered-112	One HPV primary series dose was administered	IMMZ.D2.DT.HPV.Single dose Inputs	IMMZ.D2.DT.HPV.Single dose Inputs	IMMZ.D2.DT.HPV.Single dose Inputs	IMMZ.D2.DT.HPV.Single dose Inputs
One Hib booster dose was administered-120	One Hib booster dose was administered	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs
One Hib booster dose was administered. Hib immunization schedule has been completed-120	One Hib booster dose was administered. Hib immunization schedule has been completed	IMMZ.D18.S.Hib.2 doses with booster dose schedule Completion	IMMZ.D18.S.Hib.2 doses with booster dose schedule Completion	IMMZ.D18.S.Hib.2 doses with booster dose schedule Completion	IMMZ.D18.S.Hib.2 doses with booster dose schedule Completion
One Hib primary series dose was administered-122	One Hib primary series dose was administered	IMMZ.D2.DT.Hib.3 doses with booster dose Inputs	IMMZ.D2.DT.Hib.3 doses with booster dose Inputs	IMMZ.D2.DT.Hib.3 doses with booster dose Inputs	IMMZ.D2.DT.Hib.3 doses with booster dose Inputs
One Hib primary series doses was administered-122	One Hib primary series doses was administered	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs	IMMZ.D2.DT.Hib.2 doses with booster dose Inputs
One JE dose from primary series was administered. The primary series has been completed-88	One JE dose from primary series was administered. The primary series has been completed	IMMZ.D18.S.JE.Live recombinant vaccination schedule Completion	IMMZ.D18.S.JE.Live recombinant vaccination schedule Completion	IMMZ.D18.S.JE.Live recombinant vaccination schedule Completion	IMMZ.D18.S.JE.Live recombinant vaccination schedule Completion
One JE primary series dose was administered-111	One JE primary series dose was administered	IMMZ.D2.DT.JE.Live attenuated vaccine Inputs	IMMZ.D2.DT.JE.Live attenuated vaccine Inputs	IMMZ.D2.DT.JE.Live attenuated vaccine Inputs	IMMZ.D2.DT.JE.Live attenuated vaccine Inputs
One JE primary series doses were administered-111	One JE primary series doses were administered	IMMZ.D2.DT.JE.Live recombinant vaccine Inputs	IMMZ.D2.DT.JE.Live recombinant vaccine Inputs	IMMZ.D2.DT.JE.Live recombinant vaccine Inputs	IMMZ.D2.DT.JE.Live recombinant vaccine Inputs
One TBE primary series dose was administered-112	One TBE primary series dose was administered	IMMZ.D2.DT.TBE.EnceVir Inputs	IMMZ.D2.DT.TBE.EnceVir Inputs	IMMZ.D2.DT.TBE.EnceVir Inputs	IMMZ.D2.DT.TBE.EnceVir Inputs
One cholera primary series dose was administered-116	One cholera primary series dose was administered	IMMZ.D2.DT.Cholera.WC vaccines Inputs	IMMZ.D2.DT.Cholera.WC vaccines Inputs	IMMZ.D2.DT.Cholera.WC vaccines Inputs	IMMZ.D2.DT.Cholera.WC vaccines Inputs
One dengue primary series dose was administered-115	One dengue primary series dose was administered	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs	IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs
One hepatitis A primary series dose was administered-131	One hepatitis A primary series dose was administered	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs	IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs
One malaria primary series dose was administered-116	One malaria primary series dose was administered	IMMZ.D2.DT.Malaria Inputs	IMMZ.D2.DT.Malaria Inputs	IMMZ.D2.DT.Malaria Inputs	IMMZ.D2.DT.Malaria Inputs
One meningococcal dose from primary series was administered. The primary series has been completed-99	One meningococcal dose from primary series was administered. The primary series has been completed	IMMZ.D18.S.Meningococcal.Polysaccharide vaccines schedule Completion	IMMZ.D18.S.Meningococcal.Polysaccharide vaccines schedule Completion	IMMZ.D18.S.Meningococcal.Polysaccharide vaccines schedule Completion	IMMZ.D18.S.Meningococcal.Polysaccharide vaccines schedule Completion
One meningococcal dose from the primary series was administered. The primary series has been completed-99	One meningococcal dose from the primary series was administered. The primary series has been completed	IMMZ.D18.S.Meningococcal.MenA conjugate vaccine 1-dose schedule Completion	IMMZ.D18.S.Meningococcal.MenA conjugate vaccine 1-dose schedule Completion	IMMZ.D18.S.Meningococcal.MenA conjugate vaccine 1-dose schedule Completion	IMMZ.D18.S.Meningococcal.MenA conjugate vaccine 1-dose schedule Completion
One meningococcal primary series dose was administered-122	One meningococcal primary series dose was administered	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs	IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs
One mumps primary series dose was administered-125	One mumps primary series dose was administered	IMMZ.D2.DT.Mumps Inputs	IMMZ.D2.DT.Mumps Inputs	IMMZ.D2.DT.Mumps Inputs	IMMZ.D2.DT.Mumps Inputs
One pertussis booster dose was administered-126	One pertussis booster dose was administered	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs	IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs
One pertussis booster dose was administered-127	One pertussis booster dose was administered	IMMZ.D2.DT.DTP.On-time start Inputs	IMMZ.D2.DT.DTP.On-time start Inputs	IMMZ.D2.DT.DTP.On-time start Inputs	IMMZ.D2.DT.DTP.On-time start Inputs
One pneumococcal booster dose was administered-119	One pneumococcal booster dose was administered	IMMZ.D2.DT.Pneumococcal.3 doses Inputs	IMMZ.D2.DT.Pneumococcal.3 doses Inputs	IMMZ.D2.DT.Pneumococcal.3 doses Inputs	IMMZ.D2.DT.Pneumococcal.3 doses Inputs
One pneumococcal booster dose was administered.-119	One pneumococcal booster dose was administered.	IMMZ.D18.S.Pneumococcal.3 doses schedule Completion	IMMZ.D18.S.Pneumococcal.3 doses schedule Completion	IMMZ.D18.S.Pneumococcal.3 doses schedule Completion	IMMZ.D18.S.Pneumococcal.3 doses schedule Completion
One pneumococcal primary series dose was administered-121	One pneumococcal primary series dose was administered	IMMZ.D2.DT.Pneumococcal.3 doses Inputs	IMMZ.D2.DT.Pneumococcal.3 doses Inputs	IMMZ.D2.DT.Pneumococcal.3 doses Inputs	IMMZ.D2.DT.Pneumococcal.3 doses Inputs
One poliovirus primary series dose was administered-130	One poliovirus primary series dose was administered	IMMZ.D2.DT.Polio.IPV-only Inputs	IMMZ.D2.DT.Polio.IPV-only Inputs	IMMZ.D2.DT.Polio.IPV-only Inputs	IMMZ.D2.DT.Polio.IPV-only Inputs
One rabies primary series doses were administered-115	One rabies primary series doses were administered	IMMZ.D2.DT.Rabies Inputs	IMMZ.D2.DT.Rabies Inputs	IMMZ.D2.DT.Rabies Inputs	IMMZ.D2.DT.Rabies Inputs
One rotavirus primary series dose was administered-118	One rotavirus primary series dose was administered	IMMZ.D2.DT.Rotavirus Inputs	IMMZ.D2.DT.Rotavirus Inputs	IMMZ.D2.DT.Rotavirus Inputs	IMMZ.D2.DT.Rotavirus Inputs
One rubella dose from the primary series was administered. The primary series has been completed-104	One rubella dose from the primary series was administered. The primary series has been completed	IMMZ.D18.S.Rubella.Low incidence schedule Completion	IMMZ.D18.S.Rubella.Low incidence schedule Completion	IMMZ.D18.S.Rubella.Low incidence schedule Completion	IMMZ.D18.S.Rubella.Low incidence schedule Completion
One rubella primary series dose was administered-127	One rubella primary series dose was administered	IMMZ.D2.DT.Rubella.Low incidence Inputs	IMMZ.D2.DT.Rubella.Low incidence Inputs	IMMZ.D2.DT.Rubella.Low incidence Inputs	IMMZ.D2.DT.Rubella.Low incidence Inputs
One tetanus and diphtheria booster dose was administered-140	One tetanus and diphtheria booster dose was administered	IMMZ.D2.DT.DTP.Pregnancy Inputs	IMMZ.D2.DT.DTP.Pregnancy Inputs	IMMZ.D2.DT.DTP.Pregnancy Inputs	IMMZ.D2.DT.DTP.Pregnancy Inputs
One tetanus and diphtheria booster dose was administered-141	One tetanus and diphtheria booster dose was administered	IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Inputs	IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Inputs	IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Inputs	IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Inputs
One tetanus and diphtheria booster doses were administered-140	One tetanus and diphtheria booster doses were administered	IMMZ.D2.DT.DTP.Pregnancy starting with 3 doses Inputs	IMMZ.D2.DT.DTP.Pregnancy starting with 3 doses Inputs	IMMZ.D2.DT.DTP.Pregnancy starting with 3 doses Inputs	IMMZ.D2.DT.DTP.Pregnancy starting with 3 doses Inputs
One typhoid dose from primary series was administered. The primary series has been completed-93	One typhoid dose from primary series was administered. The primary series has been completed	IMMZ.D18.S.Typhoid.TCV schedule Completion	IMMZ.D18.S.Typhoid.TCV schedule Completion	IMMZ.D18.S.Typhoid.TCV schedule Completion	IMMZ.D18.S.Typhoid.TCV schedule Completion
One typhoid dose from the primary series was administered. The primary series has been completed-93	One typhoid dose from the primary series was administered. The primary series has been completed	IMMZ.D18.S.Typhoid.ViPS schedule Completion	IMMZ.D18.S.Typhoid.ViPS schedule Completion	IMMZ.D18.S.Typhoid.ViPS schedule Completion	IMMZ.D18.S.Typhoid.ViPS schedule Completion
One typhoid primary series dose was administered-116	One typhoid primary series dose was administered	IMMZ.D2.DT.Typhoid.ViPS Inputs	IMMZ.D2.DT.Typhoid.ViPS Inputs	IMMZ.D2.DT.Typhoid.ViPS Inputs	IMMZ.D2.DT.Typhoid.ViPS Inputs
One varicella dose from primary series was administered. The primary series has been completed-106	One varicella dose from primary series was administered. The primary series has been completed	IMMZ.D18.S.Varicella.1-dose schedule Completion	IMMZ.D18.S.Varicella.1-dose schedule Completion	IMMZ.D18.S.Varicella.1-dose schedule Completion	IMMZ.D18.S.Varicella.1-dose schedule Completion
One yellow fever dose from primary series was administered. The primary series has been completed-98	One yellow fever dose from primary series was administered. The primary series has been completed	IMMZ.D18.S.Yellow fever schedule Completion	IMMZ.D18.S.Yellow fever schedule Completion	IMMZ.D18.S.Yellow fever schedule Completion	IMMZ.D18.S.Yellow fever schedule Completion
One yellow fever primary series dose was administered-121	One yellow fever primary series dose was administered	IMMZ.D2.DT.Yellow fever Inputs	IMMZ.D2.DT.Yellow fever Inputs	IMMZ.D2.DT.Yellow fever Inputs	IMMZ.D2.DT.Yellow fever Inputs
Pertussis immunization schedule is complete-106	Pertussis immunization schedule is complete	IMMZ.D2.DT.DTP.Delayed or interrupted series Output	IMMZ.D2.DT.DTP.Delayed or interrupted series Output	IMMZ.D2.DT.DTP.Delayed or interrupted series Output	IMMZ.D2.DT.DTP.Delayed or interrupted series Output
Pertussis-containing booster dose was administered. Pertussis immunization schedule has been completed-234	Pertussis-containing booster dose was administered. Pertussis immunization schedule has been completed	IMMZ.D18.S.DTP.Delayed or interrupted schedule Completion	IMMZ.D18.S.DTP.Delayed or interrupted schedule Completion	IMMZ.D18.S.DTP.Delayed or interrupted schedule Completion	IMMZ.D18.S.DTP.Delayed or interrupted schedule Completion
Pneumococcal booster dose was administered-119	Pneumococcal booster dose was administered	IMMZ.D18.S.Pneumococcal.2 doses with booster dose schedule Completion	IMMZ.D18.S.Pneumococcal.2 doses with booster dose schedule Completion	IMMZ.D18.S.Pneumococcal.2 doses with booster dose schedule Completion	IMMZ.D18.S.Pneumococcal.2 doses with booster dose schedule Completion
Pneumococcal immunization schedule is complete-148	Pneumococcal immunization schedule is complete	IMMZ.D2.DT.Pneumococcal.3 doses Output	IMMZ.D2.DT.Pneumococcal.3 doses Output	IMMZ.D2.DT.Pneumococcal.3 doses Output	IMMZ.D2.DT.Pneumococcal.3 doses Output
Pneumococcal immunization schedule is complete-49	Pneumococcal immunization schedule is complete	IMMZ.D2.DT.Pneumococcal.3 doses Output	IMMZ.D2.DT.Pneumococcal.3 doses Output	IMMZ.D2.DT.Pneumococcal.3 doses Output	IMMZ.D2.DT.Pneumococcal.3 doses Output
Pneumococcal vaccination could be contraindicated. Clinical judgement is required. Create a clinical note-66	Pneumococcal vaccination could be contraindicated. Clinical judgement is required. Create a clinical note	IMMZ.D5.DT.Pneumococcal contraindications Output	IMMZ.D5.DT.Pneumococcal contraindications Output	IMMZ.D5.DT.Pneumococcal contraindications Output	IMMZ.D5.DT.Pneumococcal contraindications Output
Pneumococcal vaccination could be contraindicated. Clinical judgement is required. Create a clinical note.-66	Pneumococcal vaccination could be contraindicated. Clinical judgement is required. Create a clinical note.	IMMZ.D5.DT.Pneumococcal contraindications Output	IMMZ.D5.DT.Pneumococcal contraindications Output	IMMZ.D5.DT.Pneumococcal contraindications Output	IMMZ.D5.DT.Pneumococcal contraindications Output
Polio birth dose (a zero dose) was administered-146	Polio birth dose (a zero dose) was administered	IMMZ.D18.S.Polio.Birth dose schedule Completion	IMMZ.D18.S.Polio.Birth dose schedule Completion	IMMZ.D18.S.Polio.Birth dose schedule Completion	IMMZ.D18.S.Polio.Birth dose schedule Completion
Polio booster dose was administered-128	Polio booster dose was administered	IMMZ.D2.DT.Polio.IPV-only Inputs	IMMZ.D2.DT.Polio.IPV-only Inputs	IMMZ.D2.DT.Polio.IPV-only Inputs	IMMZ.D2.DT.Polio.IPV-only Inputs
Polio immunization schedule is complete-157	Polio immunization schedule is complete	IMMZ.D2.DT.Polio.IPV-only Output	IMMZ.D2.DT.Polio.IPV-only Output	IMMZ.D2.DT.Polio.IPV-only Output	IMMZ.D2.DT.Polio.IPV-only Output
Polio immunization schedule is complete-49	Polio immunization schedule is complete	IMMZ.D2.DT.Polio.IPV-only Output	IMMZ.D2.DT.Polio.IPV-only Output	IMMZ.D2.DT.Polio.IPV-only Output	IMMZ.D2.DT.Polio.IPV-only Output
Poliovirus vaccination could be contraindicated. Clinical judgement required-66	Poliovirus vaccination could be contraindicated. Clinical judgement required	IMMZ.D5.DT.Polio contraindications Output	IMMZ.D5.DT.Polio contraindications Output	IMMZ.D5.DT.Polio contraindications Output	IMMZ.D5.DT.Polio contraindications Output
Poliovirus vaccination with bOPV is contraindicated-281	Poliovirus vaccination with bOPV is contraindicated	IMMZ.D5.DT.Polio contraindications Output	IMMZ.D5.DT.Polio contraindications Output	IMMZ.D5.DT.Polio contraindications Output	IMMZ.D5.DT.Polio contraindications Output
Primary DTP series is complete. Client is due for pertussis booster dose-202	Primary DTP series is complete. Client is due for pertussis booster dose	IMMZ.D2.DT.DTP.Delayed or interrupted series Output	IMMZ.D2.DT.DTP.Delayed or interrupted series Output	IMMZ.D2.DT.DTP.Delayed or interrupted series Output	IMMZ.D2.DT.DTP.Delayed or interrupted series Output
Primary DTP series is complete. Client is due for tetanus and diphtheria booster dose-215	Primary DTP series is complete. Client is due for tetanus and diphtheria booster dose	IMMZ.D2.DT.DTP.Delayed or interrupted series Output	IMMZ.D2.DT.DTP.Delayed or interrupted series Output	IMMZ.D2.DT.DTP.Delayed or interrupted series Output	IMMZ.D2.DT.DTP.Delayed or interrupted series Output
Primary DTP series is complete. Client is not due for pertussis booster dose-206	Primary DTP series is complete. Client is not due for pertussis booster dose	IMMZ.D2.DT.DTP.Delayed or interrupted series Output	IMMZ.D2.DT.DTP.Delayed or interrupted series Output	IMMZ.D2.DT.DTP.Delayed or interrupted series Output	IMMZ.D2.DT.DTP.Delayed or interrupted series Output
Primary DTP series is complete. Client is not due for tetanus and diphtheria booster dose-218	Primary DTP series is complete. Client is not due for tetanus and diphtheria booster dose	IMMZ.D2.DT.DTP.On-time start Output	IMMZ.D2.DT.DTP.On-time start Output	IMMZ.D2.DT.DTP.On-time start Output	IMMZ.D2.DT.DTP.On-time start Output
Primary DTP series is complete. Client is not due for tetanus and diphtheria booster dose-219	Primary DTP series is complete. Client is not due for tetanus and diphtheria booster dose	IMMZ.D2.DT.DTP.Delayed or interrupted series Output	IMMZ.D2.DT.DTP.Delayed or interrupted series Output	IMMZ.D2.DT.DTP.Delayed or interrupted series Output	IMMZ.D2.DT.DTP.Delayed or interrupted series Output
Primary series for cholera has been completed and latest cholera dose was administered approximately less than 2 years ago-284	Primary series for cholera has been completed and latest cholera dose was administered approximately less than 2 years ago	IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Trigger	IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Trigger	IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Trigger	IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Trigger
Primary series for cholera has been completed and latest cholera dose was administered approximately less than 6 months ago-295	Primary series for cholera has been completed and latest cholera dose was administered approximately less than 6 months ago	IMMZ.D18.S.Cholera.WC-rBS vaccine 3-dose schedule Trigger	IMMZ.D18.S.Cholera.WC-rBS vaccine 3-dose schedule Trigger	IMMZ.D18.S.Cholera.WC-rBS vaccine 3-dose schedule Trigger	IMMZ.D18.S.Cholera.WC-rBS vaccine 3-dose schedule Trigger
Primary series for cholera has been completed and latest cholera dose was administered more than 3 years ago-204	Primary series for cholera has been completed and latest cholera dose was administered more than 3 years ago	IMMZ.D18.S.Cholera.WC vaccines schedule Trigger	IMMZ.D18.S.Cholera.WC vaccines schedule Trigger	IMMZ.D18.S.Cholera.WC vaccines schedule Trigger	IMMZ.D18.S.Cholera.WC vaccines schedule Trigger
Primary series has been completed-99	Primary series has been completed	IMMZ.D18.S.Meningococcal.Polysaccharide vaccines schedule Trigger	IMMZ.D18.S.Meningococcal.Polysaccharide vaccines schedule Trigger	IMMZ.D18.S.Meningococcal.Polysaccharide vaccines schedule Trigger	IMMZ.D18.S.Meningococcal.Polysaccharide vaccines schedule Trigger
Primary series is complete-174	Primary series is complete	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Output	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Output	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Output	IMMZ.D2.DT.Polio.Sequential IPV–bOPV Output
Primary series is complete-93	Primary series is complete	IMMZ.D2.DT.Typhoid.Ty21a Inputs	IMMZ.D2.DT.Typhoid.Ty21a Inputs	IMMZ.D2.DT.Typhoid.Ty21a Inputs	IMMZ.D2.DT.Typhoid.Ty21a Inputs
Primary series is complete. Client is due for Hib booster dose-145	Primary series is complete. Client is due for Hib booster dose	IMMZ.D2.DT.Hib.2 doses with booster dose Output	IMMZ.D2.DT.Hib.2 doses with booster dose Output	IMMZ.D2.DT.Hib.2 doses with booster dose Output	IMMZ.D2.DT.Hib.2 doses with booster dose Output
Primary series is complete. Client is due for IPV booster dose-152	Primary series is complete. Client is due for IPV booster dose	IMMZ.D2.DT.Polio.IPV-only Output	IMMZ.D2.DT.Polio.IPV-only Output	IMMZ.D2.DT.Polio.IPV-only Output	IMMZ.D2.DT.Polio.IPV-only Output
Primary series is complete. Client is due for TBE booster dose-134	Primary series is complete. Client is due for TBE booster dose	IMMZ.D2.DT.TBE.EnceVir Output	IMMZ.D2.DT.TBE.EnceVir Output	IMMZ.D2.DT.TBE.EnceVir Output	IMMZ.D2.DT.TBE.EnceVir Output
Primary series is complete. Client is due for cholera booster dose-126	Primary series is complete. Client is due for cholera booster dose	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Output	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Output	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Output	IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Output
Primary series is complete. Client is due for cholera booster dose-138	Primary series is complete. Client is due for cholera booster dose	IMMZ.D2.DT.Cholera.WC vaccines Output	IMMZ.D2.DT.Cholera.WC vaccines Output	IMMZ.D2.DT.Cholera.WC vaccines Output	IMMZ.D2.DT.Cholera.WC vaccines Output
Primary series is complete. Client is due for typhoid booster dose-138	Primary series is complete. Client is due for typhoid booster dose	IMMZ.D2.DT.Typhoid.ViPS Output	IMMZ.D2.DT.Typhoid.ViPS Output	IMMZ.D2.DT.Typhoid.ViPS Output	IMMZ.D2.DT.Typhoid.ViPS Output
Primary series is complete. Client is not due for Hib booster dose-149	Primary series is complete. Client is not due for Hib booster dose	IMMZ.D2.DT.Hib.2 doses with booster dose Output	IMMZ.D2.DT.Hib.2 doses with booster dose Output	IMMZ.D2.DT.Hib.2 doses with booster dose Output	IMMZ.D2.DT.Hib.2 doses with booster dose Output
Primary series is complete. Client is not due for IPV booster dose-156	Primary series is complete. Client is not due for IPV booster dose	IMMZ.D2.DT.Polio.IPV-only Output	IMMZ.D2.DT.Polio.IPV-only Output	IMMZ.D2.DT.Polio.IPV-only Output	IMMZ.D2.DT.Polio.IPV-only Output
Primary series is complete. Client is not due for TBE booster dose-138	Primary series is complete. Client is not due for TBE booster dose	IMMZ.D2.DT.TBE.EnceVir Output	IMMZ.D2.DT.TBE.EnceVir Output	IMMZ.D2.DT.TBE.EnceVir Output	IMMZ.D2.DT.TBE.EnceVir Output
Primary series is complete. Client is not due for cholera booster dose-130	Primary series is complete. Client is not due for cholera booster dose	IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Output	IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Output	IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Output	IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Output
Primary series is complete. Client is not due for cholera booster dose-142	Primary series is complete. Client is not due for cholera booster dose	IMMZ.D2.DT.Cholera.WC vaccines Output	IMMZ.D2.DT.Cholera.WC vaccines Output	IMMZ.D2.DT.Cholera.WC vaccines Output	IMMZ.D2.DT.Cholera.WC vaccines Output
Primary series is complete. Client is not due for typhoid booster dose-142	Primary series is complete. Client is not due for typhoid booster dose	IMMZ.D2.DT.Typhoid.ViPS Output	IMMZ.D2.DT.Typhoid.ViPS Output	IMMZ.D2.DT.Typhoid.ViPS Output	IMMZ.D2.DT.Typhoid.ViPS Output
Primary series is not complete-93	Primary series is not complete	IMMZ.D2.DT.Typhoid.Ty21a Inputs	IMMZ.D2.DT.Typhoid.Ty21a Inputs	IMMZ.D2.DT.Typhoid.Ty21a Inputs	IMMZ.D2.DT.Typhoid.Ty21a Inputs
Rabies immunization schedule is complete-142	Rabies immunization schedule is complete	IMMZ.D2.DT.Rabies Output	IMMZ.D2.DT.Rabies Output	IMMZ.D2.DT.Rabies Output	IMMZ.D2.DT.Rabies Output
Revaccination with booster series has been completed in the last 3 years-191	Revaccination with booster series has been completed in the last 3 years	IMMZ.D18.S.Cholera.WC vaccines schedule Completion	IMMZ.D18.S.Cholera.WC vaccines schedule Completion	IMMZ.D18.S.Cholera.WC vaccines schedule Completion	IMMZ.D18.S.Cholera.WC vaccines schedule Completion
Rotavirus immunization schedule is complete-49	Rotavirus immunization schedule is complete	IMMZ.D2.DT.Rotavirus Output	IMMZ.D2.DT.Rotavirus Output	IMMZ.D2.DT.Rotavirus Output	IMMZ.D2.DT.Rotavirus Output
Rotavirus immunization schedule is complete-50	Rotavirus immunization schedule is complete	IMMZ.D2.DT.Rotavirus Output	IMMZ.D2.DT.Rotavirus Output	IMMZ.D2.DT.Rotavirus Output	IMMZ.D2.DT.Rotavirus Output
Rotavirus vaccination could be contraindicated. Clinical judgement is required. Create a clinical note-66	Rotavirus vaccination could be contraindicated. Clinical judgement is required. Create a clinical note	IMMZ.D5.DT.Rotavirus contraindications Output	IMMZ.D5.DT.Rotavirus contraindications Output	IMMZ.D5.DT.Rotavirus contraindications Output	IMMZ.D5.DT.Rotavirus contraindications Output
Rotavirus vaccination is contraindicated-56	Rotavirus vaccination is contraindicated	IMMZ.D5.DT.Rotavirus contraindications Output	IMMZ.D5.DT.Rotavirus contraindications Output	IMMZ.D5.DT.Rotavirus contraindications Output	IMMZ.D5.DT.Rotavirus contraindications Output
Routine measles immunization schedule is complete-167	Routine measles immunization schedule is complete	IMMZ.D18.S.Measles.Supplementary dose schedule Trigger	IMMZ.D18.S.Measles.Supplementary dose schedule Trigger	IMMZ.D18.S.Measles.Supplementary dose schedule Trigger	IMMZ.D18.S.Measles.Supplementary dose schedule Trigger
Rubella immunization schedule is complete-154	Rubella immunization schedule is complete	IMMZ.D2.DT.Rubella.High incidence Output	IMMZ.D2.DT.Rubella.High incidence Output	IMMZ.D2.DT.Rubella.High incidence Output	IMMZ.D2.DT.Rubella.High incidence Output
Rubella immunization schedule is complete-155	Rubella immunization schedule is complete	IMMZ.D2.DT.Rubella.Low incidence Output	IMMZ.D2.DT.Rubella.Low incidence Output	IMMZ.D2.DT.Rubella.Low incidence Output	IMMZ.D2.DT.Rubella.Low incidence Output
Rubella vaccination could be contraindicated. Clinical judgement is required. Create a clinical note-66	Rubella vaccination could be contraindicated. Clinical judgement is required. Create a clinical note	IMMZ.D5.DT.Rubella contraindications Output	IMMZ.D5.DT.Rubella contraindications Output	IMMZ.D5.DT.Rubella contraindications Output	IMMZ.D5.DT.Rubella contraindications Output
Rubella vaccination is contraindicated-56	Rubella vaccination is contraindicated	IMMZ.D5.DT.Rubella contraindications Output	IMMZ.D5.DT.Rubella contraindications Output	IMMZ.D5.DT.Rubella contraindications Output	IMMZ.D5.DT.Rubella contraindications Output
Second DTP dose from the primary series was administered-123	Second DTP dose from the primary series was administered	IMMZ.D18.S.DTP.Delayed or interrupted schedule Trigger	IMMZ.D18.S.DTP.Delayed or interrupted schedule Trigger	IMMZ.D18.S.DTP.Delayed or interrupted schedule Trigger	IMMZ.D18.S.DTP.Delayed or interrupted schedule Trigger
Second DTP dose from the primary series was administered-124	Second DTP dose from the primary series was administered	IMMZ.D18.S.DTP.On-time start schedule Trigger	IMMZ.D18.S.DTP.On-time start schedule Trigger	IMMZ.D18.S.DTP.On-time start schedule Trigger	IMMZ.D18.S.DTP.On-time start schedule Trigger
Second HPV dose from the primary series was administered and client's HIV status is positive or client is immunocompromised-140	Second HPV dose from the primary series was administered and client's HIV status is positive or client is immunocompromised	IMMZ.D18.S.Single-dose schedule Trigger	IMMZ.D18.S.Single-dose schedule Trigger	IMMZ.D18.S.Single-dose schedule Trigger	IMMZ.D18.S.Single-dose schedule Trigger
Second HPV dose from the primary series was administered and client's HIV status is positive or client is immunocompromised-178	Second HPV dose from the primary series was administered and client's HIV status is positive or client is immunocompromised	IMMZ.D18.S.HPV.2-dose schedule Trigger	IMMZ.D18.S.HPV.2-dose schedule Trigger	IMMZ.D18.S.HPV.2-dose schedule Trigger	IMMZ.D18.S.HPV.2-dose schedule Trigger
Second HPV dose from the primary series was administered-112	Second HPV dose from the primary series was administered	IMMZ.D18.S.HPV.2-dose schedule Completion	IMMZ.D18.S.HPV.2-dose schedule Completion	IMMZ.D18.S.HPV.2-dose schedule Completion	IMMZ.D18.S.HPV.2-dose schedule Completion
Second HPV dose from the primary series was administered-74	Second HPV dose from the primary series was administered	IMMZ.D18.S.Single-dose schedule Completion	IMMZ.D18.S.Single-dose schedule Completion	IMMZ.D18.S.Single-dose schedule Completion	IMMZ.D18.S.Single-dose schedule Completion
Second Hib dose from the primary series was administered-122	Second Hib dose from the primary series was administered	IMMZ.D18.S.Hib.3 doses with booster dose schedule Completion	IMMZ.D18.S.Hib.3 doses with booster dose schedule Completion	IMMZ.D18.S.Hib.3 doses with booster dose schedule Completion	IMMZ.D18.S.Hib.3 doses with booster dose schedule Completion
Second Hib dose from the primary series was administered. Client's age is less than 5 years-167	Second Hib dose from the primary series was administered. Client's age is less than 5 years	IMMZ.D18.S.Hib.2 doses with booster dose schedule Trigger	IMMZ.D18.S.Hib.2 doses with booster dose schedule Trigger	IMMZ.D18.S.Hib.2 doses with booster dose schedule Trigger	IMMZ.D18.S.Hib.2 doses with booster dose schedule Trigger
Second Hib dose from the primary series was administered. The primary series has been completed-99	Second Hib dose from the primary series was administered. The primary series has been completed	IMMZ.D18.S.Hib.2 doses with booster dose schedule Completion	IMMZ.D18.S.Hib.2 doses with booster dose schedule Completion	IMMZ.D18.S.Hib.2 doses with booster dose schedule Completion	IMMZ.D18.S.Hib.2 doses with booster dose schedule Completion
Second IPV dose from the primary series was administered-76	Second IPV dose from the primary series was administered	IMMZ.D18.S.Polio.Sequential IPV–bOPV schedule Trigger	IMMZ.D18.S.Polio.Sequential IPV–bOPV schedule Trigger	IMMZ.D18.S.Polio.Sequential IPV–bOPV schedule Trigger	IMMZ.D18.S.Polio.Sequential IPV–bOPV schedule Trigger
Second IPV dose from the primary series was administered-92	Second IPV dose from the primary series was administered	IMMZ.D18.S.Polio.IPV-only schedule Trigger	IMMZ.D18.S.Polio.IPV-only schedule Trigger	IMMZ.D18.S.Polio.IPV-only schedule Trigger	IMMZ.D18.S.Polio.IPV-only schedule Trigger
Second JE dose from the primary series was administered. The primary series has been completed-88	Second JE dose from the primary series was administered. The primary series has been completed	IMMZ.D18.S.JE.Inactivated Vero cell-derived vaccination schedule Completion	IMMZ.D18.S.JE.Inactivated Vero cell-derived vaccination schedule Completion	IMMZ.D18.S.JE.Inactivated Vero cell-derived vaccination schedule Completion	IMMZ.D18.S.JE.Inactivated Vero cell-derived vaccination schedule Completion
Second TBE dose from the primary series was administered-112	Second TBE dose from the primary series was administered	IMMZ.D18.S.TBE.EnceVir schedule Trigger	IMMZ.D18.S.TBE.EnceVir schedule Trigger	IMMZ.D18.S.TBE.EnceVir schedule Trigger	IMMZ.D18.S.TBE.EnceVir schedule Trigger
Second bOPV dose from the primary series was administered-115	Second bOPV dose from the primary series was administered	IMMZ.D18.S.Polio.bOPV plus IPV schedule Trigger	IMMZ.D18.S.Polio.bOPV plus IPV schedule Trigger	IMMZ.D18.S.Polio.bOPV plus IPV schedule Trigger	IMMZ.D18.S.Polio.bOPV plus IPV schedule Trigger
Second bOPV dose from the primary series was administered. The primary series has been completed-107	Second bOPV dose from the primary series was administered. The primary series has been completed	IMMZ.D18.S.Polio.Sequential IPV–bOPV schedule Completion	IMMZ.D18.S.Polio.Sequential IPV–bOPV schedule Completion	IMMZ.D18.S.Polio.Sequential IPV–bOPV schedule Completion	IMMZ.D18.S.Polio.Sequential IPV–bOPV schedule Completion
Second cholera dose was administered-125	Second cholera dose was administered	IMMZ.D18.S.Cholera.WC-rBS vaccine 3-dose schedule Trigger	IMMZ.D18.S.Cholera.WC-rBS vaccine 3-dose schedule Trigger	IMMZ.D18.S.Cholera.WC-rBS vaccine 3-dose schedule Trigger	IMMZ.D18.S.Cholera.WC-rBS vaccine 3-dose schedule Trigger
Second cholera dose was administered-68	Second cholera dose was administered	IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Completion	IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Completion	IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Completion	IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Completion
Second dengue dose from the primary series was administered-115	Second dengue dose from the primary series was administered	IMMZ.D18.S.Dengue schedule Trigger	IMMZ.D18.S.Dengue schedule Trigger	IMMZ.D18.S.Dengue schedule Trigger	IMMZ.D18.S.Dengue schedule Trigger
Second hepatitis A dose from the primary series was administered. The primary series has been completed-108	Second hepatitis A dose from the primary series was administered. The primary series has been completed	IMMZ.D18.S.Hepatitis A.Inactivated HAV 2-dose schedule Completion	IMMZ.D18.S.Hepatitis A.Inactivated HAV 2-dose schedule Completion	IMMZ.D18.S.Hepatitis A.Inactivated HAV 2-dose schedule Completion	IMMZ.D18.S.Hepatitis A.Inactivated HAV 2-dose schedule Completion
Second malaria dose from the primary series was administered-116	Second malaria dose from the primary series was administered	IMMZ.D18.S.Malaria schedule Trigger	IMMZ.D18.S.Malaria schedule Trigger	IMMZ.D18.S.Malaria schedule Trigger	IMMZ.D18.S.Malaria schedule Trigger
Second meningococcal dose from the primary series was administered. The primary series has been completed for clients that started the series when client's age was less than or equal to 11 months-99	Second meningococcal dose from the primary series was administered. The primary series has been completed for clients that started the series when client's age was less than or equal to 11 months	IMMZ.D18.S.Meningococcal.Monovalent MenC conjugate vaccine schedule Completion	IMMZ.D18.S.Meningococcal.Monovalent MenC conjugate vaccine schedule Completion	IMMZ.D18.S.Meningococcal.Monovalent MenC conjugate vaccine schedule Completion	IMMZ.D18.S.Meningococcal.Monovalent MenC conjugate vaccine schedule Completion
Second meningococcal dose from the primary series was administered. The primary series has been completed-99	Second meningococcal dose from the primary series was administered. The primary series has been completed	IMMZ.D18.S.Meningococcal.Quadrivalent conjugate vaccines 2-dose schedule Completion	IMMZ.D18.S.Meningococcal.Quadrivalent conjugate vaccines 2-dose schedule Completion	IMMZ.D18.S.Meningococcal.Quadrivalent conjugate vaccines 2-dose schedule Completion	IMMZ.D18.S.Meningococcal.Quadrivalent conjugate vaccines 2-dose schedule Completion
Second mumps dose from the primary series was administered. The primary series has been completed-103	Second mumps dose from the primary series was administered. The primary series has been completed	IMMZ.D18.S.Mumps schedule Completion	IMMZ.D18.S.Mumps schedule Completion	IMMZ.D18.S.Mumps schedule Completion	IMMZ.D18.S.Mumps schedule Completion
Second pneumococcal booster dose was administered-119	Second pneumococcal booster dose was administered	IMMZ.D18.S.Pneumococcal.2 doses with booster dose schedule Completion	IMMZ.D18.S.Pneumococcal.2 doses with booster dose schedule Completion	IMMZ.D18.S.Pneumococcal.2 doses with booster dose schedule Completion	IMMZ.D18.S.Pneumococcal.2 doses with booster dose schedule Completion
Second pneumococcal dose from the primary series was administered and first pneumococcal dose was administered within 12 months post birth-276	Second pneumococcal dose from the primary series was administered and first pneumococcal dose was administered within 12 months post birth	IMMZ.D18.S.Pneumococcal.2 doses with booster dose schedule Trigger	IMMZ.D18.S.Pneumococcal.2 doses with booster dose schedule Trigger	IMMZ.D18.S.Pneumococcal.2 doses with booster dose schedule Trigger	IMMZ.D18.S.Pneumococcal.2 doses with booster dose schedule Trigger
Second pneumococcal dose from the primary series was administered to client, who is less than or equal to 5 years of age. First pneumococcal dose was administered within 12 months post birth.-302	Second pneumococcal dose from the primary series was administered to client, who is less than or equal to 5 years of age. First pneumococcal dose was administered within 12 months post birth.	IMMZ.D18.S.Pneumococcal.3 doses schedule Trigger	IMMZ.D18.S.Pneumococcal.3 doses schedule Trigger	IMMZ.D18.S.Pneumococcal.3 doses schedule Trigger	IMMZ.D18.S.Pneumococcal.3 doses schedule Trigger
Second pneumococcal dose from the primary series was administered-121	Second pneumococcal dose from the primary series was administered	IMMZ.D18.S.Pneumococcal.3 doses schedule Completion	IMMZ.D18.S.Pneumococcal.3 doses schedule Completion	IMMZ.D18.S.Pneumococcal.3 doses schedule Completion	IMMZ.D18.S.Pneumococcal.3 doses schedule Completion
Second pneumococcal dose from the primary series was administered. The primary series has been completed.-99	Second pneumococcal dose from the primary series was administered. The primary series has been completed.	IMMZ.D18.S.Pneumococcal.2 doses with booster dose schedule Completion	IMMZ.D18.S.Pneumococcal.2 doses with booster dose schedule Completion	IMMZ.D18.S.Pneumococcal.2 doses with booster dose schedule Completion	IMMZ.D18.S.Pneumococcal.2 doses with booster dose schedule Completion
Second rabies dose from the primary series was administered. The primary series has been completed-92	Second rabies dose from the primary series was administered. The primary series has been completed	IMMZ.D18.S.Rabies schedule Completion	IMMZ.D18.S.Rabies schedule Completion	IMMZ.D18.S.Rabies schedule Completion	IMMZ.D18.S.Rabies schedule Completion
Second rotavirus dose from the primary series was administered-118	Second rotavirus dose from the primary series was administered	IMMZ.D18.S.Rotavirus schedule Completion	IMMZ.D18.S.Rotavirus schedule Completion	IMMZ.D18.S.Rotavirus schedule Completion	IMMZ.D18.S.Rotavirus schedule Completion
Second tetanus and diphtheria booster dose was administered-140	Second tetanus and diphtheria booster dose was administered	IMMZ.D18.S.DTP.Pregnancy starting with 4 doses schedule Trigger	IMMZ.D18.S.DTP.Pregnancy starting with 4 doses schedule Trigger	IMMZ.D18.S.DTP.Pregnancy starting with 4 doses schedule Trigger	IMMZ.D18.S.DTP.Pregnancy starting with 4 doses schedule Trigger
Second tetanus and diphtheria booster dose was administered. Tetanus and diphtheria immunization schedule has been completed-260	Second tetanus and diphtheria booster dose was administered. Tetanus and diphtheria immunization schedule has been completed	IMMZ.D18.S.DTP.Delayed or interrupted schedule Completion	IMMZ.D18.S.DTP.Delayed or interrupted schedule Completion	IMMZ.D18.S.DTP.Delayed or interrupted schedule Completion	IMMZ.D18.S.DTP.Delayed or interrupted schedule Completion
Second varicella dose from the primary series was administered. The primary series has been completed-107	Second varicella dose from the primary series was administered. The primary series has been completed	IMMZ.D18.S.Varicella.2-dose schedule Completion	IMMZ.D18.S.Varicella.2-dose schedule Completion	IMMZ.D18.S.Varicella.2-dose schedule Completion	IMMZ.D18.S.Varicella.2-dose schedule Completion
TBE booster dose was administered less than 3 years ago-217	TBE booster dose was administered less than 3 years ago	IMMZ.D18.S.TBE.EnceVir schedule Completion	IMMZ.D18.S.TBE.EnceVir schedule Completion	IMMZ.D18.S.TBE.EnceVir schedule Completion	IMMZ.D18.S.TBE.EnceVir schedule Completion
TBE booster dose was administered less than 3 years ago-218	TBE booster dose was administered less than 3 years ago	IMMZ.D18.S.TBE.TBE-Moscow schedule Completion	IMMZ.D18.S.TBE.TBE-Moscow schedule Completion	IMMZ.D18.S.TBE.TBE-Moscow schedule Completion	IMMZ.D18.S.TBE.TBE-Moscow schedule Completion
TBE booster dose was administered-110	TBE booster dose was administered	IMMZ.D18.S.TBE.Encepur schedule Completion	IMMZ.D18.S.TBE.Encepur schedule Completion	IMMZ.D18.S.TBE.Encepur schedule Completion	IMMZ.D18.S.TBE.Encepur schedule Completion
Tetanus and diphtheria immunization schedule is complete-119	Tetanus and diphtheria immunization schedule is complete	IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Output	IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Output	IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Output	IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Output
Tetanus and pertussis vaccination could be contraindicated. Clinical judgement is required. Create a clinical note-250	Tetanus and pertussis vaccination could be contraindicated. Clinical judgement is required. Create a clinical note	IMMZ.D5.DT.DTP contraindications Output	IMMZ.D5.DT.DTP contraindications Output	IMMZ.D5.DT.DTP contraindications Output	IMMZ.D5.DT.DTP contraindications Output
Tetanus vaccination is contraindicated-112	Tetanus vaccination is contraindicated	IMMZ.D5.DT.DTP contraindications Output	IMMZ.D5.DT.DTP contraindications Output	IMMZ.D5.DT.DTP contraindications Output	IMMZ.D5.DT.DTP contraindications Output
The booster series has been completed-81	The booster series has been completed	IMMZ.D18.S.Typhoid.Ty21a schedule Completion	IMMZ.D18.S.Typhoid.Ty21a schedule Completion	IMMZ.D18.S.Typhoid.Ty21a schedule Completion	IMMZ.D18.S.Typhoid.Ty21a schedule Completion
The client currently has a severe acute illness-54	The client currently has a severe acute illness	IMMZ.D5.DT.DTP contraindications Inputs	IMMZ.D5.DT.DTP contraindications Inputs	IMMZ.D5.DT.DTP contraindications Inputs	IMMZ.D5.DT.DTP contraindications Inputs
The client has TB disease-44	The client has TB disease	IMMZ.D5.DT.Rubella contraindications Inputs	IMMZ.D5.DT.Rubella contraindications Inputs	IMMZ.D5.DT.Rubella contraindications Inputs	IMMZ.D5.DT.Rubella contraindications Inputs
The client has a history of anaphylactic reactions-67	The client has a history of anaphylactic reactions	IMMZ.D5.DT.Pneumococcal contraindications Inputs	IMMZ.D5.DT.Pneumococcal contraindications Inputs	IMMZ.D5.DT.Pneumococcal contraindications Inputs	IMMZ.D5.DT.Pneumococcal contraindications Inputs
The client has a history of severe allergic reactions-59	The client has a history of severe allergic reactions	IMMZ.D5.DT.Yellow fever contraindications Inputs	IMMZ.D5.DT.Yellow fever contraindications Inputs	IMMZ.D5.DT.Yellow fever contraindications Inputs	IMMZ.D5.DT.Yellow fever contraindications Inputs
The client has a history of severe allergic reactions-60	The client has a history of severe allergic reactions	IMMZ.D5.DT.Hepatitis A contraindications Inputs	IMMZ.D5.DT.Hepatitis A contraindications Inputs	IMMZ.D5.DT.Hepatitis A contraindications Inputs	IMMZ.D5.DT.Hepatitis A contraindications Inputs
The client has a symptomatic HIV infection-59	The client has a symptomatic HIV infection	IMMZ.D5.DT.Measles contraindications Inputs	IMMZ.D5.DT.Measles contraindications Inputs	IMMZ.D5.DT.Measles contraindications Inputs	IMMZ.D5.DT.Measles contraindications Inputs
The client has acute gastroenteritis-55	The client has acute gastroenteritis	IMMZ.D5.DT.Rotavirus contraindications Inputs	IMMZ.D5.DT.Rotavirus contraindications Inputs	IMMZ.D5.DT.Rotavirus contraindications Inputs	IMMZ.D5.DT.Rotavirus contraindications Inputs
The client has allergy to vaccine components-60	The client has allergy to vaccine components	IMMZ.D5.DT.Mumps contraindications Inputs	IMMZ.D5.DT.Mumps contraindications Inputs	IMMZ.D5.DT.Mumps contraindications Inputs	IMMZ.D5.DT.Mumps contraindications Inputs
The client has altered immunocompetence-58	The client has altered immunocompetence	IMMZ.D5.DT.Rotavirus contraindications Inputs	IMMZ.D5.DT.Rotavirus contraindications Inputs	IMMZ.D5.DT.Rotavirus contraindications Inputs	IMMZ.D5.DT.Rotavirus contraindications Inputs
The client has bladder exstrophy-51	The client has bladder exstrophy	IMMZ.D5.DT.Rotavirus contraindications Inputs	IMMZ.D5.DT.Rotavirus contraindications Inputs	IMMZ.D5.DT.Rotavirus contraindications Inputs	IMMZ.D5.DT.Rotavirus contraindications Inputs
The client has chronic gastrointestinal disease-66	The client has chronic gastrointestinal disease	IMMZ.D5.DT.Rotavirus contraindications Inputs	IMMZ.D5.DT.Rotavirus contraindications Inputs	IMMZ.D5.DT.Rotavirus contraindications Inputs	IMMZ.D5.DT.Rotavirus contraindications Inputs
The client has history of anaphylactic reactions-66	The client has history of anaphylactic reactions	IMMZ.D5.DT.Dengue contraindications Inputs	IMMZ.D5.DT.Dengue contraindications Inputs	IMMZ.D5.DT.Dengue contraindications Inputs	IMMZ.D5.DT.Dengue contraindications Inputs
The client has history of anaphylactic reactions-67	The client has history of anaphylactic reactions	IMMZ.D5.DT.Measles contraindications Inputs	IMMZ.D5.DT.Measles contraindications Inputs	IMMZ.D5.DT.Measles contraindications Inputs	IMMZ.D5.DT.Measles contraindications Inputs
The client has history of severe allergic reactions-59	The client has history of severe allergic reactions	IMMZ.D5.DT.Dengue contraindications Inputs	IMMZ.D5.DT.Dengue contraindications Inputs	IMMZ.D5.DT.Dengue contraindications Inputs	IMMZ.D5.DT.Dengue contraindications Inputs
The client has history of severe allergic reactions-60	The client has history of severe allergic reactions	IMMZ.D5.DT.BCG contraindications Inputs	IMMZ.D5.DT.BCG contraindications Inputs	IMMZ.D5.DT.BCG contraindications Inputs	IMMZ.D5.DT.BCG contraindications Inputs
The client has hypersensitivity to any component of the vaccine-72	The client has hypersensitivity to any component of the vaccine	IMMZ.D5.DT.Typhoid contraindications Inputs	IMMZ.D5.DT.Typhoid contraindications Inputs	IMMZ.D5.DT.Typhoid contraindications Inputs	IMMZ.D5.DT.Typhoid contraindications Inputs
The client has hypersensitivity to any of the vaccine components-72	The client has hypersensitivity to any of the vaccine components	IMMZ.D5.DT.Malaria contraindications Inputs	IMMZ.D5.DT.Malaria contraindications Inputs	IMMZ.D5.DT.Malaria contraindications Inputs	IMMZ.D5.DT.Malaria contraindications Inputs
The client has immune deficiency-60	The client has immune deficiency	IMMZ.D5.DT.Varicella contraindications Inputs	IMMZ.D5.DT.Varicella contraindications Inputs	IMMZ.D5.DT.Varicella contraindications Inputs	IMMZ.D5.DT.Varicella contraindications Inputs
The client has immunodeficiency syndromes-60	The client has immunodeficiency syndromes	IMMZ.D5.DT.Dengue contraindications Inputs	IMMZ.D5.DT.Dengue contraindications Inputs	IMMZ.D5.DT.Dengue contraindications Inputs	IMMZ.D5.DT.Dengue contraindications Inputs
The client has moderate to severe fever-58	The client has moderate to severe fever	IMMZ.D5.DT.TBE contraindications Inputs	IMMZ.D5.DT.TBE contraindications Inputs	IMMZ.D5.DT.TBE contraindications Inputs	IMMZ.D5.DT.TBE contraindications Inputs
The client has prior history of intussusception-66	The client has prior history of intussusception	IMMZ.D5.DT.Rotavirus contraindications Inputs	IMMZ.D5.DT.Rotavirus contraindications Inputs	IMMZ.D5.DT.Rotavirus contraindications Inputs	IMMZ.D5.DT.Rotavirus contraindications Inputs
The client has severe immunodeficiency-61	The client has severe immunodeficiency	IMMZ.D5.DT.Rotavirus contraindications Inputs	IMMZ.D5.DT.Rotavirus contraindications Inputs	IMMZ.D5.DT.Rotavirus contraindications Inputs	IMMZ.D5.DT.Rotavirus contraindications Inputs
The client has spina bifida-46	The client has spina bifida	IMMZ.D5.DT.Rotavirus contraindications Inputs	IMMZ.D5.DT.Rotavirus contraindications Inputs	IMMZ.D5.DT.Rotavirus contraindications Inputs	IMMZ.D5.DT.Rotavirus contraindications Inputs
The client has symptomatic HIV infection-59	The client has symptomatic HIV infection	IMMZ.D5.DT.Dengue contraindications Inputs	IMMZ.D5.DT.Dengue contraindications Inputs	IMMZ.D5.DT.Dengue contraindications Inputs	IMMZ.D5.DT.Dengue contraindications Inputs
The client is currently lactating-48	The client is currently lactating	IMMZ.D5.DT.Dengue contraindications Inputs	IMMZ.D5.DT.Dengue contraindications Inputs	IMMZ.D5.DT.Dengue contraindications Inputs	IMMZ.D5.DT.Dengue contraindications Inputs
The client is currently pregnant-52	The client is currently pregnant	IMMZ.D5.DT.Varicella contraindications Inputs	IMMZ.D5.DT.Varicella contraindications Inputs	IMMZ.D5.DT.Varicella contraindications Inputs	IMMZ.D5.DT.Varicella contraindications Inputs
The client is currently taking antibiotics-52	The client is currently taking antibiotics	IMMZ.D5.DT.Typhoid contraindications Inputs	IMMZ.D5.DT.Typhoid contraindications Inputs	IMMZ.D5.DT.Typhoid contraindications Inputs	IMMZ.D5.DT.Typhoid contraindications Inputs
The client is exposed to immunosuppressive treatment-72	The client is exposed to immunosuppressive treatment	IMMZ.D5.DT.Rubella contraindications Inputs	IMMZ.D5.DT.Rubella contraindications Inputs	IMMZ.D5.DT.Rubella contraindications Inputs	IMMZ.D5.DT.Rubella contraindications Inputs
The client is immunocomprised-51	The client is immunocomprised	IMMZ.D5.DT.JE contraindications Inputs	IMMZ.D5.DT.JE contraindications Inputs	IMMZ.D5.DT.JE contraindications Inputs	IMMZ.D5.DT.JE contraindications Inputs
The client is immunocompromised-51	The client is immunocompromised	IMMZ.D5.DT.Varicella contraindications Inputs	IMMZ.D5.DT.Varicella contraindications Inputs	IMMZ.D5.DT.Varicella contraindications Inputs	IMMZ.D5.DT.Varicella contraindications Inputs
The client is lactating-47	The client is lactating	IMMZ.D5.DT.Yellow fever contraindications Inputs	IMMZ.D5.DT.Yellow fever contraindications Inputs	IMMZ.D5.DT.Yellow fever contraindications Inputs	IMMZ.D5.DT.Yellow fever contraindications Inputs
The client is not immunologically stable-31	The client is not immunologically stable	IMMZ.D5.DT.Typhoid contraindications Inputs	IMMZ.D5.DT.Typhoid contraindications Inputs	IMMZ.D5.DT.Typhoid contraindications Inputs	IMMZ.D5.DT.Typhoid contraindications Inputs
The client is planning to get pregnant in next month-76	The client is planning to get pregnant in next month	IMMZ.D5.DT.Rubella contraindications Inputs	IMMZ.D5.DT.Rubella contraindications Inputs	IMMZ.D5.DT.Rubella contraindications Inputs	IMMZ.D5.DT.Rubella contraindications Inputs
The client is planning to get pregnant in the next month-76	The client is planning to get pregnant in the next month	IMMZ.D5.DT.Varicella contraindications Inputs	IMMZ.D5.DT.Varicella contraindications Inputs	IMMZ.D5.DT.Varicella contraindications Inputs	IMMZ.D5.DT.Varicella contraindications Inputs

Code

Display

table

Comments

At least one booster dose was administered-110

At least one booster dose was administered

IMMZ.D2.DT.TBE.Encepur Inputs

At least one booster series dose was administered-115

At least one booster series dose was administered

IMMZ.D2.DT.Cholera.WC vaccines Inputs

At least one cholera primary series dose was administered-117

At least one cholera primary series dose was administered

IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs

BCG immunization schedule is complete-140

BCG immunization schedule is complete

IMMZ.D2.DT.BCG Output

BCG vaccination could be contraindicated. Clinical judgement is required. Create a clinical note.-67

BCG vaccination could be contraindicated. Clinical judgement is required. Create a clinical note.

IMMZ.D5.DT.BCG contraindications Output

BCG vaccination is contraindicated-57

BCG vaccination is contraindicated

IMMZ.D5.DT.BCG contraindications Output

Bacille Calmette–Guérin (BCG) vaccination is contraindicated-57

Bacille Calmette–Guérin (BCG) vaccination is contraindicated

IMMZ.D5.DT.BCG contraindications Output

Booster IPV dose was administered. Polio immunization schedule has been completed-112

Booster IPV dose was administered. Polio immunization schedule has been completed

IMMZ.D18.S.Polio.IPV-only schedule Completion

Booster dose was administered approximately less than 2 years ago-175

Booster dose was administered approximately less than 2 years ago

IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Completion

Booster dose was administered approximately less than 6 months ago-176

Booster dose was administered approximately less than 6 months ago

IMMZ.D18.S.Cholera.WC-rBS vaccine 3-dose schedule Completion

Booster series is complete-81

Booster series is complete

IMMZ.D2.DT.Cholera.WC vaccines Output

Child's birth and no cholera doses have been administered-134

Child's birth and no cholera doses have been administered

IMMZ.D18.S.Cholera.WC vaccines schedule Trigger

Child's birth when client's biological sex is female-34

Child's birth when client's biological sex is female

IMMZ.D18.S.HPV.2-dose schedule Trigger

Child's birth-0

Child's birth

IMMZ.D18.S.Varicella.2-dose schedule Trigger

Child's birth-761

Child's birth

IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Trigger

Child's birth-792

Child's birth

IMMZ.D18.S.Cholera.WC-rBS vaccine 3-dose schedule Trigger

Client did not have preterm birth-22

Client did not have preterm birth

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

Client had preterm birth-22

Client had preterm birth

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

Client is at high risk for pneumococcal infection-48

Client is at high risk for pneumococcal infection

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

Client is clinically well-24

Client is clinically well

IMMZ.D2.DT.BCG Inputs

Client is currently not receiving antiretroviral therapy-26

Client is currently not receiving antiretroviral therapy

IMMZ.D2.DT.BCG Inputs

Client is currently pregnant-27

Client is currently pregnant

IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Inputs

Client is currently receiving antiretroviral therapy-25

Client is currently receiving antiretroviral therapy

IMMZ.D2.DT.BCG Inputs

Client is due for BCG vaccination-44

Client is due for BCG vaccination

IMMZ.D2.DT.BCG Output

Client is due for DTP vaccination-95

Client is due for DTP vaccination

IMMZ.D2.DT.DTP.Delayed or interrupted series Output

Client is due for HPV vaccination-44

Client is due for HPV vaccination

IMMZ.D2.DT.HPV.Single dose Output

Client is due for Hepatitis A vaccination-44

Client is due for Hepatitis A vaccination

IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Output

Client is due for Hib vaccination-44

Client is due for Hib vaccination

IMMZ.D2.DT.Hib.2 doses with booster dose Output

Client is due for IPV vaccination-44

Client is due for IPV vaccination

IMMZ.D2.DT.Polio.IPV-only Output

Client is due for IPV vaccination-86

Client is due for IPV vaccination

IMMZ.D2.DT.Polio.Sequential IPV–bOPV Output

Client is due for JE vaccination-44

Client is due for JE vaccination

IMMZ.D2.DT.JE.Live recombinant vaccine Output

Client is due for MCV1-44

Client is due for MCV1

IMMZ.D2.DT.Measles.Low transmission Output

Client is due for MCV2-44

Client is due for MCV2

IMMZ.D2.DT.Measles.Low transmission Output

Client is due for TBE vaccination-44

Client is due for TBE vaccination

IMMZ.D2.DT.TBE.EnceVir Output

Client is due for Typhoid vaccination-44

Client is due for Typhoid vaccination

IMMZ.D2.DT.Typhoid.Ty21a Output

Client is due for bOPV and IPV vaccination-133

Client is due for bOPV and IPV vaccination

IMMZ.D2.DT.Polio.bOPV plus IPV Output

Client is due for bOPV vaccination-87

Client is due for bOPV vaccination

IMMZ.D2.DT.Polio.Sequential IPV–bOPV Output

Client is due for cholera booster dose-44

Client is due for cholera booster dose

IMMZ.D2.DT.Cholera.WC vaccines Output

Client is due for cholera vaccination-155

Client is due for cholera vaccination

IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Output

Client is due for cholera vaccination-167

Client is due for cholera vaccination

IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Output

Client is due for cholera vaccination-44

Client is due for cholera vaccination

IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Output

Client is due for dengue vaccination-44

Client is due for dengue vaccination

IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Output

Client is due for malaria vaccination-44

Client is due for malaria vaccination

IMMZ.D2.DT.Malaria Output

Client is due for meningococcal vaccination-44

Client is due for meningococcal vaccination

IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Output

Client is due for mumps vaccination-44

Client is due for mumps vaccination

IMMZ.D2.DT.Mumps Output

Client is due for pneumococcal booster dose-44

Client is due for pneumococcal booster dose

IMMZ.D2.DT.Pneumococcal.3 doses Output

Client is due for pneumococcal vaccination-44

Client is due for pneumococcal vaccination

IMMZ.D2.DT.Pneumococcal.3 doses Output

Client is due for rabies vaccination-44

Client is due for rabies vaccination

IMMZ.D2.DT.Rabies Output

Client is due for rotavirus vaccination-44

Client is due for rotavirus vaccination

IMMZ.D2.DT.Rotavirus Output

Client is due for rubella vaccination-44

Client is due for rubella vaccination

IMMZ.D2.DT.Rubella.Low incidence Output

Client is due for tetanus and diphtheria booster dose-114

Client is due for tetanus and diphtheria booster dose

IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Output

Client is due for the bOPV birth dose-87

Client is due for the bOPV birth dose

IMMZ.D2.DT.Polio.Birth dose Output

Client is due for typhoid booster dose-44

Client is due for typhoid booster dose

IMMZ.D2.DT.Typhoid.Ty21a Output

Client is due for yellow fever vaccination-44

Client is due for yellow fever vaccination

IMMZ.D2.DT.Yellow fever Output

Client is immunocompromised-26

Client is immunocompromised

IMMZ.D2.DT.HPV.Single dose Inputs

Client is immunologically stable-31

Client is immunologically stable

IMMZ.D2.DT.BCG Inputs

Client is not at high risk for pneumococcal infection-49

Client is not at high risk for pneumococcal infection

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

Client is not clinically well-25

Client is not clinically well

IMMZ.D2.DT.BCG Inputs

Client is not due for BCG vaccination-48

Client is not due for BCG vaccination

IMMZ.D2.DT.BCG Output

Client is not due for DTP vaccination-99

Client is not due for DTP vaccination

IMMZ.D2.DT.DTP.Delayed or interrupted series Output

Client is not due for HPV vaccination-48

Client is not due for HPV vaccination

IMMZ.D2.DT.HPV.Single dose Output

Client is not due for Hepatitis A vaccination-48

Client is not due for Hepatitis A vaccination

IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Output

Client is not due for Hib vaccination-48

Client is not due for Hib vaccination

IMMZ.D2.DT.Hib.2 doses with booster dose Output

Client is not due for IPV vaccination-48

Client is not due for IPV vaccination

IMMZ.D2.DT.Polio.IPV-only Output

Client is not due for JE vaccination-48

Client is not due for JE vaccination

IMMZ.D2.DT.JE.Live recombinant vaccine Output

Client is not due for MCV0-48

Client is not due for MCV0

IMMZ.D2.DT.Measles.MCV dose 0 Output

Client is not due for MCV1-48

Client is not due for MCV1

IMMZ.D2.DT.Measles.Low transmission Output

Client is not due for MCV2-48

Client is not due for MCV2

IMMZ.D2.DT.Measles.Low transmission Output

Client is not due for TBE vaccination-48

Client is not due for TBE vaccination

IMMZ.D2.DT.TBE.EnceVir Output

Client is not due for Typhoid vaccination-48

Client is not due for Typhoid vaccination

IMMZ.D2.DT.Typhoid.Ty21a Output

Client is not due for bOPV vaccination-48

Client is not due for bOPV vaccination

IMMZ.D2.DT.Polio.Sequential IPV–bOPV Output

Client is not due for cholera booster dose-48

Client is not due for cholera booster dose

IMMZ.D2.DT.Cholera.WC vaccines Output

Client is not due for cholera vaccination-48

Client is not due for cholera vaccination

IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Output

Client is not due for dengue vaccination-48

Client is not due for dengue vaccination

IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Output

Client is not due for first dose of measles-containing vaccine (MCV1)-48

Client is not due for first dose of measles-containing vaccine (MCV1)

IMMZ.D2.DT.Measles.Ongoing transmission Output

Client is not due for malaria vaccination-48

Client is not due for malaria vaccination

IMMZ.D2.DT.Malaria Output

Client is not due for measles supplementary dose-48

Client is not due for measles supplementary dose

IMMZ.D2.DT.Measles.Supplementary dose Output

Client is not due for meningococcal vaccination-48

Client is not due for meningococcal vaccination

IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Output

Client is not due for mumps vaccination-48

Client is not due for mumps vaccination

IMMZ.D2.DT.Mumps Output

Client is not due for pertussis booster dose-48

Client is not due for pertussis booster dose

IMMZ.D2.DT.DTP.On-time start Output

Client is not due for pneumococcal booster dose-48

Client is not due for pneumococcal booster dose

IMMZ.D2.DT.Pneumococcal.3 doses Output

Client is not due for pneumococcal vaccination-48

Client is not due for pneumococcal vaccination

IMMZ.D2.DT.Pneumococcal.3 doses Output

Client is not due for polio vaccination-48

Client is not due for polio vaccination

IMMZ.D2.DT.Polio.bOPV plus IPV Output

Client is not due for rabies vaccination-48

Client is not due for rabies vaccination

IMMZ.D2.DT.Rabies Output

Client is not due for rotavirus vaccination if immunization schedule is not complete.-109

Client is not due for rotavirus vaccination if immunization schedule is not complete.

IMMZ.D2.DT.Rotavirus Output

Client is not due for rotavirus vaccination-48

Client is not due for rotavirus vaccination

IMMZ.D2.DT.Rotavirus Output

Client is not due for rubella vaccination-48

Client is not due for rubella vaccination

IMMZ.D2.DT.Rubella.Low incidence Output

Client is not due for second dose of measles-containing vaccine (MCV2)-48

Client is not due for second dose of measles-containing vaccine (MCV2)

IMMZ.D2.DT.Measles.Ongoing transmission Output

Client is not due for tetanus and diphtheria booster dose-118

Client is not due for tetanus and diphtheria booster dose

IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Output

Client is not due for the bOPV birth dose-48

Client is not due for the bOPV birth dose

IMMZ.D2.DT.Polio.Birth dose Output

Client is not due for typhoid booster dose-48

Client is not due for typhoid booster dose

IMMZ.D2.DT.Typhoid.Ty21a Output

Client is not due for yellow fever vaccination-48

Client is not due for yellow fever vaccination

IMMZ.D2.DT.Yellow fever Output

Client is not immunocompromised-26

Client is not immunocompromised

IMMZ.D2.DT.HPV.Single dose Inputs

Client is not immunologically stable-32

Client is not immunologically stable

IMMZ.D2.DT.BCG Inputs

Client should follow 'delayed or interrupted series' decision logic-0

Client should follow 'delayed or interrupted series' decision logic

IMMZ.D2.DT.DTP.Pregnancy Output

Client should follow 'pregnancy starting with 3 doses' decision logic-0

Client should follow 'pregnancy starting with 3 doses' decision logic

IMMZ.D2.DT.DTP.Pregnancy Output

Client should follow 'pregnancy starting with 4 doses' decision logic-0

Client should follow 'pregnancy starting with 4 doses' decision logic

IMMZ.D2.DT.DTP.Pregnancy Output

Client's HIV status is negative or unknown-29

Client's HIV status is negative or unknown

IMMZ.D2.DT.HPV.Single dose Inputs

Client's HIV status is positive-29

Client's HIV status is positive

IMMZ.D2.DT.HPV.Single dose Inputs

Client's TB infection test result is negative-39

Client's TB infection test result is negative

IMMZ.D2.DT.BCG Inputs

Client's TB infection test result is positive-39

Client's TB infection test result is positive

IMMZ.D2.DT.BCG Inputs

Client's TB infection test result is unknown (test not done or no result yet)-34

Client's TB infection test result is unknown (test not done or no result yet)

IMMZ.D2.DT.BCG Inputs

Client's age is 2–5 years-50

Client's age is 2–5 years

IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Inputs

Client's age is 6–9 months-52

Client's age is 6–9 months

IMMZ.D5.DT.Yellow fever contraindications Inputs

Client's age is at least 6 weeks and not more than 5 years-49

Client's age is at least 6 weeks and not more than 5 years

IMMZ.D2.DT.Hib.2 doses with booster dose Inputs

Client's age is at least 6 weeks and not more than 5 years-50

Client's age is at least 6 weeks and not more than 5 years

IMMZ.D2.DT.Hib.2 doses with booster dose Inputs

Client's age is between 1 year and 6 years-49

Client's age is between 1 year and 6 years

IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs

Client's age is between 28 days and 5 years-50

Client's age is between 28 days and 5 years

IMMZ.D2.DT.BCG Inputs

Client's age is between 6 months and 24 months-52

Client's age is between 6 months and 24 months

IMMZ.D2.DT.Rotavirus Inputs

Client's age is between 6 months and 45 years-52

Client's age is between 6 months and 45 years

IMMZ.D2.DT.Typhoid.TCV Inputs

Client's age is between 6 months and 9 months-52

Client's age is between 6 months and 9 months

IMMZ.D2.DT.Measles.MCV dose 0 Inputs

Client's age is between 6 weeks and 1 year-49

Client's age is between 6 weeks and 1 year

IMMZ.D2.DT.DTP.On-time start Inputs

Client's age is between 6 weeks and 14 weeks-51

Client's age is between 6 weeks and 14 weeks

IMMZ.D2.DT.Polio.bOPV plus IPV Inputs

Client's age is between 6 weeks and 24 months-52

Client's age is between 6 weeks and 24 months

IMMZ.D2.DT.Rotavirus Inputs

Client's age is between 6 weeks and 3 months-51

Client's age is between 6 weeks and 3 months

IMMZ.D2.DT.Polio.bOPV plus IPV Inputs

Client's age is between 6 weeks and 5 years-50

Client's age is between 6 weeks and 5 years

IMMZ.D2.DT.Hib.2 doses with booster dose Inputs

Client's age is between 6 weeks and not more than 5 years-50

Client's age is between 6 weeks and not more than 5 years

IMMZ.D2.DT.Hib.3 doses with booster dose Inputs

Client's age is between 9 and 14 years-51

Client's age is between 9 and 14 years

IMMZ.D2.DT.HPV.2 doses Inputs

Client's age is between 9 and 20 years-51

Client's age is between 9 and 20 years

IMMZ.D2.DT.HPV.Single dose Inputs

Client's age is between 9 years and 45 years-51

Client's age is between 9 years and 45 years

IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs

Client's age is less than 1 week-39

Client's age is less than 1 week

IMMZ.D2.DT.Polio.Birth dose Inputs

Client's age is less than 1 year-14

Client's age is less than 1 year

IMMZ.D5.DT.BCG contraindications Inputs

Client's age is less than 1 year-39

Client's age is less than 1 year

IMMZ.D2.DT.Cholera.WC vaccines Inputs

Client's age is less than 12 months-42

Client's age is less than 12 months

IMMZ.D2.DT.Mumps Inputs

Client's age is less than 14 weeks-41

Client's age is less than 14 weeks

IMMZ.D2.DT.Polio.bOPV plus IPV Inputs

Client's age is less than 15 months-42

Client's age is less than 15 months

IMMZ.D2.DT.Measles.Low transmission Inputs

Client's age is less than 18 months-42

Client's age is less than 18 months

IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs

Client's age is less than 2 months-41

Client's age is less than 2 months

IMMZ.D2.DT.Meningococcal.Monovalent MenC conjugate vaccine Inputs

Client's age is less than 2 years-40

Client's age is less than 2 years

IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs

Client's age is less than 3 months-41

Client's age is less than 3 months

IMMZ.D2.DT.Meningococcal.MenA conjugate vaccine 2 doses Inputs

Client's age is less than 3 years-40

Client's age is less than 3 years

IMMZ.D2.DT.TBE.EnceVir Inputs

Client's age is less than 4 years-40

Client's age is less than 4 years

IMMZ.D2.DT.DTP.On-time start Inputs

Client's age is less than 5 months-41

Client's age is less than 5 months

IMMZ.D2.DT.Malaria Inputs

Client's age is less than 6 months-41

Client's age is less than 6 months

IMMZ.D5.DT.Yellow fever contraindications Inputs

Client's age is less than 6 weeks-40

Client's age is less than 6 weeks

IMMZ.D2.DT.Hib.2 doses with booster dose Inputs

Client's age is less than 6 weeks-41

Client's age is less than 6 weeks

IMMZ.D2.DT.Rotavirus Inputs

Client's age is less than 6 years-40

Client's age is less than 6 years

IMMZ.D2.DT.Typhoid.Ty21a Inputs

Client's age is less than 8 months-41

Client's age is less than 8 months

IMMZ.D2.DT.JE.Live attenuated vaccine Inputs

Client's age is less than 8 weeks-40

Client's age is less than 8 weeks

IMMZ.D2.DT.Polio.Sequential IPV–bOPV Inputs

Client's age is less than 9 months-41

Client's age is less than 9 months

IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Inputs

Client's age is less than 9 years-40

Client's age is less than 9 years

IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs

Client's age is less than or equal to 28 days-40

Client's age is less than or equal to 28 days

IMMZ.D2.DT.BCG Inputs

Client's age is more than 1 year-39

Client's age is more than 1 year

IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs

Client's age is more than 2 years-40

Client's age is more than 2 years

IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs

Client's age is more than 20 years-41

Client's age is more than 20 years

IMMZ.D2.DT.HPV.Single dose Inputs

Client's age is more than 24 months-27

Client's age is more than 24 months

IMMZ.D2.DT.Rotavirus Inputs

Client's age is more than 3 months-41

Client's age is more than 3 months

IMMZ.D2.DT.Polio.bOPV plus IPV Inputs

Client's age is more than 45 years-41

Client's age is more than 45 years

IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs

Client's age is more than 5 years-40

Client's age is more than 5 years

IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs

Client's age is more than 6 years-40

Client's age is more than 6 years

IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs

Client's age is more than 9 months-41

Client's age is more than 9 months

IMMZ.D2.DT.Meningococcal.MenA conjugate vaccine 1 dose Inputs

Client's age is more than or equal to 1 week-39

Client's age is more than or equal to 1 week

IMMZ.D2.DT.Polio.Birth dose Inputs

Client's age is more than or equal to 1 year-14

Client's age is more than or equal to 1 year

IMMZ.D5.DT.BCG contraindications Inputs

Client's age is more than or equal to 1 year-39

Client's age is more than or equal to 1 year

IMMZ.D2.DT.Cholera.WC vaccines Inputs

Client's age is more than or equal to 12 months-42

Client's age is more than or equal to 12 months

IMMZ.D2.DT.Mumps Inputs

Client's age is more than or equal to 14 weeks-41

Client's age is more than or equal to 14 weeks

IMMZ.D2.DT.Polio.bOPV plus IPV Inputs

Client's age is more than or equal to 15 months-42

Client's age is more than or equal to 15 months

IMMZ.D2.DT.Measles.Low transmission Inputs

Client's age is more than or equal to 18 months-42

Client's age is more than or equal to 18 months

IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs

Client's age is more than or equal to 2 months-41

Client's age is more than or equal to 2 months

IMMZ.D2.DT.Meningococcal.Monovalent MenC conjugate vaccine Inputs

Client's age is more than or equal to 2 years-40

Client's age is more than or equal to 2 years

IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 1 dose Inputs

Client's age is more than or equal to 3 months-41

Client's age is more than or equal to 3 months

IMMZ.D2.DT.Meningococcal.MenA conjugate vaccine 2 doses Inputs

Client's age is more than or equal to 3 years-40

Client's age is more than or equal to 3 years

IMMZ.D2.DT.TBE.EnceVir Inputs

Client's age is more than or equal to 4 years-40

Client's age is more than or equal to 4 years

IMMZ.D2.DT.DTP.On-time start Inputs

Client's age is more than or equal to 45 years-41

Client's age is more than or equal to 45 years

IMMZ.D2.DT.Typhoid.TCV Inputs

Client's age is more than or equal to 5 months-41

Client's age is more than or equal to 5 months

IMMZ.D2.DT.Malaria Inputs

Client's age is more than or equal to 6 months-41

Client's age is more than or equal to 6 months

IMMZ.D2.DT.JE.Inactivated Vero cell-derived vaccine Inputs

Client's age is more than or equal to 6 weeks-40

Client's age is more than or equal to 6 weeks

IMMZ.D2.DT.Polio.IPV-only Inputs

Client's age is more than or equal to 6 years-40

Client's age is more than or equal to 6 years

IMMZ.D2.DT.Typhoid.Ty21a Inputs

Client's age is more than or equal to 60 years-41

Client's age is more than or equal to 60 years

IMMZ.D5.DT.Yellow fever contraindications Inputs

Client's age is more than or equal to 8 months-41

Client's age is more than or equal to 8 months

IMMZ.D2.DT.JE.Live attenuated vaccine Inputs

Client's age is more than or equal to 8 weeks-40

Client's age is more than or equal to 8 weeks

IMMZ.D2.DT.Polio.Sequential IPV–bOPV Inputs

Client's age is more than or equal to 9 months-41

Client's age is more than or equal to 9 months

IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Inputs

Client's age is more than or equal to 9 years-40

Client's age is more than or equal to 9 years

IMMZ.D2.DT.DTP.On-time start Inputs

Client's age more than or equal to 15 years-41

Client's age more than or equal to 15 years

IMMZ.D2.DT.HPV.2 doses Inputs

Client's age was 6 weeks when the primary series was started-138

Client's age was 6 weeks when the primary series was started

IMMZ.D2.DT.Polio.IPV-only Inputs

Client's age was less than 1 year when first Hib dose was administered-129

Client's age was less than 1 year when first Hib dose was administered

IMMZ.D2.DT.Hib.2 doses with booster dose Inputs

Client's age was less than or equal to 11 months when the primary series was started-110

Client's age was less than or equal to 11 months when the primary series was started

IMMZ.D2.DT.Meningococcal.Monovalent MenC conjugate vaccine Inputs

Client's age was less than or equal to 23 months when the primary series was started-110

Client's age was less than or equal to 23 months when the primary series was started

IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Inputs

Client's age was more than 1 year when first Hib dose was administered-129

Client's age was more than 1 year when first Hib dose was administered

IMMZ.D2.DT.Hib.2 doses with booster dose Inputs

Client's age was more than 11 months when the primary series was started-110

Client's age was more than 11 months when the primary series was started

IMMZ.D2.DT.Meningococcal.Monovalent MenC conjugate vaccine Inputs

Client's age was more than 23 months when the primary series was started-110

Client's age was more than 23 months when the primary series was started

IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Inputs

Client's age was more than 6 weeks when the primary series was started-138

Client's age was more than 6 weeks when the primary series was started

IMMZ.D2.DT.Polio.IPV-only Inputs

Client's biological sex is female-16

Client's biological sex is female

IMMZ.D2.DT.HPV.2 doses Inputs

Client's biological sex is not female-16

Client's biological sex is not female

IMMZ.D2.DT.HPV.2 doses Inputs

Client's dengue serostatus is negative-32

Client's dengue serostatus is negative

IMMZ.D2.DT.Dengue.3 doses with pre-vaccination screening Inputs

Client's dengue serostatus is positive-32

Client's dengue serostatus is positive

IMMZ.D2.DT.Dengue.3 doses with pre-vaccination screening Inputs

Clinical judgement is required. Create a clinical note-66

Clinical judgement is required. Create a clinical note

IMMZ.D5.DT.Rabies contraindications Output

Clinical judgement is required. Create a clinical note.-66

Clinical judgement is required. Create a clinical note.

IMMZ.D2.DT.HPV.Single dose Output

Clinical judgement is required. Create clinical note-66

Clinical judgement is required. Create clinical note

IMMZ.D5.DT.Varicella contraindications Output

Clinical judgement is required. Create clinical note-67

Clinical judgement is required. Create clinical note

IMMZ.D5.DT.Varicella contraindications Output

Clinical judgement is required. Create clinical note.-66

Clinical judgement is required. Create clinical note.

IMMZ.D2.DT.BCG Output

Clinical judgement is required. Create clinical note.-67

Clinical judgement is required. Create clinical note.

IMMZ.D2.DT.BCG Output

Clinical judgement is required.-89

Clinical judgement is required.

IMMZ.D2.DT.TBE.FSME-Immun Output

Clinical judgement required. Create a clinical note-66

Clinical judgement required. Create a clinical note

IMMZ.D5.DT.Measles contraindications Output

Consider MCV0.-90

Consider MCV0.

IMMZ.D2.DT.Measles.MCV dose 0 Output

Consider measles supplementary dose. Create a clinical note-66

Consider measles supplementary dose. Create a clinical note

IMMZ.D2.DT.Measles.Supplementary dose Output

Decision ID-0

Decision ID

IMMZ.D2.DT.Measles.Supplementary dose Inputs

Dengue immunization schedule is complete-143

Dengue immunization schedule is complete

IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Output

Dengue vaccination could be contraindicated. Clinical judgement is required. Create a clinical note.-66

Dengue vaccination could be contraindicated. Clinical judgement is required. Create a clinical note.

IMMZ.D5.DT.Dengue contraindications Output

Dengue vaccination is contraindicated-56

Dengue vaccination is contraindicated

IMMZ.D5.DT.Dengue contraindications Output

Dose number of the latest dose is one-68

Dose number of the latest dose is one

IMMZ.D2.DT.Cholera.WC vaccines Inputs

Dose number of the latest dose is two-68

Dose number of the latest dose is two

IMMZ.D2.DT.Cholera.WC vaccines Inputs

Dose number of the latest primary series dose is less than three-106

Dose number of the latest primary series dose is less than three

IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Inputs

Dose number of the latest primary series dose is more than or equal to two-107

Dose number of the latest primary series dose is more than or equal to two

IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs

Dose number of the latest primary series dose is one-106

Dose number of the latest primary series dose is one

IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs

Dose number of the latest primary series dose is three-106

Dose number of the latest primary series dose is three

IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Inputs

Dose number of the latest primary series dose is two-106

Dose number of the latest primary series dose is two

IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Inputs

First DTP dose from the primary series was administered-123

First DTP dose from the primary series was administered

IMMZ.D18.S.DTP.Delayed or interrupted schedule Trigger

First HPV dose from the primary series was administered and client's HIV status is positive or client is immunocompromised-140

First HPV dose from the primary series was administered and client's HIV status is positive or client is immunocompromised

IMMZ.D18.S.Single-dose schedule Trigger

First HPV dose from the primary series was administered-112

First HPV dose from the primary series was administered

IMMZ.D18.S.HPV.2-dose schedule Trigger

First HPV dose from the primary series was administered-74

First HPV dose from the primary series was administered

IMMZ.D18.S.Single-dose schedule Completion

First Hib dose from the primary series was administered to the client within 1 year of age. Client's age is less than 5 years-302

First Hib dose from the primary series was administered to the client within 1 year of age. Client's age is less than 5 years

IMMZ.D18.S.Hib.2 doses with booster dose schedule Trigger

First Hib dose from the primary series was administered-279

First Hib dose from the primary series was administered

IMMZ.D18.S.Hib.2 doses with booster dose schedule Completion

First IPV dose from the primary series was administered-76

First IPV dose from the primary series was administered

IMMZ.D18.S.Polio.Sequential IPV–bOPV schedule Trigger

First IPV dose from the primary series was administered-92

First IPV dose from the primary series was administered

IMMZ.D18.S.Polio.IPV-only schedule Trigger

First TBE dose from the primary series was administered-112

First TBE dose from the primary series was administered

IMMZ.D18.S.TBE.EnceVir schedule Trigger

First bOPV dose from the primary series was administered-115

First bOPV dose from the primary series was administered

IMMZ.D18.S.Polio.bOPV plus IPV schedule Trigger

First bOPV dose from the primary series was administered-77

First bOPV dose from the primary series was administered

IMMZ.D18.S.Polio.Sequential IPV–bOPV schedule Trigger

First cholera booster dose administered-103

First cholera booster dose administered

IMMZ.D18.S.Cholera.WC vaccines schedule Trigger

First cholera booster dose was administered-105

First cholera booster dose was administered

IMMZ.D18.S.Cholera.WC vaccines schedule Completion

First cholera dose administered-105

First cholera dose administered

IMMZ.D18.S.Cholera.WC vaccines schedule Trigger

First cholera dose was administered-107

First cholera dose was administered

IMMZ.D18.S.Cholera.WC vaccines schedule Completion

First cholera dose was administered-115

First cholera dose was administered

IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Trigger

First cholera dose was administered-125

First cholera dose was administered

IMMZ.D18.S.Cholera.WC-rBS vaccine 3-dose schedule Trigger

First cholera dose was administered-68

First cholera dose was administered

IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Completion

First dengue dose from the primary series was administered-115

First dengue dose from the primary series was administered

IMMZ.D18.S.Dengue schedule Trigger

First hepatitis A dose from the primary series was administered-131

First hepatitis A dose from the primary series was administered

IMMZ.D18.S.Hepatitis A.Inactivated HAV 2-dose schedule Trigger

First hepatitis A dose from the primary series was administered. The primary series has been completed-108

First hepatitis A dose from the primary series was administered. The primary series has been completed

IMMZ.D18.S.Hepatitis A.Live attenuated HAV 1-dose schedule Completion

First malaria dose from the primary series was administered-116

First malaria dose from the primary series was administered

IMMZ.D18.S.Malaria schedule Trigger

First meningococcal dose from the primary series was administered and client started the series when client's age was less than or equal to 11 months-237

First meningococcal dose from the primary series was administered and client started the series when client's age was less than or equal to 11 months

IMMZ.D18.S.Meningococcal.Monovalent MenC conjugate vaccine schedule Trigger

First meningococcal dose from the primary series was administered-338

First meningococcal dose from the primary series was administered

IMMZ.D18.S.Meningococcal.Monovalent MenC conjugate vaccine schedule Completion

First meningococcal dose from the primary series was administered-84

First meningococcal dose from the primary series was administered

IMMZ.D18.S.Meningococcal.Quadrivalent conjugate vaccines 2-dose schedule Trigger

First mumps dose from the primary series was administered-125

First mumps dose from the primary series was administered

IMMZ.D18.S.Mumps schedule Trigger

First pneumococcal dose from the primary series was administered to client, who is less than or equal to 5 years of age, within 24 months post birth-280

First pneumococcal dose from the primary series was administered to client, who is less than or equal to 5 years of age, within 24 months post birth

IMMZ.D18.S.Pneumococcal.3 doses schedule Trigger

First pneumococcal dose from the primary series was administered to client, who is less than or equal to 5 years of age. Pneumococcal dose was not administered within 24 months post birth. Client is at high risk for pneumococcal infection.-333

IMMZ.D18.S.Pneumococcal.3 doses schedule Trigger

First pneumococcal dose from the primary series was administered to the client, who is less than or equal to 5 years of age, either within 24 months of birth or if client is at high risk for pneumococcal infection-333

IMMZ.D18.S.Pneumococcal.2 doses with booster dose schedule Trigger

First pneumococcal dose from the primary series was administered-121

First pneumococcal dose from the primary series was administered

IMMZ.D18.S.Pneumococcal.3 doses schedule Completion

First rabies dose from the primary series was administered-115

First rabies dose from the primary series was administered

IMMZ.D18.S.Rabies schedule Trigger

First rotavirus dose from the primary series was administered-118

First rotavirus dose from the primary series was administered

IMMZ.D18.S.Rotavirus schedule Trigger

First tetanus and diphtheria booster dose was administered-140

First tetanus and diphtheria booster dose was administered

IMMZ.D18.S.DTP.Pregnancy starting with 3 doses schedule Trigger

First varicella dose from the primary series was administered-128

First varicella dose from the primary series was administered

IMMZ.D18.S.Varicella.2-dose schedule Trigger

Five poliovirus primary series doses were administered-130

Five poliovirus primary series doses were administered

IMMZ.D2.DT.Polio.bOPV plus IPV Inputs

For a series containing more than two doses, two rotavirus primary series doses of mixed series or a series with unknown vaccine products were administered-324

For a series containing more than two doses, two rotavirus primary series doses of mixed series or a series with unknown vaccine products were administered

IMMZ.D18.S.Rotavirus schedule Trigger

Four malaria primary series doses were administered-116

Four malaria primary series doses were administered

IMMZ.D2.DT.Malaria Inputs

Four poliovirus primary series doses were administered-130

Four poliovirus primary series doses were administered

IMMZ.D2.DT.Polio.Sequential IPV–bOPV Inputs

Fourth malaria dose from the primary series was administered. The primary series has been completed-94

Fourth malaria dose from the primary series was administered. The primary series has been completed

IMMZ.D18.S.Malaria schedule Completion

From the four doses administered, one is IPV and three are bOPV-115

From the four doses administered, one is IPV and three are bOPV

IMMZ.D2.DT.Polio.bOPV plus IPV Inputs

From the four doses administered, two are IPV and two are bOPV-115

From the four doses administered, two are IPV and two are bOPV

IMMZ.D2.DT.Polio.bOPV plus IPV Inputs

From the three doses administered, one is IPV and two are bOPV-115

From the three doses administered, one is IPV and two are bOPV

IMMZ.D2.DT.Polio.bOPV plus IPV Inputs

From the three doses administered, one is bOPV and two are IPV-115

From the three doses administered, one is bOPV and two are IPV

IMMZ.D2.DT.Polio.bOPV plus IPV Inputs

From the two doses administered one is bOPV and one is IPV-115

From the two doses administered one is bOPV and one is IPV

IMMZ.D2.DT.Polio.bOPV plus IPV Inputs

HPV immunization schedule is complete-49

HPV immunization schedule is complete

IMMZ.D2.DT.HPV.Single dose Output

HPV vaccination could be contraindicated. Clinical judgement is required. Create a clinical note-66

HPV vaccination could be contraindicated. Clinical judgement is required. Create a clinical note

IMMZ.D5.DT.HPV contraindications Output

Hepatitis A immunization schedule is complete-158

Hepatitis A immunization schedule is complete

IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Output

Hepatitis A vaccination could be contraindicated. Clinical judgement is required. Create a clinical note-66

Hepatitis A vaccination could be contraindicated. Clinical judgement is required. Create a clinical note

IMMZ.D5.DT.Hepatitis A contraindications Output

Hib immunization schedule is complete-150

Hib immunization schedule is complete

IMMZ.D2.DT.Hib.2 doses with booster dose Output

Hib immunization schedule is complete-49

Hib immunization schedule is complete

IMMZ.D2.DT.Hib.2 doses with booster dose Output

Hib vaccination could be contraindicated. Clinical judgement is required. Create a clinical note.-66

Hib vaccination could be contraindicated. Clinical judgement is required. Create a clinical note.

IMMZ.D5.DT.Hib contraindications Output

Human papillomavirus (HPV) vaccination is contraindicated-56

Human papillomavirus (HPV) vaccination is contraindicated

IMMZ.D5.DT.HPV contraindications Output

IMMZ.D5.DT.Measles contraindications-0

IMMZ.D5.DT.Measles contraindications

IMMZ.D2.DT.Measles.Supplementary dose Inputs

JE immunization schedule is complete-138

JE immunization schedule is complete

IMMZ.D2.DT.JE.Live recombinant vaccine Output

Live attentuated Hepatitis A-containing vaccine is contraindicated-131

Live attentuated Hepatitis A-containing vaccine is contraindicated

IMMZ.D5.DT.Hepatitis A contraindications Output

Live vaccine was administered in last 4 weeks-92

Live vaccine was administered in last 4 weeks

IMMZ.D2.DT.Rotavirus Inputs

Live vaccine was administered in the last 4 weeks-92

Live vaccine was administered in the last 4 weeks

IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs

Live vaccine was administered in the last four weeks-92

Live vaccine was administered in the last four weeks

IMMZ.D2.DT.BCG Inputs

Live vaccine was administered in the last the 4 weeks-92

Live vaccine was administered in the last the 4 weeks

IMMZ.D2.DT.Rubella.Low incidence Inputs

Live vaccine was administered in the past 4 weeks-92

Live vaccine was administered in the past 4 weeks

IMMZ.D2.DT.Mumps Inputs

Live vaccine, other than typhoid, was administered in the past 4 weeks-132

Live vaccine, other than typhoid, was administered in the past 4 weeks

IMMZ.D2.DT.Typhoid.Ty21a Inputs

Live vaccines was administered in the last 4 weeks-92

Live vaccines was administered in the last 4 weeks

IMMZ.D2.DT.Rotavirus Inputs

MCV supplementary dose was administered-131

MCV supplementary dose was administered

IMMZ.D18.S.Measles.Supplementary dose schedule Completion

MCV0 was administered-119

MCV0 was administered

IMMZ.D18.S.Measles.MCV dose 0 schedule Completion

MCV0 was not administered-119

MCV0 was not administered

IMMZ.D2.DT.Measles.MCV dose 0 Inputs

MCV1 was administered-127

MCV1 was administered

IMMZ.D18.S.Measles.Low transmission schedule Trigger

MCV2 was administered-127

MCV2 was administered

IMMZ.D2.DT.Measles.Low transmission Inputs

MCV2 was administered. The primary series has been completed-104

MCV2 was administered. The primary series has been completed

IMMZ.D18.S.Measles.Low transmission schedule Completion

MCV2 was administered. The primary series has been completed.-104

MCV2 was administered. The primary series has been completed.

IMMZ.D18.S.Measles.Ongoing transmission schedule Completion

Malaria immunization schedule is complete-144

Malaria immunization schedule is complete

IMMZ.D2.DT.Malaria Output

Malaria vaccination could be contraindicated. Clinical judgement is required. Create a clinical note-66

Malaria vaccination could be contraindicated. Clinical judgement is required. Create a clinical note

IMMZ.D5.DT.Malaria contraindications Output

Measles immunization schedule is complete-49

Measles immunization schedule is complete

IMMZ.D2.DT.Measles.Supplementary dose Output

Measles primary series is complete-104

Measles primary series is complete

IMMZ.D2.DT.Measles.Low transmission Output

Measles routine immunization schedule is complete-104

Measles routine immunization schedule is complete

IMMZ.D2.DT.Measles.Supplementary dose Inputs

Measles supplementary dose was administered-131

Measles supplementary dose was administered

IMMZ.D2.DT.Measles.Supplementary dose Inputs

Measles supplementary dose was not administered-131

Measles supplementary dose was not administered

IMMZ.D2.DT.Measles.Supplementary dose Inputs

Measles vaccination contraindicated-56

Measles vaccination contraindicated

IMMZ.D5.DT.Measles contraindications Output

Measles vaccination could be contraindicated. Clinical judgement required. Create a clinical note-66

Measles vaccination could be contraindicated. Clinical judgement required. Create a clinical note

IMMZ.D5.DT.Measles contraindications Output

Meningococcal booster dose was administered for the client that started the series when client's age was less than or equal to 11 months. Immunization schedule has been completed-120

Meningococcal booster dose was administered for the client that started the series when client's age was less than or equal to 11 months. Immunization schedule has been completed

IMMZ.D18.S.Meningococcal.Monovalent MenC conjugate vaccine schedule Completion

Meningococcal booster dose was administered-120

Meningococcal booster dose was administered

IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs

Meningococcal booster dose was administered. The immunization schedule has been completed-120

Meningococcal booster dose was administered. The immunization schedule has been completed

IMMZ.D18.S.Meningococcal.Polysaccharide vaccines schedule Completion

Meningococcal immunization schedule is complete-149

Meningococcal immunization schedule is complete

IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Output

Meningococcal immunization schedule is complete-49

Meningococcal immunization schedule is complete

IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Output

Meningococcal vaccination could be contraindicated. Clinical judgement is required. Create a clinical note-130

Meningococcal vaccination could be contraindicated. Clinical judgement is required. Create a clinical note

IMMZ.D5.DT.Meningococcal contraindications Output

Mumps immunization schedule is complete-153

Mumps immunization schedule is complete

IMMZ.D2.DT.Mumps Output

Mumps vaccination could be contraindicated. Clinical judgement is required.-88

Mumps vaccination could be contraindicated. Clinical judgement is required.

IMMZ.D5.DT.Mumps contraindications Output

Mumps vaccination is contraindicated-56

Mumps vaccination is contraindicated

IMMZ.D5.DT.Mumps contraindications Output

No BCG primary series dose was administered-112

No BCG primary series dose was administered

IMMZ.D2.DT.BCG Inputs

No DTP doses were administered and client's age is more than 1 year-129

No DTP doses were administered and client's age is more than 1 year

IMMZ.D18.S.DTP.Delayed or interrupted schedule Trigger

No DTP primary series doses were administered-123

No DTP primary series doses were administered

IMMZ.D2.DT.DTP.On-time start Inputs

No DTP primary series doses were administered-124

No DTP primary series doses were administered

IMMZ.D2.DT.DTP.Pregnancy Inputs

No HPV primary series doses were administered-112

No HPV primary series doses were administered

IMMZ.D2.DT.HPV.Single dose Inputs

No Hib booster doses were administered-120

No Hib booster doses were administered

IMMZ.D2.DT.Hib.2 doses with booster dose Inputs

No Hib booster doses were administered-121

No Hib booster doses were administered

IMMZ.D2.DT.Hib.3 doses with booster dose Inputs

No Hib primary series doses were administered-123

No Hib primary series doses were administered

IMMZ.D2.DT.Hib.2 doses with booster dose Inputs

No Hib primary series doses were administered-124

No Hib primary series doses were administered

IMMZ.D2.DT.Hib.3 doses with booster dose Inputs

No JE primary series doses were administered-111

No JE primary series doses were administered

IMMZ.D2.DT.JE.Live recombinant vaccine Inputs

No TBE booster dose was administered-110

No TBE booster dose was administered

IMMZ.D2.DT.TBE.Encepur Inputs

No TBE primary series doses were administered-112

No TBE primary series doses were administered

IMMZ.D2.DT.TBE.EnceVir Inputs

No cholera booster series dose was administered-114

No cholera booster series dose was administered

IMMZ.D2.DT.Cholera.WC vaccines Inputs

No cholera primary series dose was administered-116

No cholera primary series dose was administered

IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs

No dengue doses from primary series were administered-115

No dengue doses from primary series were administered

IMMZ.D18.S.Dengue schedule Trigger

No dengue primary series doses were administered-115

No dengue primary series doses were administered

IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs

No hepatitis A primary series dose was administered-131

No hepatitis A primary series dose was administered

IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs

No hepatitis A primary series doses were administered-131

No hepatitis A primary series doses were administered

IMMZ.D2.DT.Hepatitis A.Inactivated HAV 2 doses Inputs

No live vaccine was administered in last 4 weeks-92

No live vaccine was administered in last 4 weeks

IMMZ.D2.DT.Rotavirus Inputs

No live vaccine was administered in the last 4 weeks-101

No live vaccine was administered in the last 4 weeks

IMMZ.D2.DT.JE.Live attenuated vaccine Inputs

No live vaccine was administered in the last 4 weeks-92

No live vaccine was administered in the last 4 weeks

IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs

No live vaccine was administered in the last four weeks-92

No live vaccine was administered in the last four weeks

IMMZ.D2.DT.BCG Inputs

No live vaccine was administered in the past 4 weeks-92

No live vaccine was administered in the past 4 weeks

IMMZ.D2.DT.Mumps Inputs

No live vaccine was administered-90

No live vaccine was administered

IMMZ.D2.DT.BCG Inputs

No live vaccine, other than typhoid, was administered in the past 4 weeks-132

No live vaccine, other than typhoid, was administered in the past 4 weeks

IMMZ.D2.DT.Typhoid.Ty21a Inputs

No malaria primary series doses were administered-116

No malaria primary series doses were administered

IMMZ.D2.DT.Malaria Inputs

No measles primary series doses were administered-127

No measles primary series doses were administered

IMMZ.D2.DT.Measles.Low transmission Inputs

No meningococcal booster dose was administered-120

No meningococcal booster dose was administered

IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs

No meningococcal primary series dose was administered-122

No meningococcal primary series dose was administered

IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs

No mumps primary series doses were administered-125

No mumps primary series doses were administered

IMMZ.D2.DT.Mumps Inputs

No pertussis booster doses were administered-126

No pertussis booster doses were administered

IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs

No pertussis booster doses were administered-127

No pertussis booster doses were administered

IMMZ.D2.DT.DTP.On-time start Inputs

No pneumococcal booster dose was administered-119

No pneumococcal booster dose was administered

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

No pneumococcal primary series doses were administered-121

No pneumococcal primary series doses were administered

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

No polio booster dose was administered-128

No polio booster dose was administered

IMMZ.D2.DT.Polio.IPV-only Inputs

No poliovirus primary series doses were administered-130

No poliovirus primary series doses were administered

IMMZ.D2.DT.Polio.IPV-only Inputs

No rabies primary series doses were administered-115

No rabies primary series doses were administered

IMMZ.D2.DT.Rabies Inputs

No rotavirus primary series doses were administered-118

No rotavirus primary series doses were administered

IMMZ.D2.DT.Rotavirus Inputs

No rubella primary series dose was administered-127

No rubella primary series dose was administered

IMMZ.D2.DT.Rubella.Low incidence Inputs

No tetanus and diphtheria booster dose was administered-140

No tetanus and diphtheria booster dose was administered

IMMZ.D2.DT.DTP.Pregnancy Inputs

No tetanus and diphtheria booster doses were administered-140

No tetanus and diphtheria booster doses were administered

IMMZ.D2.DT.DTP.Pregnancy starting with 3 doses Inputs

No tetanus and diphtheria booster doses were administered-141

No tetanus and diphtheria booster doses were administered

IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs

No typhoid primary series doses were administered-116

No typhoid primary series doses were administered

IMMZ.D2.DT.Typhoid.ViPS Inputs

No yellow fever primary series doses were administered-121

No yellow fever primary series doses were administered

IMMZ.D2.DT.Yellow fever Inputs

One BCG dose from the primary series was administered. The primary series has been completed-89

One BCG dose from the primary series was administered. The primary series has been completed

IMMZ.D18.S.BCG schedule Completion

One BCG primary series dose was administered-112

One BCG primary series dose was administered

IMMZ.D2.DT.BCG Inputs

One DTP primary series dose was administered-123

One DTP primary series dose was administered

IMMZ.D2.DT.DTP.On-time start Inputs

One DTP primary series dose was administered-124

One DTP primary series dose was administered

IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs

One HPV primary series dose was administered-112

One HPV primary series dose was administered

IMMZ.D2.DT.HPV.Single dose Inputs

One Hib booster dose was administered-120

One Hib booster dose was administered

IMMZ.D2.DT.Hib.2 doses with booster dose Inputs

One Hib booster dose was administered. Hib immunization schedule has been completed-120

One Hib booster dose was administered. Hib immunization schedule has been completed

IMMZ.D18.S.Hib.2 doses with booster dose schedule Completion

One Hib primary series dose was administered-122

One Hib primary series dose was administered

IMMZ.D2.DT.Hib.3 doses with booster dose Inputs

One Hib primary series doses was administered-122

One Hib primary series doses was administered

IMMZ.D2.DT.Hib.2 doses with booster dose Inputs

One JE dose from primary series was administered. The primary series has been completed-88

One JE dose from primary series was administered. The primary series has been completed

IMMZ.D18.S.JE.Live recombinant vaccination schedule Completion

One JE primary series dose was administered-111

One JE primary series dose was administered

IMMZ.D2.DT.JE.Live attenuated vaccine Inputs

One JE primary series doses were administered-111

One JE primary series doses were administered

IMMZ.D2.DT.JE.Live recombinant vaccine Inputs

One TBE primary series dose was administered-112

One TBE primary series dose was administered

IMMZ.D2.DT.TBE.EnceVir Inputs

One cholera primary series dose was administered-116

One cholera primary series dose was administered

IMMZ.D2.DT.Cholera.WC vaccines Inputs

One dengue primary series dose was administered-115

One dengue primary series dose was administered

IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs

One hepatitis A primary series dose was administered-131

One hepatitis A primary series dose was administered

IMMZ.D2.DT.Hepatitis A.Live attenuated HAV 1 dose Inputs

One malaria primary series dose was administered-116

One malaria primary series dose was administered

IMMZ.D2.DT.Malaria Inputs

One meningococcal dose from primary series was administered. The primary series has been completed-99

One meningococcal dose from primary series was administered. The primary series has been completed

IMMZ.D18.S.Meningococcal.Polysaccharide vaccines schedule Completion

One meningococcal dose from the primary series was administered. The primary series has been completed-99

One meningococcal dose from the primary series was administered. The primary series has been completed

IMMZ.D18.S.Meningococcal.MenA conjugate vaccine 1-dose schedule Completion

One meningococcal primary series dose was administered-122

One meningococcal primary series dose was administered

IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs

One mumps primary series dose was administered-125

One mumps primary series dose was administered

IMMZ.D2.DT.Mumps Inputs

One pertussis booster dose was administered-126

One pertussis booster dose was administered

IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs

One pertussis booster dose was administered-127

One pertussis booster dose was administered

IMMZ.D2.DT.DTP.On-time start Inputs

One pneumococcal booster dose was administered-119

One pneumococcal booster dose was administered

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

One pneumococcal booster dose was administered.-119

One pneumococcal booster dose was administered.

IMMZ.D18.S.Pneumococcal.3 doses schedule Completion

One pneumococcal primary series dose was administered-121

One pneumococcal primary series dose was administered

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

One poliovirus primary series dose was administered-130

One poliovirus primary series dose was administered

IMMZ.D2.DT.Polio.IPV-only Inputs

One rabies primary series doses were administered-115

One rabies primary series doses were administered

IMMZ.D2.DT.Rabies Inputs

One rotavirus primary series dose was administered-118

One rotavirus primary series dose was administered

IMMZ.D2.DT.Rotavirus Inputs

One rubella dose from the primary series was administered. The primary series has been completed-104

One rubella dose from the primary series was administered. The primary series has been completed

IMMZ.D18.S.Rubella.Low incidence schedule Completion

One rubella primary series dose was administered-127

One rubella primary series dose was administered

IMMZ.D2.DT.Rubella.Low incidence Inputs

One tetanus and diphtheria booster dose was administered-140

One tetanus and diphtheria booster dose was administered

IMMZ.D2.DT.DTP.Pregnancy Inputs

One tetanus and diphtheria booster dose was administered-141

One tetanus and diphtheria booster dose was administered

IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Inputs

One tetanus and diphtheria booster doses were administered-140

One tetanus and diphtheria booster doses were administered

IMMZ.D2.DT.DTP.Pregnancy starting with 3 doses Inputs

One typhoid dose from primary series was administered. The primary series has been completed-93

One typhoid dose from primary series was administered. The primary series has been completed

IMMZ.D18.S.Typhoid.TCV schedule Completion

One typhoid dose from the primary series was administered. The primary series has been completed-93

One typhoid dose from the primary series was administered. The primary series has been completed

IMMZ.D18.S.Typhoid.ViPS schedule Completion

One typhoid primary series dose was administered-116

One typhoid primary series dose was administered

IMMZ.D2.DT.Typhoid.ViPS Inputs

One varicella dose from primary series was administered. The primary series has been completed-106

One varicella dose from primary series was administered. The primary series has been completed

IMMZ.D18.S.Varicella.1-dose schedule Completion

One yellow fever dose from primary series was administered. The primary series has been completed-98

One yellow fever dose from primary series was administered. The primary series has been completed

IMMZ.D18.S.Yellow fever schedule Completion

One yellow fever primary series dose was administered-121

One yellow fever primary series dose was administered

IMMZ.D2.DT.Yellow fever Inputs

Pertussis immunization schedule is complete-106

Pertussis immunization schedule is complete

IMMZ.D2.DT.DTP.Delayed or interrupted series Output

Pertussis-containing booster dose was administered. Pertussis immunization schedule has been completed-234

Pertussis-containing booster dose was administered. Pertussis immunization schedule has been completed

IMMZ.D18.S.DTP.Delayed or interrupted schedule Completion

Pneumococcal booster dose was administered-119

Pneumococcal booster dose was administered

IMMZ.D18.S.Pneumococcal.2 doses with booster dose schedule Completion

Pneumococcal immunization schedule is complete-148

Pneumococcal immunization schedule is complete

IMMZ.D2.DT.Pneumococcal.3 doses Output

Pneumococcal immunization schedule is complete-49

Pneumococcal immunization schedule is complete

IMMZ.D2.DT.Pneumococcal.3 doses Output

Pneumococcal vaccination could be contraindicated. Clinical judgement is required. Create a clinical note-66

Pneumococcal vaccination could be contraindicated. Clinical judgement is required. Create a clinical note

IMMZ.D5.DT.Pneumococcal contraindications Output

Pneumococcal vaccination could be contraindicated. Clinical judgement is required. Create a clinical note.-66

Pneumococcal vaccination could be contraindicated. Clinical judgement is required. Create a clinical note.

IMMZ.D5.DT.Pneumococcal contraindications Output

Polio birth dose (a zero dose) was administered-146

Polio birth dose (a zero dose) was administered

IMMZ.D18.S.Polio.Birth dose schedule Completion

Polio booster dose was administered-128

Polio booster dose was administered

IMMZ.D2.DT.Polio.IPV-only Inputs

Polio immunization schedule is complete-157

Polio immunization schedule is complete

IMMZ.D2.DT.Polio.IPV-only Output

Polio immunization schedule is complete-49

Polio immunization schedule is complete

IMMZ.D2.DT.Polio.IPV-only Output

Poliovirus vaccination could be contraindicated. Clinical judgement required-66

Poliovirus vaccination could be contraindicated. Clinical judgement required

IMMZ.D5.DT.Polio contraindications Output

Poliovirus vaccination with bOPV is contraindicated-281

Poliovirus vaccination with bOPV is contraindicated

IMMZ.D5.DT.Polio contraindications Output

Primary DTP series is complete. Client is due for pertussis booster dose-202

Primary DTP series is complete. Client is due for pertussis booster dose

IMMZ.D2.DT.DTP.Delayed or interrupted series Output

Primary DTP series is complete. Client is due for tetanus and diphtheria booster dose-215

Primary DTP series is complete. Client is due for tetanus and diphtheria booster dose

IMMZ.D2.DT.DTP.Delayed or interrupted series Output

Primary DTP series is complete. Client is not due for pertussis booster dose-206

Primary DTP series is complete. Client is not due for pertussis booster dose

IMMZ.D2.DT.DTP.Delayed or interrupted series Output

Primary DTP series is complete. Client is not due for tetanus and diphtheria booster dose-218

Primary DTP series is complete. Client is not due for tetanus and diphtheria booster dose

IMMZ.D2.DT.DTP.On-time start Output

Primary DTP series is complete. Client is not due for tetanus and diphtheria booster dose-219

Primary DTP series is complete. Client is not due for tetanus and diphtheria booster dose

IMMZ.D2.DT.DTP.Delayed or interrupted series Output

Primary series for cholera has been completed and latest cholera dose was administered approximately less than 2 years ago-284

Primary series for cholera has been completed and latest cholera dose was administered approximately less than 2 years ago

IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Trigger

Primary series for cholera has been completed and latest cholera dose was administered approximately less than 6 months ago-295

Primary series for cholera has been completed and latest cholera dose was administered approximately less than 6 months ago

IMMZ.D18.S.Cholera.WC-rBS vaccine 3-dose schedule Trigger

Primary series for cholera has been completed and latest cholera dose was administered more than 3 years ago-204

Primary series for cholera has been completed and latest cholera dose was administered more than 3 years ago

IMMZ.D18.S.Cholera.WC vaccines schedule Trigger

Primary series has been completed-99

Primary series has been completed

IMMZ.D18.S.Meningococcal.Polysaccharide vaccines schedule Trigger

Primary series is complete-174

Primary series is complete

IMMZ.D2.DT.Polio.Sequential IPV–bOPV Output

Primary series is complete-93

Primary series is complete

IMMZ.D2.DT.Typhoid.Ty21a Inputs

Primary series is complete. Client is due for Hib booster dose-145

Primary series is complete. Client is due for Hib booster dose

IMMZ.D2.DT.Hib.2 doses with booster dose Output

Primary series is complete. Client is due for IPV booster dose-152

Primary series is complete. Client is due for IPV booster dose

IMMZ.D2.DT.Polio.IPV-only Output

Primary series is complete. Client is due for TBE booster dose-134

Primary series is complete. Client is due for TBE booster dose

IMMZ.D2.DT.TBE.EnceVir Output

Primary series is complete. Client is due for cholera booster dose-126

Primary series is complete. Client is due for cholera booster dose

IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Output

Primary series is complete. Client is due for cholera booster dose-138

Primary series is complete. Client is due for cholera booster dose

IMMZ.D2.DT.Cholera.WC vaccines Output

Primary series is complete. Client is due for typhoid booster dose-138

Primary series is complete. Client is due for typhoid booster dose

IMMZ.D2.DT.Typhoid.ViPS Output

Primary series is complete. Client is not due for Hib booster dose-149

Primary series is complete. Client is not due for Hib booster dose

IMMZ.D2.DT.Hib.2 doses with booster dose Output

Primary series is complete. Client is not due for IPV booster dose-156

Primary series is complete. Client is not due for IPV booster dose

IMMZ.D2.DT.Polio.IPV-only Output

Primary series is complete. Client is not due for TBE booster dose-138

Primary series is complete. Client is not due for TBE booster dose

IMMZ.D2.DT.TBE.EnceVir Output

Primary series is complete. Client is not due for cholera booster dose-130

Primary series is complete. Client is not due for cholera booster dose

IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Output

Primary series is complete. Client is not due for cholera booster dose-142

Primary series is complete. Client is not due for cholera booster dose

IMMZ.D2.DT.Cholera.WC vaccines Output

Primary series is complete. Client is not due for typhoid booster dose-142

Primary series is complete. Client is not due for typhoid booster dose

IMMZ.D2.DT.Typhoid.ViPS Output

Primary series is not complete-93

Primary series is not complete

IMMZ.D2.DT.Typhoid.Ty21a Inputs

Rabies immunization schedule is complete-142

Rabies immunization schedule is complete

IMMZ.D2.DT.Rabies Output

Revaccination with booster series has been completed in the last 3 years-191

Revaccination with booster series has been completed in the last 3 years

IMMZ.D18.S.Cholera.WC vaccines schedule Completion

Rotavirus immunization schedule is complete-49

Rotavirus immunization schedule is complete

IMMZ.D2.DT.Rotavirus Output

Rotavirus immunization schedule is complete-50

Rotavirus immunization schedule is complete

IMMZ.D2.DT.Rotavirus Output

Rotavirus vaccination could be contraindicated. Clinical judgement is required. Create a clinical note-66

Rotavirus vaccination could be contraindicated. Clinical judgement is required. Create a clinical note

IMMZ.D5.DT.Rotavirus contraindications Output

Rotavirus vaccination is contraindicated-56

Rotavirus vaccination is contraindicated

IMMZ.D5.DT.Rotavirus contraindications Output

Routine measles immunization schedule is complete-167

Routine measles immunization schedule is complete

IMMZ.D18.S.Measles.Supplementary dose schedule Trigger

Rubella immunization schedule is complete-154

Rubella immunization schedule is complete

IMMZ.D2.DT.Rubella.High incidence Output

Rubella immunization schedule is complete-155

Rubella immunization schedule is complete

IMMZ.D2.DT.Rubella.Low incidence Output

Rubella vaccination could be contraindicated. Clinical judgement is required. Create a clinical note-66

Rubella vaccination could be contraindicated. Clinical judgement is required. Create a clinical note

IMMZ.D5.DT.Rubella contraindications Output

Rubella vaccination is contraindicated-56

Rubella vaccination is contraindicated

IMMZ.D5.DT.Rubella contraindications Output

Second DTP dose from the primary series was administered-123

Second DTP dose from the primary series was administered

IMMZ.D18.S.DTP.Delayed or interrupted schedule Trigger

Second DTP dose from the primary series was administered-124

Second DTP dose from the primary series was administered

IMMZ.D18.S.DTP.On-time start schedule Trigger

Second HPV dose from the primary series was administered and client's HIV status is positive or client is immunocompromised-140

Second HPV dose from the primary series was administered and client's HIV status is positive or client is immunocompromised

IMMZ.D18.S.Single-dose schedule Trigger

Second HPV dose from the primary series was administered and client's HIV status is positive or client is immunocompromised-178

Second HPV dose from the primary series was administered and client's HIV status is positive or client is immunocompromised

IMMZ.D18.S.HPV.2-dose schedule Trigger

Second HPV dose from the primary series was administered-112

Second HPV dose from the primary series was administered

IMMZ.D18.S.HPV.2-dose schedule Completion

Second HPV dose from the primary series was administered-74

Second HPV dose from the primary series was administered

IMMZ.D18.S.Single-dose schedule Completion

Second Hib dose from the primary series was administered-122

Second Hib dose from the primary series was administered

IMMZ.D18.S.Hib.3 doses with booster dose schedule Completion

Second Hib dose from the primary series was administered. Client's age is less than 5 years-167

Second Hib dose from the primary series was administered. Client's age is less than 5 years

IMMZ.D18.S.Hib.2 doses with booster dose schedule Trigger

Second Hib dose from the primary series was administered. The primary series has been completed-99

Second Hib dose from the primary series was administered. The primary series has been completed

IMMZ.D18.S.Hib.2 doses with booster dose schedule Completion

Second IPV dose from the primary series was administered-76

Second IPV dose from the primary series was administered

IMMZ.D18.S.Polio.Sequential IPV–bOPV schedule Trigger

Second IPV dose from the primary series was administered-92

Second IPV dose from the primary series was administered

IMMZ.D18.S.Polio.IPV-only schedule Trigger

Second JE dose from the primary series was administered. The primary series has been completed-88

Second JE dose from the primary series was administered. The primary series has been completed

IMMZ.D18.S.JE.Inactivated Vero cell-derived vaccination schedule Completion

Second TBE dose from the primary series was administered-112

Second TBE dose from the primary series was administered

IMMZ.D18.S.TBE.EnceVir schedule Trigger

Second bOPV dose from the primary series was administered-115

Second bOPV dose from the primary series was administered

IMMZ.D18.S.Polio.bOPV plus IPV schedule Trigger

Second bOPV dose from the primary series was administered. The primary series has been completed-107

Second bOPV dose from the primary series was administered. The primary series has been completed

IMMZ.D18.S.Polio.Sequential IPV–bOPV schedule Completion

Second cholera dose was administered-125

Second cholera dose was administered

IMMZ.D18.S.Cholera.WC-rBS vaccine 3-dose schedule Trigger

Second cholera dose was administered-68

Second cholera dose was administered

IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule Completion

Second dengue dose from the primary series was administered-115

Second dengue dose from the primary series was administered

IMMZ.D18.S.Dengue schedule Trigger

Second hepatitis A dose from the primary series was administered. The primary series has been completed-108

Second hepatitis A dose from the primary series was administered. The primary series has been completed

IMMZ.D18.S.Hepatitis A.Inactivated HAV 2-dose schedule Completion

Second malaria dose from the primary series was administered-116

Second malaria dose from the primary series was administered

IMMZ.D18.S.Malaria schedule Trigger

Second meningococcal dose from the primary series was administered. The primary series has been completed for clients that started the series when client's age was less than or equal to 11 months-99

Second meningococcal dose from the primary series was administered. The primary series has been completed for clients that started the series when client's age was less than or equal to 11 months

IMMZ.D18.S.Meningococcal.Monovalent MenC conjugate vaccine schedule Completion

Second meningococcal dose from the primary series was administered. The primary series has been completed-99

Second meningococcal dose from the primary series was administered. The primary series has been completed

IMMZ.D18.S.Meningococcal.Quadrivalent conjugate vaccines 2-dose schedule Completion

Second mumps dose from the primary series was administered. The primary series has been completed-103

Second mumps dose from the primary series was administered. The primary series has been completed

IMMZ.D18.S.Mumps schedule Completion

Second pneumococcal booster dose was administered-119

Second pneumococcal booster dose was administered

IMMZ.D18.S.Pneumococcal.2 doses with booster dose schedule Completion

Second pneumococcal dose from the primary series was administered and first pneumococcal dose was administered within 12 months post birth-276

Second pneumococcal dose from the primary series was administered and first pneumococcal dose was administered within 12 months post birth

IMMZ.D18.S.Pneumococcal.2 doses with booster dose schedule Trigger

Second pneumococcal dose from the primary series was administered to client, who is less than or equal to 5 years of age. First pneumococcal dose was administered within 12 months post birth.-302

Second pneumococcal dose from the primary series was administered to client, who is less than or equal to 5 years of age. First pneumococcal dose was administered within 12 months post birth.

IMMZ.D18.S.Pneumococcal.3 doses schedule Trigger

Second pneumococcal dose from the primary series was administered-121

Second pneumococcal dose from the primary series was administered

IMMZ.D18.S.Pneumococcal.3 doses schedule Completion

Second pneumococcal dose from the primary series was administered. The primary series has been completed.-99

Second pneumococcal dose from the primary series was administered. The primary series has been completed.

IMMZ.D18.S.Pneumococcal.2 doses with booster dose schedule Completion

Second rabies dose from the primary series was administered. The primary series has been completed-92

Second rabies dose from the primary series was administered. The primary series has been completed

IMMZ.D18.S.Rabies schedule Completion

Second rotavirus dose from the primary series was administered-118

Second rotavirus dose from the primary series was administered

IMMZ.D18.S.Rotavirus schedule Completion

Second tetanus and diphtheria booster dose was administered-140

Second tetanus and diphtheria booster dose was administered

IMMZ.D18.S.DTP.Pregnancy starting with 4 doses schedule Trigger

Second tetanus and diphtheria booster dose was administered. Tetanus and diphtheria immunization schedule has been completed-260

Second tetanus and diphtheria booster dose was administered. Tetanus and diphtheria immunization schedule has been completed

IMMZ.D18.S.DTP.Delayed or interrupted schedule Completion

Second varicella dose from the primary series was administered. The primary series has been completed-107

Second varicella dose from the primary series was administered. The primary series has been completed

IMMZ.D18.S.Varicella.2-dose schedule Completion

TBE booster dose was administered less than 3 years ago-217

TBE booster dose was administered less than 3 years ago

IMMZ.D18.S.TBE.EnceVir schedule Completion

TBE booster dose was administered less than 3 years ago-218

TBE booster dose was administered less than 3 years ago

IMMZ.D18.S.TBE.TBE-Moscow schedule Completion

TBE booster dose was administered-110

TBE booster dose was administered

IMMZ.D18.S.TBE.Encepur schedule Completion

Tetanus and diphtheria immunization schedule is complete-119

Tetanus and diphtheria immunization schedule is complete

IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Output

Tetanus and pertussis vaccination could be contraindicated. Clinical judgement is required. Create a clinical note-250

Tetanus and pertussis vaccination could be contraindicated. Clinical judgement is required. Create a clinical note

IMMZ.D5.DT.DTP contraindications Output

Tetanus vaccination is contraindicated-112

Tetanus vaccination is contraindicated

IMMZ.D5.DT.DTP contraindications Output

The booster series has been completed-81

The booster series has been completed

IMMZ.D18.S.Typhoid.Ty21a schedule Completion

The client currently has a severe acute illness-54

The client currently has a severe acute illness

IMMZ.D5.DT.DTP contraindications Inputs

The client has TB disease-44

The client has TB disease

IMMZ.D5.DT.Rubella contraindications Inputs

The client has a history of anaphylactic reactions-67

The client has a history of anaphylactic reactions

IMMZ.D5.DT.Pneumococcal contraindications Inputs

The client has a history of severe allergic reactions-59

The client has a history of severe allergic reactions

IMMZ.D5.DT.Yellow fever contraindications Inputs

The client has a history of severe allergic reactions-60

The client has a history of severe allergic reactions

IMMZ.D5.DT.Hepatitis A contraindications Inputs

The client has a symptomatic HIV infection-59

The client has a symptomatic HIV infection

IMMZ.D5.DT.Measles contraindications Inputs

The client has acute gastroenteritis-55

The client has acute gastroenteritis

IMMZ.D5.DT.Rotavirus contraindications Inputs

The client has allergy to vaccine components-60

The client has allergy to vaccine components

IMMZ.D5.DT.Mumps contraindications Inputs

The client has altered immunocompetence-58

The client has altered immunocompetence

IMMZ.D5.DT.Rotavirus contraindications Inputs

The client has bladder exstrophy-51

The client has bladder exstrophy

IMMZ.D5.DT.Rotavirus contraindications Inputs

The client has chronic gastrointestinal disease-66

The client has chronic gastrointestinal disease

IMMZ.D5.DT.Rotavirus contraindications Inputs

The client has history of anaphylactic reactions-66

The client has history of anaphylactic reactions

IMMZ.D5.DT.Dengue contraindications Inputs

The client has history of anaphylactic reactions-67

The client has history of anaphylactic reactions

IMMZ.D5.DT.Measles contraindications Inputs

The client has history of severe allergic reactions-59

The client has history of severe allergic reactions

IMMZ.D5.DT.Dengue contraindications Inputs

The client has history of severe allergic reactions-60

The client has history of severe allergic reactions

IMMZ.D5.DT.BCG contraindications Inputs

The client has hypersensitivity to any component of the vaccine-72

The client has hypersensitivity to any component of the vaccine

IMMZ.D5.DT.Typhoid contraindications Inputs

The client has hypersensitivity to any of the vaccine components-72

The client has hypersensitivity to any of the vaccine components

IMMZ.D5.DT.Malaria contraindications Inputs

The client has immune deficiency-60

The client has immune deficiency

IMMZ.D5.DT.Varicella contraindications Inputs

The client has immunodeficiency syndromes-60

The client has immunodeficiency syndromes

IMMZ.D5.DT.Dengue contraindications Inputs

The client has moderate to severe fever-58

The client has moderate to severe fever

IMMZ.D5.DT.TBE contraindications Inputs

The client has prior history of intussusception-66

The client has prior history of intussusception

IMMZ.D5.DT.Rotavirus contraindications Inputs

The client has severe immunodeficiency-61

The client has severe immunodeficiency

IMMZ.D5.DT.Rotavirus contraindications Inputs

The client has spina bifida-46

The client has spina bifida

IMMZ.D5.DT.Rotavirus contraindications Inputs

The client has symptomatic HIV infection-59

The client has symptomatic HIV infection

IMMZ.D5.DT.Dengue contraindications Inputs

The client is currently lactating-48

The client is currently lactating

IMMZ.D5.DT.Dengue contraindications Inputs

The client is currently pregnant-52

The client is currently pregnant

IMMZ.D5.DT.Varicella contraindications Inputs

The client is currently taking antibiotics-52

The client is currently taking antibiotics

IMMZ.D5.DT.Typhoid contraindications Inputs

The client is exposed to immunosuppressive treatment-72

The client is exposed to immunosuppressive treatment

IMMZ.D5.DT.Rubella contraindications Inputs

The client is immunocomprised-51

The client is immunocomprised

IMMZ.D5.DT.JE contraindications Inputs

The client is immunocompromised-51

The client is immunocompromised

IMMZ.D5.DT.Varicella contraindications Inputs

The client is lactating-47

The client is lactating

IMMZ.D5.DT.Yellow fever contraindications Inputs

The client is not immunologically stable-31

The client is not immunologically stable

IMMZ.D5.DT.Typhoid contraindications Inputs

The client is planning to get pregnant in next month-76

The client is planning to get pregnant in next month

IMMZ.D5.DT.Rubella contraindications Inputs

The client is planning to get pregnant in the next month-76

The client is planning to get pregnant in the next month

IMMZ.D5.DT.Varicella contraindications Inputs

The client is pregnant-52

The client is pregnant

IMMZ.D5.DT.Measles contraindications Inputs

The client is receiving blood products-58

The client is receiving blood products

IMMZ.D5.DT.Rubella contraindications Inputs

The client is receiving or has received medications that may be immunosuppressive-72

The client is receiving or has received medications that may be immunosuppressive

IMMZ.D5.DT.Varicella contraindications Inputs

The client is severely immunocompromised-60

The client is severely immunocompromised

IMMZ.D5.DT.Dengue contraindications Inputs

The client is severely immunosuppressed-59

The client is severely immunosuppressed

IMMZ.D5.DT.Mumps contraindications Inputs

The client's HIV status is positive-29

The client's HIV status is positive

IMMZ.D5.DT.Typhoid contraindications Inputs

The client's age is between 6 weeks and 5 years-50

The client's age is between 6 weeks and 5 years

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

The client's age is less than 12 months-42

The client's age is less than 12 months

IMMZ.D2.DT.Pneumococcal.2 doses with booster dose Inputs

The client's age is less than 24 months-42

The client's age is less than 24 months

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

The client's age is less than 6 weeks-40

The client's age is less than 6 weeks

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

The client's age is less than or equal to 5 years-40

The client's age is less than or equal to 5 years

IMMZ.D2.DT.Pneumococcal.2 doses with booster dose Inputs

The client's age is less than or equal to 5 years-41

The client's age is less than or equal to 5 years

IMMZ.D2.DT.Pneumococcal.2 doses with booster dose Inputs

The client's age is less than or equal to five years-40

The client's age is less than or equal to five years

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

The client's age is more than 5 years-40

The client's age is more than 5 years

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

The client's age is more than or equal to 12 months and less than 24 months-54

The client's age is more than or equal to 12 months and less than 24 months

IMMZ.D2.DT.Pneumococcal.2 doses with booster dose Inputs

The client's age is more than or equal to 24 months-42

The client's age is more than or equal to 24 months

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

The first pneumococcal dose was administered after 12 months post birth-131

The first pneumococcal dose was administered after 12 months post birth

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

The first pneumococcal dose was administered after 24 months post birth-109

The first pneumococcal dose was administered after 24 months post birth

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

The first pneumococcal dose was administered at 12–24 months post birth-121

The first pneumococcal dose was administered at 12–24 months post birth

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

The first pneumococcal dose was administered within 12 months post birth-109

The first pneumococcal dose was administered within 12 months post birth

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

The first pneumococcal dose was administered within 12 months post birth-131

The first pneumococcal dose was administered within 12 months post birth

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

The first pneumococcal dose was administered within 24 months post birth-109

The first pneumococcal dose was administered within 24 months post birth

IMMZ.D2.DT.Pneumococcal.2 doses with booster dose Inputs

The latest DTP dose was administered less than 1 year ago-112

The latest DTP dose was administered less than 1 year ago

IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs

The latest DTP dose was administered less than 4 weeks ago-113

The latest DTP dose was administered less than 4 weeks ago

IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs

The latest DTP dose was administered less than 6 months ago-114

The latest DTP dose was administered less than 6 months ago

IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs

The latest DTP dose was administered more than 1 year ago-112

The latest DTP dose was administered more than 1 year ago

IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs

The latest DTP dose was administered more than 4 weeks ago-113

The latest DTP dose was administered more than 4 weeks ago

IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs

The latest DTP dose was administered more than 6 months ago-114

The latest DTP dose was administered more than 6 months ago

IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs

The latest HPV dose was administered less than 6 months ago-103

The latest HPV dose was administered less than 6 months ago

IMMZ.D2.DT.HPV.Single dose Inputs

The latest HPV dose was administered more than 6 months ago-102

The latest HPV dose was administered more than 6 months ago

IMMZ.D2.DT.HPV.2 doses Inputs

The latest HPV dose was administered more than 6 months ago-103

The latest HPV dose was administered more than 6 months ago

IMMZ.D2.DT.HPV.Single dose Inputs

The latest Hepatitis A dose was administered less than 6 months ago-115

The latest Hepatitis A dose was administered less than 6 months ago

IMMZ.D2.DT.Hepatitis A.Inactivated HAV 2 doses Inputs

The latest Hepatitis A dose was administered more than 6 months ago-115

The latest Hepatitis A dose was administered more than 6 months ago

IMMZ.D2.DT.Hepatitis A.Inactivated HAV 2 doses Inputs

The latest Hib dose was administered less than 4 weeks ago-113

The latest Hib dose was administered less than 4 weeks ago

IMMZ.D2.DT.Hib.3 doses with booster dose Inputs

The latest Hib dose was administered less than 6 months ago-114

The latest Hib dose was administered less than 6 months ago

IMMZ.D2.DT.Hib.2 doses with booster dose Inputs

The latest Hib dose was administered less than 8 weeks ago-113

The latest Hib dose was administered less than 8 weeks ago

IMMZ.D2.DT.Hib.2 doses with booster dose Inputs

The latest Hib dose was administered more than 4 weeks ago-113

The latest Hib dose was administered more than 4 weeks ago

IMMZ.D2.DT.Hib.3 doses with booster dose Inputs

The latest Hib dose was administered more than 6 months ago-114

The latest Hib dose was administered more than 6 months ago

IMMZ.D2.DT.Hib.2 doses with booster dose Inputs

The latest Hib dose was administered more than 8 weeks ago-113

The latest Hib dose was administered more than 8 weeks ago

IMMZ.D2.DT.Hib.2 doses with booster dose Inputs

The latest IPV dose was administered less than 4 months ago-159

The latest IPV dose was administered less than 4 months ago

IMMZ.D2.DT.Polio.bOPV plus IPV Inputs

The latest IPV dose was administered more than 4 months ago-159

The latest IPV dose was administered more than 4 months ago

IMMZ.D2.DT.Polio.bOPV plus IPV Inputs

The latest JE dose was administered less than 4 weeks ago-94

The latest JE dose was administered less than 4 weeks ago

IMMZ.D2.DT.JE.Inactivated Vero cell-derived vaccine Inputs

The latest JE dose was administered more than 4 weeks ago-94

The latest JE dose was administered more than 4 weeks ago

IMMZ.D2.DT.JE.Inactivated Vero cell-derived vaccine Inputs

The latest TBE dose was administered less than 1 month ago-95

The latest TBE dose was administered less than 1 month ago

IMMZ.D2.DT.TBE.TBE-Moscow Inputs

The latest TBE dose was administered less than 12 months ago-104

The latest TBE dose was administered less than 12 months ago

IMMZ.D2.DT.TBE.EnceVir Inputs

The latest TBE dose was administered less than 3 years ago-102

The latest TBE dose was administered less than 3 years ago

IMMZ.D2.DT.TBE.EnceVir Inputs

The latest TBE dose was administered less than 3 years ago-103

The latest TBE dose was administered less than 3 years ago

IMMZ.D2.DT.TBE.FSME-Immun Inputs

The latest TBE dose was administered less than 5 months ago-103

The latest TBE dose was administered less than 5 months ago

IMMZ.D2.DT.TBE.FSME-Immun Inputs

The latest TBE dose was administered less than 5 months ago-96

The latest TBE dose was administered less than 5 months ago

IMMZ.D2.DT.TBE.EnceVir Inputs

The latest TBE dose was administered less than 9 months ago-103

The latest TBE dose was administered less than 9 months ago

IMMZ.D2.DT.TBE.Encepur Inputs

The latest TBE dose was administered more than 1 month ago-95

The latest TBE dose was administered more than 1 month ago

IMMZ.D2.DT.TBE.TBE-Moscow Inputs

The latest TBE dose was administered more than 12 months ago-97

The latest TBE dose was administered more than 12 months ago

IMMZ.D2.DT.TBE.EnceVir Inputs

The latest TBE dose was administered more than 3 years ago-102

The latest TBE dose was administered more than 3 years ago

IMMZ.D2.DT.TBE.Encepur Inputs

The latest TBE dose was administered more than 3 years ago-95

The latest TBE dose was administered more than 3 years ago

IMMZ.D2.DT.TBE.EnceVir Inputs

The latest TBE dose was administered more than 5 months ago-103

The latest TBE dose was administered more than 5 months ago

IMMZ.D2.DT.TBE.FSME-Immun Inputs

The latest TBE dose was administered more than 5 months ago-96

The latest TBE dose was administered more than 5 months ago

IMMZ.D2.DT.TBE.EnceVir Inputs

The latest TBE dose was administered more than 9 months ago-103

The latest TBE dose was administered more than 9 months ago

IMMZ.D2.DT.TBE.Encepur Inputs

The latest bOPV dose was administered less than 4 weeks ago-159

The latest bOPV dose was administered less than 4 weeks ago

IMMZ.D2.DT.Polio.bOPV plus IPV Inputs

The latest bOPV dose was administered more than 4 weeks ago-159

The latest bOPV dose was administered more than 4 weeks ago

IMMZ.D2.DT.Polio.bOPV plus IPV Inputs

The latest cholera dose was administered approximately less than 2 years ago {Member States defined interval}-139

The latest cholera dose was administered approximately less than 2 years ago {Member States defined interval}

IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs

The latest cholera dose was administered approximately less than 6 months ago {Member States defined exact interval}-107

The latest cholera dose was administered approximately less than 6 months ago {Member States defined exact interval}

IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Inputs

The latest cholera dose was administered approximately more than 2 years ago {Member States defined interval}-139

The latest cholera dose was administered approximately more than 2 years ago {Member States defined interval}

IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs

The latest cholera dose was administered approximately more than 6 months ago {Member States defined exact interval}-107

The latest cholera dose was administered approximately more than 6 months ago {Member States defined exact interval}

IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Inputs

The latest cholera dose was administered less than 1 week ago-105

The latest cholera dose was administered less than 1 week ago

IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs

The latest cholera dose was administered less than 14 days ago-106

The latest cholera dose was administered less than 14 days ago

IMMZ.D2.DT.Cholera.WC vaccines Inputs

The latest cholera dose was administered less than 3 years ago-106

The latest cholera dose was administered less than 3 years ago

IMMZ.D2.DT.Cholera.WC vaccines Inputs

The latest cholera dose was administered less than {Member States defined lower limit} days ago-132

The latest cholera dose was administered less than {Member States defined lower limit} days ago

IMMZ.D2.DT.Cholera.WC-rBS vaccine 3 doses Inputs

The latest cholera dose was administered more than 1 week and less than 6 weeks ago-115

The latest cholera dose was administered more than 1 week and less than 6 weeks ago

IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs

The latest cholera dose was administered more than 14 days ago and less than 3 years ago-118

The latest cholera dose was administered more than 14 days ago and less than 3 years ago

IMMZ.D2.DT.Cholera.WC vaccines Inputs

The latest cholera dose was administered more than 14 days ago-106

The latest cholera dose was administered more than 14 days ago

IMMZ.D2.DT.Cholera.WC vaccines Inputs

The latest cholera dose was administered more than 3 years ago-106

The latest cholera dose was administered more than 3 years ago

IMMZ.D2.DT.Cholera.WC vaccines Inputs

The latest cholera dose was administered more than 6 weeks ago-106

The latest cholera dose was administered more than 6 weeks ago

IMMZ.D2.DT.Cholera.WC-rBS vaccine 2 doses Inputs

The latest dengue dose was administered less than 6 months ago-106

The latest dengue dose was administered less than 6 months ago

IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs

The latest dengue dose was administered more than 6 months ago-106

The latest dengue dose was administered more than 6 months ago

IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs

The latest malaria dose was administered less than 4 weeks ago-99

The latest malaria dose was administered less than 4 weeks ago

IMMZ.D2.DT.Malaria Inputs

The latest malaria dose was administered more than 4 weeks ago-106

The latest malaria dose was administered more than 4 weeks ago

IMMZ.D2.DT.Malaria Inputs

The latest meningococcal dose was administered less than 1 year ago-111

The latest meningococcal dose was administered less than 1 year ago

IMMZ.D2.DT.Meningococcal.Monovalent MenC conjugate vaccine Inputs

The latest meningococcal dose was administered less than 2 months ago-106

The latest meningococcal dose was administered less than 2 months ago

IMMZ.D2.DT.Meningococcal.Monovalent MenC conjugate vaccine Inputs

The latest meningococcal dose was administered less than 3 months ago-106

The latest meningococcal dose was administered less than 3 months ago

IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Inputs

The latest meningococcal dose was administered less than 3 years ago-105

The latest meningococcal dose was administered less than 3 years ago

IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs

The latest meningococcal dose was administered less than 8 weeks ago-105

The latest meningococcal dose was administered less than 8 weeks ago

IMMZ.D2.DT.Meningococcal.MenA conjugate vaccine 2 doses Inputs

The latest meningococcal dose was administered more than 1 year ago-111

The latest meningococcal dose was administered more than 1 year ago

IMMZ.D2.DT.Meningococcal.Monovalent MenC conjugate vaccine Inputs

The latest meningococcal dose was administered more than 2 months ago-106

The latest meningococcal dose was administered more than 2 months ago

IMMZ.D2.DT.Meningococcal.Monovalent MenC conjugate vaccine Inputs

The latest meningococcal dose was administered more than 3 months ago-106

The latest meningococcal dose was administered more than 3 months ago

IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Inputs

The latest meningococcal dose was administered more than 3 years ago-105

The latest meningococcal dose was administered more than 3 years ago

IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Inputs

The latest meningococcal dose was administered more than 8 weeks ago-105

The latest meningococcal dose was administered more than 8 weeks ago

IMMZ.D2.DT.Meningococcal.MenA conjugate vaccine 2 doses Inputs

The latest mumps dose was administered less than 4 weeks ago-108

The latest mumps dose was administered less than 4 weeks ago

IMMZ.D2.DT.Mumps Inputs

The latest mumps dose was administered more than 4 weeks ago-108

The latest mumps dose was administered more than 4 weeks ago

IMMZ.D2.DT.Mumps Inputs

The latest pneumococcal dose was administered after 12 months post birth-116

The latest pneumococcal dose was administered after 12 months post birth

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

The latest pneumococcal dose was administered less than 4 weeks ago-104

The latest pneumococcal dose was administered less than 4 weeks ago

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

The latest pneumococcal dose was administered less than 4 weeks ago-111

The latest pneumococcal dose was administered less than 4 weeks ago

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

The latest pneumococcal dose was administered less than 8 weeks ago-104

The latest pneumococcal dose was administered less than 8 weeks ago

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

The latest pneumococcal dose was administered less than 8 weeks ago-111

The latest pneumococcal dose was administered less than 8 weeks ago

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

The latest pneumococcal dose was administered more than 4 weeks ago-104

The latest pneumococcal dose was administered more than 4 weeks ago

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

The latest pneumococcal dose was administered more than 4 weeks ago-111

The latest pneumococcal dose was administered more than 4 weeks ago

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

The latest pneumococcal dose was administered more than 8 weeks ago-104

The latest pneumococcal dose was administered more than 8 weeks ago

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

The latest pneumococcal dose was administered more than 8 weeks ago-111

The latest pneumococcal dose was administered more than 8 weeks ago

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

The latest pneumococcal dose was administered within 12 months post birth-116

The latest pneumococcal dose was administered within 12 months post birth

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

The latest poliovirus dose was administered less than 4 weeks ago-120

The latest poliovirus dose was administered less than 4 weeks ago

IMMZ.D2.DT.Polio.IPV-only Inputs

The latest poliovirus dose was administered less than 6 months ago-121

The latest poliovirus dose was administered less than 6 months ago

IMMZ.D2.DT.Polio.IPV-only Inputs

The latest poliovirus dose was administered more than 4 weeks ago-120

The latest poliovirus dose was administered more than 4 weeks ago

IMMZ.D2.DT.Polio.IPV-only Inputs

The latest poliovirus dose was administered more than 6 months ago-121

The latest poliovirus dose was administered more than 6 months ago

IMMZ.D2.DT.Polio.IPV-only Inputs

The latest rabies dose was administered less than 7 days ago-97

The latest rabies dose was administered less than 7 days ago

IMMZ.D2.DT.Rabies Inputs

The latest rabies dose was administered more than 7 days ago-97

The latest rabies dose was administered more than 7 days ago

IMMZ.D2.DT.Rabies Inputs

The latest tetanus and diphtheria dose was administered less than 1 year ago-131

The latest tetanus and diphtheria dose was administered less than 1 year ago

IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Inputs

The latest tetanus and diphtheria dose was administered less than 4 weeks ago-132

The latest tetanus and diphtheria dose was administered less than 4 weeks ago

IMMZ.D2.DT.DTP.Pregnancy starting with 3 doses Inputs

The latest tetanus and diphtheria dose was administered more than 1 year ago-131

The latest tetanus and diphtheria dose was administered more than 1 year ago

IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Inputs

The latest tetanus and diphtheria dose was administered more than 4 weeks ago-132

The latest tetanus and diphtheria dose was administered more than 4 weeks ago

IMMZ.D2.DT.DTP.Pregnancy starting with 3 doses Inputs

The latest typhoid dose was administered less than 3 years ago-106

The latest typhoid dose was administered less than 3 years ago

IMMZ.D2.DT.Typhoid.Ty21a Inputs

The latest typhoid dose was administered more than 3 years ago-106

The latest typhoid dose was administered more than 3 years ago

IMMZ.D2.DT.Typhoid.Ty21a Inputs

The poliovirus dose administered is IPV-115

The poliovirus dose administered is IPV

IMMZ.D2.DT.Polio.bOPV plus IPV Inputs

The poliovirus dose administered is bOPV-115

The poliovirus dose administered is bOPV

IMMZ.D2.DT.Polio.bOPV plus IPV Inputs

The primary DTP series has been completed and client is currently pregnant-132

The primary DTP series has been completed and client is currently pregnant

IMMZ.D18.S.DTP.Pregnancy starting with 3 doses schedule Trigger

The primary DTP series has been completed and client's age is between 1 and 6 years-154

The primary DTP series has been completed and client's age is between 1 and 6 years

IMMZ.D18.S.DTP.On-time start schedule Trigger

The primary DTP series has been completed and client's age is between 1 year and 6 years-154

The primary DTP series has been completed and client's age is between 1 year and 6 years

IMMZ.D18.S.DTP.Delayed or interrupted schedule Trigger

The primary DTP series has been completed, first tetanus and diphtheria booster dose was administered and client is currently pregnant-276

The primary DTP series has been completed, first tetanus and diphtheria booster dose was administered and client is currently pregnant

IMMZ.D18.S.DTP.Pregnancy starting with 4 doses schedule Trigger

The primary DTP series has been completed-100

The primary DTP series has been completed

IMMZ.D18.S.DTP.Delayed or interrupted schedule Trigger

The primary series has been completed and client started the series when client's age was less than or equal to 11 months-236

The primary series has been completed and client started the series when client's age was less than or equal to 11 months

IMMZ.D18.S.Meningococcal.Monovalent MenC conjugate vaccine schedule Trigger

The primary series has been completed and one booster dose was administered to the client, who is more than 12 months of age. The latest pneumococcal dose was administered within 12 months post birth. Client is either HIV positive or had a preterm birth-453

IMMZ.D18.S.Pneumococcal.2 doses with booster dose schedule Trigger

The primary series has been completed-89

The primary series has been completed

IMMZ.D18.S.TBE.EnceVir schedule Trigger

The primary series has been completed-93

The primary series has been completed

IMMZ.D18.S.Cholera.WC vaccines schedule Completion

The primary series is complete-169

The primary series is complete

IMMZ.D2.DT.TBE.Encepur Output

The primary series is complete. Client is due for meningococcal booster dose-144

The primary series is complete. Client is due for meningococcal booster dose

IMMZ.D2.DT.Meningococcal.Monovalent MenC conjugate vaccine Output

The primary series is complete. Client is not due for TBE booster dose-138

The primary series is complete. Client is not due for TBE booster dose

IMMZ.D2.DT.TBE.Encepur Output

The primary series is complete. Client is not due for meningococcal booster dose.-148

The primary series is complete. Client is not due for meningococcal booster dose.

IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Output

The primary series is complete. Clinical judgement is required for meningococcal booster dose. Create a clinical note-166

The primary series is complete. Clinical judgement is required for meningococcal booster dose. Create a clinical note

IMMZ.D2.DT.Meningococcal.Polysaccharide vaccines Output

The series administered to the client contains the same product-169

The series administered to the client contains the same product

IMMZ.D2.DT.Rotavirus Inputs

The series administered to the client is a mixed series or a series with unknown vaccine products-169

The series administered to the client is a mixed series or a series with unknown vaccine products

IMMZ.D2.DT.Rotavirus Inputs

The series contain less than or equal to two doses-27

The series contain less than or equal to two doses

IMMZ.D2.DT.Rotavirus Inputs

The series contain more than two doses-27

The series contain more than two doses

IMMZ.D2.DT.Rotavirus Inputs

The three doses administered are bOPV-115

The three doses administered are bOPV

IMMZ.D2.DT.Polio.bOPV plus IPV Inputs

The two doses administered are IPV-115

The two doses administered are IPV

IMMZ.D2.DT.Polio.bOPV plus IPV Inputs

The two doses administered are bOPV-115

The two doses administered are bOPV

IMMZ.D2.DT.Polio.bOPV plus IPV Inputs

Third DTP dose from the primary series was administered. The primary DTP series has been completed-224

Third DTP dose from the primary series was administered. The primary DTP series has been completed

IMMZ.D18.S.DTP.Delayed or interrupted schedule Completion

Third HPV dose from the primary series was administered-112

Third HPV dose from the primary series was administered

IMMZ.D18.S.HPV.2-dose schedule Completion

Third HPV dose from the primary series was administered-74

Third HPV dose from the primary series was administered

IMMZ.D18.S.Single-dose schedule Completion

Third Hib dose from the primary series was administered. Child's age is less than 5 years-167

Third Hib dose from the primary series was administered. Child's age is less than 5 years

IMMZ.D18.S.Hib.3 doses with booster dose schedule Trigger

Third Hib dose from the primary series was administered. The primary series has been completed-100

Third Hib dose from the primary series was administered. The primary series has been completed

IMMZ.D18.S.Hib.3 doses with booster dose schedule Completion

Third IPV dose from the primary series was administered and the client's age was 6 weeks when the primary series was started-235

Third IPV dose from the primary series was administered and the client's age was 6 weeks when the primary series was started

IMMZ.D18.S.Polio.IPV-only schedule Trigger

Third IPV dose from the primary series was administered. The primary series has been completed-107

Third IPV dose from the primary series was administered. The primary series has been completed

IMMZ.D18.S.Polio.IPV-only schedule Completion

Third TBE dose from the primary series was administered. The primary series has been completed-89

Third TBE dose from the primary series was administered. The primary series has been completed

IMMZ.D18.S.TBE.EnceVir schedule Completion

Third bOPV dose from the primary series was administered. The primary series has been completed-107

Third bOPV dose from the primary series was administered. The primary series has been completed

IMMZ.D18.S.Polio.bOPV plus IPV schedule Completion

Third dengue dose from the primary series was administered. The primary series has been completed-93

Third dengue dose from the primary series was administered. The primary series has been completed

IMMZ.D18.S.Dengue schedule Completion

Third malaria dose from the primary series was administered-116

Third malaria dose from the primary series was administered

IMMZ.D18.S.Malaria schedule Trigger

Third pneumococcal dose from the primary series was administered to client, who is more than 12 months of age. The latest pneumococcal dose was administered within 12 months post birth. Client is either HIV positive or had preterm birth.-351

IMMZ.D18.S.Pneumococcal.3 doses schedule Trigger

Third pneumococcal dose from the primary series was administered. The primary series has been completed.-98

Third pneumococcal dose from the primary series was administered. The primary series has been completed.

IMMZ.D18.S.Pneumococcal.3 doses schedule Completion

Third rotavirus dose from the primary series was administered-118

Third rotavirus dose from the primary series was administered

IMMZ.D18.S.Rotavirus schedule Completion

Third tetanus and diphtheria booster dose was administered. Tetanus and diphtheria immunization schedule has been completed-260

Third tetanus and diphtheria booster dose was administered. Tetanus and diphtheria immunization schedule has been completed

IMMZ.D18.S.DTP.On-time start schedule Completion

Third tetanus and diphtheria-containing booster dose was administered. Tetanus and diphtheria immunization schedule has been completed-260

Third tetanus and diphtheria-containing booster dose was administered. Tetanus and diphtheria immunization schedule has been completed

IMMZ.D18.S.DTP.Pregnancy starting with 3 doses schedule Completion

Third tetanus and diphtheria-containing booster dose was administered. Tetanus and diphtheria immunization schedule has been completed.-260

Third tetanus and diphtheria-containing booster dose was administered. Tetanus and diphtheria immunization schedule has been completed.

IMMZ.D18.S.DTP.Pregnancy starting with 4 doses schedule Completion

Three DTP primary series doses were administered-123

Three DTP primary series doses were administered

IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs

Three DTP primary series doses were administered-124

Three DTP primary series doses were administered

IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Inputs

Three HPV primary series doses were administered-112

Three HPV primary series doses were administered

IMMZ.D2.DT.HPV.Single dose Inputs

Three Hib primary series doses were administered-122

Three Hib primary series doses were administered

IMMZ.D2.DT.Hib.3 doses with booster dose Inputs

Three TBE primary series doses were administered-112

Three TBE primary series doses were administered

IMMZ.D2.DT.TBE.EnceVir Inputs

Three dengue primary series doses were administered-115

Three dengue primary series doses were administered

IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs

Three doses from primary series were administered. The primary series has been completed-93

Three doses from primary series were administered. The primary series has been completed

IMMZ.D18.S.Cholera.WC-rBS vaccine 3-dose schedule Completion

Three malaria primary series doses were administered-116

Three malaria primary series doses were administered

IMMZ.D2.DT.Malaria Inputs

Three pneumococcal primary series doses were administered-121

Three pneumococcal primary series doses were administered

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

Three poliovirus primary series doses were administered-130

Three poliovirus primary series doses were administered

IMMZ.D2.DT.Polio.IPV-only Inputs

Three rotavirus primary series doses were administered-118

Three rotavirus primary series doses were administered

IMMZ.D2.DT.Rotavirus Inputs

Three tetanus and diphtheria booster doses were administered-140

Three tetanus and diphtheria booster doses were administered

IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Inputs

To be determined by Member States-0

To be determined by Member States

IMMZ.D18.S.Rabies schedule Trigger

Two DTP primary series doses were administered-123

Two DTP primary series doses were administered

IMMZ.D2.DT.DTP.On-time start Inputs

Two DTP primary series doses were administered-124

Two DTP primary series doses were administered

IMMZ.D2.DT.DTP.Delayed or interrupted series Inputs

Two HPV primary series doses were administered-112

Two HPV primary series doses were administered

IMMZ.D2.DT.HPV.Single dose Inputs

Two Hib primary series doses were administered-122

Two Hib primary series doses were administered

IMMZ.D2.DT.Hib.2 doses with booster dose Inputs

Two Hib primary series doses were administered-124

Two Hib primary series doses were administered

IMMZ.D2.DT.Hib.3 doses with booster dose Inputs

Two JE primary series doses were administered-111

Two JE primary series doses were administered

IMMZ.D2.DT.JE.Inactivated Vero cell-derived vaccine Inputs

Two TBE primary series doses were administered-112

Two TBE primary series doses were administered

IMMZ.D2.DT.TBE.EnceVir Inputs

Two cholera primary series doses were administered-116

Two cholera primary series doses were administered

IMMZ.D2.DT.Cholera.WC vaccines Inputs

Two dengue primary series doses were administered-115

Two dengue primary series doses were administered

IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening Inputs

Two hepatitis A primary series doses were administered-131

Two hepatitis A primary series doses were administered

IMMZ.D2.DT.Hepatitis A.Inactivated HAV 2 doses Inputs

Two malaria primary series doses were administered-116

Two malaria primary series doses were administered

IMMZ.D2.DT.Malaria Inputs

Two meningococcal primary series doses were administered-122

Two meningococcal primary series doses were administered

IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 doses Inputs

Two mumps primary series doses were administered-125

Two mumps primary series doses were administered

IMMZ.D2.DT.Mumps Inputs

Two pneumococcal booster doses were administered-119

Two pneumococcal booster doses were administered

IMMZ.D2.DT.Pneumococcal.2 doses with booster dose Inputs

Two pneumococcal primary series doses were administered-121

Two pneumococcal primary series doses were administered

IMMZ.D2.DT.Pneumococcal.3 doses Inputs

Two poliovirus primary series doses were administered-130

Two poliovirus primary series doses were administered

IMMZ.D2.DT.Polio.IPV-only Inputs

Two rabies primary series doses were administered-115

Two rabies primary series doses were administered

IMMZ.D2.DT.Rabies Inputs

Two rotavirus primary series doses were administered-118

Two rotavirus primary series doses were administered

IMMZ.D2.DT.Rotavirus Inputs

Two tetanus and diphtheria booster doses were administered-140

Two tetanus and diphtheria booster doses were administered

IMMZ.D2.DT.DTP.Pregnancy starting with 4 doses Inputs

Typhoid booster dose was administered less than 3 years ago-225

Typhoid booster dose was administered less than 3 years ago

IMMZ.D18.S.Typhoid.ViPS schedule Completion

Typhoid immunization schedule is complete-143

Typhoid immunization schedule is complete

IMMZ.D2.DT.Typhoid.TCV Output

Typhoid vaccination could be contraindicated. Clinical judgement is required. Create a clinical note.-66

Typhoid vaccination could be contraindicated. Clinical judgement is required. Create a clinical note.

IMMZ.D5.DT.Typhoid contraindications Output

Typhoid vaccination is contraindicated for Ty21a vaccine. Clinical judgement is required for Typbar-TCV or ViPS vaccine. Create a clinical note-224

Typhoid vaccination is contraindicated for Ty21a vaccine. Clinical judgement is required for Typbar-TCV or ViPS vaccine. Create a clinical note

IMMZ.D5.DT.Typhoid contraindications Output

Typhoid vaccination is contraindicated for Ty21a vaccine.-97

Typhoid vaccination is contraindicated for Ty21a vaccine.

IMMZ.D5.DT.Typhoid contraindications Output

Varicella vaccination could be contraindicated. Clinical judgement is required. Create clinical note-66

Varicella vaccination could be contraindicated. Clinical judgement is required. Create clinical note

IMMZ.D5.DT.Varicella contraindications Output

Varicella vaccination is contraindicated-56

Varicella vaccination is contraindicated

IMMZ.D5.DT.Varicella contraindications Output

Yellow fever immunization schedule is complete-148

Yellow fever immunization schedule is complete

IMMZ.D2.DT.Yellow fever Output

Yellow fever vaccination could be contraindicated. Clinical judgement is required. Create a clinical note-66

Yellow fever vaccination could be contraindicated. Clinical judgement is required. Create a clinical note

IMMZ.D5.DT.Yellow fever contraindications Output

Yellow fever vaccination is contraindicated-56

Yellow fever vaccination is contraindicated

IMMZ.D5.DT.Yellow fever contraindications Output

bOPV birth dose (a zero dose) was administered-146

bOPV birth dose (a zero dose) was administered

IMMZ.D2.DT.Polio.Birth dose Inputs

bOPV birth dose (a zero dose) was not administered-146

bOPV birth dose (a zero dose) was not administered

IMMZ.D2.DT.Polio.Birth dose Inputs